tegafur has been researched along with Cancer of Liver in 696 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized phase III trial compared hepatic arterial infusion (HAI) chemotherapy with 5-fluorouracil (5-FU) followed by uracil/tegafur (UFT) and leucovorin (LV) versus UFT/LV alone for patients with curatively resected liver metastases from colorectal cancer (CRC)." | 9.27 | A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundatio ( Aoyama, T; Asahara, T; Hirata, K; Kusano, M; Nakamori, S; Oba, K; Ohashi, Y; Okabayashi, K; Saji, S; Sakamoto, J; Tsuji, Y; Yoshikawa, T, 2018) |
| "Sorafenib is the sole molecular-targeted agent showing a survival benefit in patients with advanced hepatocellular carcinoma (HCC)." | 9.19 | A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. ( Arai, K; Chiba, T; Kanai, F; Kaneko, S; Ogasawara, S; Ooka, Y; Suzuki, E; Tawada, A; Yamashita, T; Yokosuka, O, 2014) |
| "Sorafenib is a multi-kinase inhibitor, which was approved as first-line treatment for patients with advanced hepatocellular carcinoma (HCC)." | 9.16 | Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. ( Kang, WK; Lee, J; Lee, SJ; Lim, HY; Park, JO; Park, SH; Park, YS; Yim, DS, 2012) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 9.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "To evaluate the efficacy and tolerability of systemic chemotherapy with irinotecan (CPT-11), UFT and leucovorin (LV) combined with hepatic arterial infusion (HAI) consisting of 5-fluorouracil (5-FU) in colorectal cancer patients with unresectable liver metastases." | 9.15 | Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases. ( Matsumoto, H; Mori, T; Takahashi, K; Yamaguchi, T; Yasutome, M, 2011) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "Sorafenib plus metronomic tegafur/uracil therapy can induce tumor stabilization in advanced hepatocellular carcinoma (HCC) patients." | 9.15 | Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. ( Chen, BB; Cheng, AL; Hsu, C; Hsu, CH; Hsu, CY; Hu, FC; Shen, YC; Shih, TT; Wei, SY; Yu, CW, 2011) |
| "Thirty-one patients with non-resectable, colorectal cancer (CRC) liver metastases received irinotecan 120 mg/m(2), followed by leucovorin (LV) 20 mg/m(2) and 5-fluorouracil (5-FU) 500 mg/m(2) administered by HAI every 2 weeks, plus UFT (tegafur-uracil) 200 mg/m(2)/day with LV 30 mg/day on days 1-22, followed by a 6-day rest." | 9.14 | Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer. ( Ariche, A; Baruch, NB; Brenner, B; Dinerman, M; Greif, F; Idelevich, E; Kashtan, H; Mavor, E; Miller, R; Shani, A; Susmalian, S, 2009) |
| "A 24-hour infusion of irinotecan combined with UFT/LV is feasible and active for metastatic colorectal cancer." | 9.14 | Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer. ( Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T; Tanaka, A, 2009) |
| "Sorafenib, a multi-kinase inhibitor with anti-angiogenic activity, was recently approved for the treatment of advanced hepatocellular carcinoma (HCC)." | 9.14 | Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. ( Chen, PJ; Cheng, AL; Ding, YH; Hsu, C; Hsu, CH; Lin, ZZ; Shao, YY; Shen, YC, 2010) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 9.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| "A prospective randomized trial was conducted to evaluate the efficacy of long-term oral administration of low-dose tegafur combined with uracil as an adjuvant chemotherapy, following transcatheter arterial embolization (TAE) in 40 patients with hepatocellular carcinoma (HCC)." | 9.08 | A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. ( Arase, Y; Chayama, K; Ikeda, K; Koida, I; Kumada, H; Saitoh, S; Tsubota, A, 1995) |
| "We report a case of multiple lung metastases from hepatocellular carcinoma(HCC)successfully treated by oral administration of tegafur/uracil(UFT)." | 8.89 | [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. ( Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S, 2013) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 7.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "No standard second-line chemotherapy has been yet established for gemcitabine-refractory biliary tract cancer (BTC)." | 7.88 | The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer. ( Furuse, J; Kasuga, A; Kawai, K; Kobayashi, T; Nagashima, F; Naruge, D; Okano, N; Yamauchi, Y, 2018) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 7.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "Sorafenib and conventional systemic cytotoxicity chemotherapy are currently being used in parallel for the patients with advanced hepatocellular carcinoma (HCC)." | 7.80 | Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma. ( Hu, X; Li, Q; Li, Y; Liang, R; Liao, S; Liao, X; Lin, Y; Liu, Z; Lv, Y; Yuan, C; Zhang, J, 2014) |
| "Sorafenib and S-1 (one mixed formulation containing 5-FU prodrug and dihydropyrimidine dehydrogenase inhibitor) were two effective agents against hepatocellular carcinoma (HCC), but whether they had synergistic effects remained unclear." | 7.79 | Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1. ( Cai, JP; Hao, XY; Hou, X; Lai, YR; Liang, LJ; Yin, XY; Zhai, JM; Zhang, LJ, 2013) |
| "Oral tegafur/uracil therapy has been indicated for patients with hepatocellular carcinoma (HCC) and is often used as a single-agent treatment." | 7.79 | Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma. ( Akizuki, S; Fushiya, N; Nishino, H; Ohnishi, A; Takagi, I, 2013) |
| "Multidrug resistant H22 (H22/FAP) hepatocellular carcinoma cells were produced in vitro by continuous exposure to increasing doses of doxorubicin, cisplatin and 5-fluorouracil (FAP regimen)." | 7.79 | Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma. ( Huang, FZ; Jiang, XZ; Liu, XY; Nie, WP; Wang, CF; Wang, YQ, 2013) |
| "The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer." | 7.79 | Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "A 65-year-old woman who had diffuse hepatocellular carcinoma(HCC)with tumor thrombus of right portalvein(Vp3) and lung metastases(Stage IVB)was treated by single-agent therapy with tegafur/uracil(UFT)." | 7.76 | [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil]. ( Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T, 2010) |
| "We report the successful treatment of multiple lung metastases after hepatic resection for hepatocellular carcinoma (HCC) with combined docetaxel, cisplatin (CDDP), and enteric-coated tegafur/uracil (UFT-E)." | 7.75 | Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. ( Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T, 2009) |
| "We herein report the complete remission of multiple recurrent hepatocellular carcinomas (HCCs) by the oral administration of tegafur/uracil (UFT) alone." | 7.75 | Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres ( Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S, 2009) |
| "We encountered a case of peritoneal dissemination of hepatocellular carcinoma, successfully treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil." | 7.74 | Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil. ( Iwasaki, Y; Miyake, Y; Sakaguchi, K; Shiraha, H; Shiratori, Y, 2007) |
| "We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1." | 7.74 | Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007) |
| "The 5 fluorouracil hepato-arterial infusion (5-FU HAI) therapy has a good effect on the liver metastases of colorectal cancer." | 7.72 | [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer]. ( Ebuchi, M; Hasegawa, K; Kato, K; Koide, A; Maruyama, M; Maruyama, S; Ohbu, M; Takashima, I, 2004) |
| "We report a case of advanced hepatocellular carcinoma (HCC) successfully controlled by the suppository administration of Tegafur alone." | 7.70 | [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur]. ( Arakawa, A; Kudo, K; Nishimura, R; Takagi, Y; Takahashi, M; Yamashita, Y, 1998) |
| "We report a case of complete remission of multiple hepatocellular carcinomas after oral administration of enteric-coated tegafur/uracil." | 7.70 | Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil. ( Asakura, H; Ebe, Y; Ichida, T; Ishikawa, T; Ishimoto, Y; Naito, M; Nomoto, M; Usuda, H; Yokoyama, J, 1999) |
| " He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week." | 7.70 | [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000) |
| "We report a case of advanced hepatocellular carcinoma (HCC), successfully treated by a combination therapy of alpha-interferon (IFN-alpha) and tegafur/uracil (UFT)." | 7.70 | Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. ( Dono, K; Eguchi, H; Gotoh, M; Kishimoto, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Umeshita, K, 2000) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 7.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| " In 22 resected patients with hepatocellular carcinoma (HCC), the concentrations of 5-fluorouracil (5-FU), tegafur and uracil were estimated in the serum, liver and cancer tissues after oral administration of UFT (tegafur, 300mg) before operation." | 7.67 | [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration]. ( Suenaga, M, 1987) |
| "A Phase II study of co-administration of uracil and tegafur (UFT) was performed in 32 patients with unresectable hepatocellular carcinoma." | 7.67 | Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group. ( , 1985) |
| "The pharmacokinetics of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT) and its conversion into 5-fluorouracil (FUra) in liver tissue were studied in ten patients with hepatocellular carcinoma (HCC)." | 7.67 | Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma. ( Imai, Y; Kawata, S; Minami, Y; Miyoshi, S; Noda, S; Saitoh, R; Tamura, S; Tarui, S, 1987) |
| "Recurrence of hepatocellular carcinoma (HCC) after surgery is frequent, and is an important factor adversely influencing the long-term survival of patients." | 6.82 | Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. ( Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K, 2016) |
| "8% and grade 3 or higher adverse events occurred in 12." | 6.79 | A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study. ( Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Miyagawa, S; Oba, M; Saiura, A; Takayama, T; Teruya, M; Yamamoto, J; Yoshimi, F, 2014) |
| " Because the replacement of 2-day-infusional 5-fluorouracil (5-FU) of FOLFIRI with oral tegafur-uracil/leucovorin (UFT/LV) would be highly beneficial for clinical management, we performed a phase I trial using oral UFT/LV and a pharmacokinetic evaluation." | 6.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| "From 2002 to 2007, a total of 10 consecutive patients with Stage IVA HCC accompanied by PVTT were studied prospectively to examine the efficacy of treatment by intra-arterial infusion of a chemotherapeutic agents consisting of etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil." | 6.73 | Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p ( Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T, 2007) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 6.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "Frequent recurrence of hepatocellular carcinoma (HCC) after surgery remains a major clinical problem." | 6.72 | Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. ( Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T, 2006) |
| "Twenty-one patients with advanced hepatocellular carcinoma were randomly divided into two groups." | 6.69 | [Effect of indomethacin on natural killer(NK) cell and T lymphocyte subsets from patients with hepatocellular carcinoma]. ( Chen, FY; Yuan, WJ; Zhang, GY, 2000) |
| "Patients with hepatocellular carcinoma (HCC) are highly compromised by failing liver function." | 6.68 | A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients. ( Haneda, T; Kamiyama, T; Nakanishi, K; Nishibe, M; Shimamura, T; Uchino, J; Une, Y, 1996) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 5.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| "This randomized phase III trial compared hepatic arterial infusion (HAI) chemotherapy with 5-fluorouracil (5-FU) followed by uracil/tegafur (UFT) and leucovorin (LV) versus UFT/LV alone for patients with curatively resected liver metastases from colorectal cancer (CRC)." | 5.27 | A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundatio ( Aoyama, T; Asahara, T; Hirata, K; Kusano, M; Nakamori, S; Oba, K; Ohashi, Y; Okabayashi, K; Saji, S; Sakamoto, J; Tsuji, Y; Yoshikawa, T, 2018) |
| "Pretreatment with tocopheryl nicotinate and indomethacin increased the K values in the control subjects, but was without effect on the K values in patients with primary hepatoma." | 5.26 | Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma. ( Hobara, N; Watanabe, A, 1979) |
| "Sorafenib is the sole molecular-targeted agent showing a survival benefit in patients with advanced hepatocellular carcinoma (HCC)." | 5.19 | A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. ( Arai, K; Chiba, T; Kanai, F; Kaneko, S; Ogasawara, S; Ooka, Y; Suzuki, E; Tawada, A; Yamashita, T; Yokosuka, O, 2014) |
| "Sorafenib is a multi-kinase inhibitor, which was approved as first-line treatment for patients with advanced hepatocellular carcinoma (HCC)." | 5.16 | Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. ( Kang, WK; Lee, J; Lee, SJ; Lim, HY; Park, JO; Park, SH; Park, YS; Yim, DS, 2012) |
| "We investigated the efficacy and safety of oral Uracil/tegafur (UFT) with leucovorin and mitomycin C (MMC) as third-line treatment for patients with extensively pretreated metastatic colorectal cancer (mCRC)." | 5.16 | Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study. ( Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D, 2012) |
| "To evaluate the efficacy and tolerability of systemic chemotherapy with irinotecan (CPT-11), UFT and leucovorin (LV) combined with hepatic arterial infusion (HAI) consisting of 5-fluorouracil (5-FU) in colorectal cancer patients with unresectable liver metastases." | 5.15 | Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases. ( Matsumoto, H; Mori, T; Takahashi, K; Yamaguchi, T; Yasutome, M, 2011) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "Sorafenib plus metronomic tegafur/uracil therapy can induce tumor stabilization in advanced hepatocellular carcinoma (HCC) patients." | 5.15 | Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. ( Chen, BB; Cheng, AL; Hsu, C; Hsu, CH; Hsu, CY; Hu, FC; Shen, YC; Shih, TT; Wei, SY; Yu, CW, 2011) |
| "Thirty-one patients with non-resectable, colorectal cancer (CRC) liver metastases received irinotecan 120 mg/m(2), followed by leucovorin (LV) 20 mg/m(2) and 5-fluorouracil (5-FU) 500 mg/m(2) administered by HAI every 2 weeks, plus UFT (tegafur-uracil) 200 mg/m(2)/day with LV 30 mg/day on days 1-22, followed by a 6-day rest." | 5.14 | Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer. ( Ariche, A; Baruch, NB; Brenner, B; Dinerman, M; Greif, F; Idelevich, E; Kashtan, H; Mavor, E; Miller, R; Shani, A; Susmalian, S, 2009) |
| "A 24-hour infusion of irinotecan combined with UFT/LV is feasible and active for metastatic colorectal cancer." | 5.14 | Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer. ( Ishikawa, K; Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T; Tanaka, A, 2009) |
| "Sorafenib, a multi-kinase inhibitor with anti-angiogenic activity, was recently approved for the treatment of advanced hepatocellular carcinoma (HCC)." | 5.14 | Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. ( Chen, PJ; Cheng, AL; Ding, YH; Hsu, C; Hsu, CH; Lin, ZZ; Shao, YY; Shen, YC, 2010) |
| "This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 5.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
| "Two studies were carried out to determine the activity and evaluate the toxicity of oral chemotherapy with uracil and tegafur in a 4:1 molar ratio (UFT) plus or minus calcium folinate in elderly patients with advanced colorectal cancer." | 5.09 | UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients. ( Abad, A; Antón, A; Aranda, E; Carrato, A; Cervantes, A; Díáz-Rubio, E; Fernández Martos, C; Gallén, M; Marcuello, E; Massuti, T; Navarro, M; Rifá, J; Sastre, J, 1999) |
| "A prospective randomized trial was conducted to evaluate the efficacy of long-term oral administration of low-dose tegafur combined with uracil as an adjuvant chemotherapy, following transcatheter arterial embolization (TAE) in 40 patients with hepatocellular carcinoma (HCC)." | 5.08 | A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. ( Arase, Y; Chayama, K; Ikeda, K; Koida, I; Kumada, H; Saitoh, S; Tsubota, A, 1995) |
| "Uracil (UFT) was administrated to 90 patients with advanced hepatocellular carcinoma for whom transcatheter arterial embolization was applied." | 5.07 | [Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas]. ( Kamata, T; Kojima, J; Monna, T, 1992) |
| "In a randomized trial, Tegafur (FT-207) or Tegafur-Uracil (UFT) was administrated to 76 patients with advanced hepatocellular carcinoma for whom transcatheter arterial embolization could not be applied." | 5.06 | [Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gall ( Kamata, T; Kojima, J; Monna, T, 1990) |
| "We report a case of multiple lung metastases from hepatocellular carcinoma(HCC)successfully treated by oral administration of tegafur/uracil(UFT)." | 4.89 | [Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil]. ( Hatano, E; Koyama, Y; Takada, Y; Tanabe, K; Taura, K; Uemoto, S, 2013) |
| "5-fluorouracil (5-FU) plus leucovorin (LV) therapy is the most widely used regimen with a high evidence as the first-line treatment for advanced colorectal cancer (CRC), as well as CPT-11 as the second-line." | 4.82 | [Chemotherapy for colorectal carcinoma]. ( Enomoto, M; Higuchi, T; Sugihara, K; Uetake, H, 2003) |
| "Combination therapy of tegafur/uracil (UFT) and leucovorin (LV) is widely used to treat colorectal cancers." | 4.02 | Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy. ( Endo, Y; Hirashita, T; Inomata, M; Itoh, H; Iwao, M; Iwashita, Y; Masuda, T; Shiraiwa, K; Suzuki, Y; Tada, K; Tanaka, R; Uchida, H, 2021) |
| "The purpose of this study was to analyze the safety and feasibility of low-dose apatinib combined with S-1 as a second-line therapy or beyond in Chinese patients with pulmonary and/or hepatic metastases of nasopharyngeal carcinoma (NPC)." | 3.96 | Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma. ( Chen, J; Huang, X; Lin, J; Wu, G; Zhang, S; Zhou, L, 2020) |
| "No standard second-line chemotherapy has been yet established for gemcitabine-refractory biliary tract cancer (BTC)." | 3.88 | The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer. ( Furuse, J; Kasuga, A; Kawai, K; Kobayashi, T; Nagashima, F; Naruge, D; Okano, N; Yamauchi, Y, 2018) |
| "S-1, an oral 5-fluorouracil (5-FU)-based medicine that combines tegafur, gimeracil and oteracil potassium is commonly used as an adjuvant chemotherapeutic drug for the treatment of colorectal cancer." | 3.83 | Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy. ( Kokuryo, T; Nagino, M; Uehara, K; Yamaguchi, J; Yamauchi, K; Yokoyama, Y, 2016) |
| "We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 3.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
| "Sorafenib and conventional systemic cytotoxicity chemotherapy are currently being used in parallel for the patients with advanced hepatocellular carcinoma (HCC)." | 3.80 | Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma. ( Hu, X; Li, Q; Li, Y; Liang, R; Liao, S; Liao, X; Lin, Y; Liu, Z; Lv, Y; Yuan, C; Zhang, J, 2014) |
| "Sorafenib and S-1 (one mixed formulation containing 5-FU prodrug and dihydropyrimidine dehydrogenase inhibitor) were two effective agents against hepatocellular carcinoma (HCC), but whether they had synergistic effects remained unclear." | 3.79 | Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1. ( Cai, JP; Hao, XY; Hou, X; Lai, YR; Liang, LJ; Yin, XY; Zhai, JM; Zhang, LJ, 2013) |
| "Oral tegafur/uracil therapy has been indicated for patients with hepatocellular carcinoma (HCC) and is often used as a single-agent treatment." | 3.79 | Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma. ( Akizuki, S; Fushiya, N; Nishino, H; Ohnishi, A; Takagi, I, 2013) |
| "Multidrug resistant H22 (H22/FAP) hepatocellular carcinoma cells were produced in vitro by continuous exposure to increasing doses of doxorubicin, cisplatin and 5-fluorouracil (FAP regimen)." | 3.79 | Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma. ( Huang, FZ; Jiang, XZ; Liu, XY; Nie, WP; Wang, CF; Wang, YQ, 2013) |
| "The aim of this study was to determine the feasibility of S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (XELOX) as first-line therapy for patients with initially unresectable metastases from colorectal cancer." | 3.79 | Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "A 65-year-old woman who had diffuse hepatocellular carcinoma(HCC)with tumor thrombus of right portalvein(Vp3) and lung metastases(Stage IVB)was treated by single-agent therapy with tegafur/uracil(UFT)." | 3.76 | [A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil]. ( Adachi, K; Hiramatsu, S; Kurai, O; Miyano, M; Oka, H; Sasaki, E; Yamasaki, T, 2010) |
| "We report the successful treatment of multiple lung metastases after hepatic resection for hepatocellular carcinoma (HCC) with combined docetaxel, cisplatin (CDDP), and enteric-coated tegafur/uracil (UFT-E)." | 3.75 | Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. ( Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T, 2009) |
| "We herein report the complete remission of multiple recurrent hepatocellular carcinomas (HCCs) by the oral administration of tegafur/uracil (UFT) alone." | 3.75 | Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres ( Asakawa, M; Fujii, H; Kono, H; Matsuda, M; Shiba, S, 2009) |
| "The subjects consisted of 23 patients with pancreatic adenocarcinoma who had liver metastases and were treated with S-1 and gemcitabine as the first-line treatment." | 3.74 | Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis. ( Ishihara, T; Kobayashi, A; Matsuyama, M; Tawada, K; Tsuyuguchi, T; Yamaguchi, T; Yokosuka, O, 2008) |
| "We encountered a case of peritoneal dissemination of hepatocellular carcinoma, successfully treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil." | 3.74 | Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil. ( Iwasaki, Y; Miyake, Y; Sakaguchi, K; Shiraha, H; Shiratori, Y, 2007) |
| "High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
| "We report a patient with type 3 gastric cancer with peritoneal dissemination and hydronephrosis who was successfully treated with intraperitoneal infusion of paclitaxel and oral administration of S-1." | 3.74 | Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Takatsuka, Y; Takiuchi, D; Tamura, S; Tomita, N, 2007) |
| "We had 2 patients with marked shrinkage of liver metastasis by administration of the oral fluorinated pyrimidine anticancer drug S-1 for advanced/recurrent breast cancer that was resistant to taxane and another antitumor drugs." | 3.73 | [Two patients effectively treated with S-1 therapy for liver metastasis of breast cancer resistant to other anticancer drugs]. ( Sato, Y, 2006) |
| "The 5 fluorouracil hepato-arterial infusion (5-FU HAI) therapy has a good effect on the liver metastases of colorectal cancer." | 3.72 | [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer]. ( Ebuchi, M; Hasegawa, K; Kato, K; Koide, A; Maruyama, M; Maruyama, S; Ohbu, M; Takashima, I, 2004) |
| "We report a patient with hepatocellular carcinoma (HCC) with intraperitoneal lymph node metastases in whom UFT (uracil + tegafur) was markedly effective." | 3.71 | [A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective]. ( Baba, Y; Imamura, Y; Kubozono, O; Maenohara, S; Moriya, H; Ogura, Y; Tahara, K, 2002) |
| "We report a case of advanced hepatocellular carcinoma (HCC) successfully controlled by the suppository administration of Tegafur alone." | 3.70 | [A case of advanced hepatocellular carcinoma responding to suppository of Tegafur]. ( Arakawa, A; Kudo, K; Nishimura, R; Takagi, Y; Takahashi, M; Yamashita, Y, 1998) |
| "We report a case of complete remission of multiple hepatocellular carcinomas after oral administration of enteric-coated tegafur/uracil." | 3.70 | Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil. ( Asakura, H; Ebe, Y; Ichida, T; Ishikawa, T; Ishimoto, Y; Naito, M; Nomoto, M; Usuda, H; Yokoyama, J, 1999) |
| " He had nausea, vomiting and anorexia due to pyloric stenosis, and was treated with 600 mg of UFT E granules/day orally for 5 consecutive days followed by 2 drug-free days (weekly-5 method), and 2 mg of lentinan intravenously twice a week." | 3.70 | [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. ( Kondo, M; Takahashi, S; Takemura, T; Yoshikawa, T, 2000) |
| "We report a case of advanced hepatocellular carcinoma (HCC), successfully treated by a combination therapy of alpha-interferon (IFN-alpha) and tegafur/uracil (UFT)." | 3.70 | Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil. ( Dono, K; Eguchi, H; Gotoh, M; Kishimoto, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Umeshita, K, 2000) |
| "UFT was administered preoperatively in 20 cases of primary hepatocellular carcinoma, and tegafur, 5-fluorouracil (5-FU), uracil, total thymidylate synthase (TS) and free TS in blood and liver tissue were determined." | 3.67 | [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis]. ( Ito, Y; Matsuoka, S; Misawa, K; Nagafuchi, E; Nakajima, Y; Ogasawara, K; Sato, N; Uchino, J; Une, Y, 1989) |
| "A 46-year-old male (performance status 1) with hepatocellular carcinoma (HCC), which diffusely involved the anterior segment of the right lobe, occluded the second portal branch and metastased to the left lobe (stage IV-A), was on combined therapy with TAE of lipiodol (LPD), mitomycin C (MMC) 10 mg and gelatin sponge at the time of angiography on March 16, 1987." | 3.67 | [Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report]. ( Inagaki, Y; Miyairi, M; Miyamoto, K, 1989) |
| " In 22 resected patients with hepatocellular carcinoma (HCC), the concentrations of 5-fluorouracil (5-FU), tegafur and uracil were estimated in the serum, liver and cancer tissues after oral administration of UFT (tegafur, 300mg) before operation." | 3.67 | [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration]. ( Suenaga, M, 1987) |
| "A Phase II study of co-administration of uracil and tegafur (UFT) was performed in 32 patients with unresectable hepatocellular carcinoma." | 3.67 | Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group. ( , 1985) |
| "The pharmacokinetics of 1-(tetrahydro-2-furanyl)-5-fluorouracil (FT) and its conversion into 5-fluorouracil (FUra) in liver tissue were studied in ten patients with hepatocellular carcinoma (HCC)." | 3.67 | Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma. ( Imai, Y; Kawata, S; Minami, Y; Miyoshi, S; Noda, S; Saitoh, R; Tamura, S; Tarui, S, 1987) |
| "Tegafur fine granule preparation orally administered to the patients with primary hepatoma and liver cirrhosis, and the concentration of tegafur and 5-fluorouracil in the blood were determined." | 3.66 | [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer]. ( Hattori, M; Horiike, N; Kanaoka, M; Ohta, Y; Onji, M; Yamashita, Y; Yoshida, T, 1982) |
| "Gemcitabine was administered at a dose of 1000 mg/m2 by 30 min infusion on days 1, S-1 40 mg/m2 orally twice daily and LV 25 mg orally twice daily on days 1 to 7 every 2 weeks." | 2.90 | A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer. ( Hakuta, R; Hamada, T; Ijichi, H; Isayama, H; Ishigaki, K; Kishikawa, T; Kogure, H; Koike, K; Matsubara, S; Mizuno, S; Nakai, Y; Saito, K; Saito, T; Sasaki, T; Tada, M; Takahara, N; Takeda, T; Tateishi, K; Uchino, R; Yamamoto, N, 2019) |
| "Recent gastric cancer clinical trials have aimed to establish the efficacy of combination therapy over monotherapy, however, the role for genomic biomarkers in these trials has remained largely unexplored." | 2.87 | Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial. ( Das, K; Imamura, H; Nishikawa, K; Sugimoto, N; Taguri, M; Tan, P; Tsuburaya, A; Yoshida, K, 2018) |
| " Thus, our study aimed to examine the efficacy and safety of Endostar continuous intravenous infusion combined with S-1 and oxaliplatin (SOX) chemotherapy in treating such patients." | 2.87 | Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer. ( Guo, X; Li, Y; Sui, Y; Tan, X; Wang, M; Yang, H, 2018) |
| "Unresectable advanced hepatocellular carcinoma is a heterogeneous disease, for which sorafenib is the first targeted agent approved for first-line therapy, and treatment options for patients with sorafenib-refractory advanced hepatocellular carcinoma are limited." | 2.84 | S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. ( Date, Y; Fang, X; Furuse, J; Hidaka, H; Ikeda, M; Kaneko, S; Kawazoe, S; Kudo, M; Moriguchi, M; Numata, K; Ohkawa, S; Okusaka, T; Sato, Y; Takeuchi, M; Tanaka, H, 2017) |
| "Recurrence of hepatocellular carcinoma (HCC) after surgery is frequent, and is an important factor adversely influencing the long-term survival of patients." | 2.82 | Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial. ( Ishizuka, M; Iso, Y; Kato, M; Kubota, K; Nemoto, T; Shimoda, M; Tago, K, 2016) |
| " Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5." | 2.82 | Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016) |
| "Patients with clinical stage II or III rectal cancer were treated with radiotherapy of 44 Gy in 22 fractions." | 2.79 | Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study. ( Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW, 2014) |
| "8% and grade 3 or higher adverse events occurred in 12." | 2.79 | A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study. ( Hasegawa, K; Ijichi, M; Kawasaki, S; Kokudo, N; Koyama, H; Makuuchi, M; Miyagawa, S; Oba, M; Saiura, A; Takayama, T; Teruya, M; Yamamoto, J; Yoshimi, F, 2014) |
| " We determined the recommended dosage for CDDP-TAI plus S-1 combination therapy for advanced HCC." | 2.79 | Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial. ( Hosoi, H; Ikeda, M; Kondo, S; Mitsunaga, S; Morizane, C; Okusaka, T; Shimizu, S; Terazawa, T; Ueno, H, 2014) |
| " The common adverse drug reactions were a decrease in hemoglobin levels, hypoalbuminemia, and anorexia, which were mild in severity (grades 1-2)." | 2.79 | Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma. ( Arioka, H; Asaoka, Y; Ikeda, M; Koike, K; Kojima, Y; Kondo, S; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Sakamoto, Y; Shiina, S; Shimizu, S; Tateishi, R; Ueno, H, 2014) |
| "S-1 in patients with advanced gastric cancer (AGC)." | 2.78 | Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer. ( Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY, 2013) |
| "Paclitaxel (160 mg/m²) was administered by infusion for 3 h on the first day." | 2.76 | A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. ( Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T, 2011) |
| "Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled." | 2.75 | Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010) |
| " Because the replacement of 2-day-infusional 5-fluorouracil (5-FU) of FOLFIRI with oral tegafur-uracil/leucovorin (UFT/LV) would be highly beneficial for clinical management, we performed a phase I trial using oral UFT/LV and a pharmacokinetic evaluation." | 2.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| "From 2002 to 2007, a total of 10 consecutive patients with Stage IVA HCC accompanied by PVTT were studied prospectively to examine the efficacy of treatment by intra-arterial infusion of a chemotherapeutic agents consisting of etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil." | 2.73 | Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p ( Imai, M; Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T, 2007) |
| "We report a patient with gallbladder cancer and multiple liver and lymph node metastases which completely responded to S-1, an oral fluoropyrimidine anticancer drug." | 2.73 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. ( Furuse, J; Ishii, H; Nakachi, K; Shimizu, S; Suzuki, E; Yoshino, M, 2007) |
| "Standard chemotherapy for advanced biliary tract cancer has not been established." | 2.72 | Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. ( Funakoshi, A; Furuse, J; Horikawa, Y; Ikeda, M; Ishii, H; Mizuno, N; Morizane, C; Nagase, M; Nakachi, K; Okusaka, T; Ueno, H; Yamao, K, 2006) |
| "Frequent recurrence of hepatocellular carcinoma (HCC) after surgery remains a major clinical problem." | 2.72 | Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. ( Hasegawa, K; Ijichi, M; Imamura, H; Kokudo, N; Makuuchi, M; Matsuyama, Y; Sano, K; Sugawara, Y; Takayama, T, 2006) |
| "We treated 12 patients with advanced gastric cancer with 80 mg/m2 of S-1 for 21 days and 60 mg/m2 of cisplatin (CDDP) on day 8 every 5 weeks." | 2.71 | Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. ( Baba, H; Endo, K; Ikeda, Y; Kohnoe, S; Okamura, T; Toh, Y; Yamamoto, M, 2003) |
| ") gemcitabine (GEM) at low dose plus oral chemotherapy with uracil-tegafur (UFT) and cyclophosphamide (CPA) in combination with radiotherapy (RT) against recurrent and advanced pancreatic cancers." | 2.71 | Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer. ( Endo, S; Hashimoto, K; Higami, T; Itakura, M; Koike, M; Maruyama, R; Nio, Y; Tsuji, M; Yamaguchi, K; Yano, S, 2005) |
| "Uracil-tegafur (UFT) has been reported to have a broad anti-tumor activity in a variety of malignancies including colorectal cancer and breast cancer." | 2.70 | Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer. ( Ikeda, M; Kuriyama, H; Okada, S; Okusaka, T; Ueno, H, 2002) |
| "Twenty-one patients with advanced hepatocellular carcinoma were randomly divided into two groups." | 2.69 | [Effect of indomethacin on natural killer(NK) cell and T lymphocyte subsets from patients with hepatocellular carcinoma]. ( Chen, FY; Yuan, WJ; Zhang, GY, 2000) |
| "Twenty-two colorectal cancer patients (infusion group) in Dukes' C stage were given hepatic arterial infusion of 5-FU (500 mg/body for 1 hr per week, repeated 50 times) and peroral UFT-E (2." | 2.69 | [Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer]. ( Fujioka, M; Idezuki, Y; Inokuma, S; Ishida, H; Kamano, T; Kishi, T; Kondo, K; Matsumoto, Y; Miura, T; Murata, N; Nakada, H; Odaka, A; Shimomura, K; Suzuki, T; Takeuchi, I; Yamada, H, 1999) |
| "Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT." | 2.69 | Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases. ( Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R, 2000) |
| "For the local recurrence of rectal cancer, it was observed in Dukes C and cases of relative curative resection." | 2.68 | [Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan]. ( Kikuchi, K; Kunii, Y, 1995) |
| "Patients with hepatocellular carcinoma (HCC) are highly compromised by failing liver function." | 2.68 | A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients. ( Haneda, T; Kamiyama, T; Nakanishi, K; Nishibe, M; Shimamura, T; Uchino, J; Une, Y, 1996) |
| "UFT (tegafur and uracil) has been studied extensively in Japan, with documented efficacy in hepatobiliary and pancreatic cancer." | 2.68 | UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas. ( Mani, S, 1997) |
| "Thirty-four patients with advanced gastric cancer were treated with combination chemotherapy employing Tegafur-Uracil (UFT), etoposide, Adriamycin, and Cisplatinum (CDDP) (UFT-EAP therapy)." | 2.67 | Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer. ( Chin, K; Hattori, T; Hayakawa, M; Maeda, H; Morise, K; Morooka, Y; Saito, H; Sugihara, M, 1994) |
| "Patients (1,256 with colon cancer, 1,221 with rectal cancer) were divided into the treatment group (group A) and the control group (surgical resection only, group B)." | 2.66 | [Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan]. ( Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Kodaira, S; Komi, N; Kondo, T; Ogawa, N; Taguchi, T; Uchino, J, 1989) |
| " The optimal dosage was considered to be between 17 mg/kg and 24 mg/kg." | 2.65 | [Joint clinical Phase II study of SF-SP]. ( Hanatani, Y; Sato, H; Sato, T, 1984) |
| "However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
| "Apatinib is a novel and highly selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor-2." | 2.55 | Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review. ( Kong, L; Kou, P; Shao, W; Wang, H; Yu, J; Zhang, J; Zhang, Y; Zhu, H, 2017) |
| "G-CSF-producing gastric cancer is rare; thus, we take this opportunity to report our case and to summarize the G-CSF-producing gastric cancer cases reported in Japan." | 2.50 | [Case report of chemotherapeutic control of a gastric cancer producing granulocyte-colony stimulating factor]. ( Misawa, S; Miyamoto, M, 2014) |
| "We describe a patient who had gastric cancer with liver metastases." | 2.50 | Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases. ( Bu, ZD; Ji, JF; Ji, X; Li, SX; Li, ZY; Shan, F; Wu, AW; Wu, XJ; Zhang, LH; Zong, XL, 2014) |
| "A 67-year-old man with bladder cancer who was treated with transurethral resection of bladder tumour(TUR-Bt)and chemotherapy at the age of 59 years was diagnosed as having urothelial cancer by biopsy 8 years later." | 2.49 | [A case of quadruple cancer of the liver, stomach, bladder, and ureter]. ( Fukuoka, M; Nishizawa, Y; Omura, N; Tachibana, S; Tatara, T; Tatsumi, Y; Yoshida, T; Yoshimura, H, 2013) |
| "The prognosis for hepatocellular carcinoma with extrahepatic metastasis or vascular invasion is very poor." | 2.47 | [A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases]. ( Kakisaka, T; Kamachi, H; Kamiyama, T; Matsushita, M; Mizukami, T; Nakanishi, K; Tahara, M; Taniguchi, M; Todo, S; Yokoo, H, 2011) |
| "We encountered a case of gastric cancer accompanied with liver metastasis, which had a good response to chemotherapy of S-1." | 2.47 | [A case of long-term survival after undergoing S-1 based multidisciplinary therapy for liver metastasis of gastric cancer]. ( Amano, R; Hirakawa, K; Ito, G; Kimura, K; Kubo, N; Maeda, K; Muguruma, K; Nagahara, H; Nakata, B; Noda, E; Ohira, M; Sakurai, K; Sawada, T; Tanaka, H; Yamada, N; Yashiro, M, 2011) |
| "Without any sign of infection, leukocytosis developed around the 30th POD." | 2.46 | Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor. ( Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T, 2010) |
| "Metastatic colorectal cancer has a poor prognosis, and the majority of patients are left with palliative measures." | 2.42 | Palliative treatment of patients with colorectal cancer. ( Glimelius, B, 2003) |
| "The preoperative diagnosis was giant hepatocellular carcinoma (HCC) of the right hepatic anterior region, and extended anterior segmentectomy of the liver was performed." | 2.42 | [Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection]. ( Hanazaki, K; Kawasaki, S; Kobayashi, A; Matsushita, A; Misawa, R; Miwa, S; Miyagawa, S; Nakagawa, K; Nakata, T; Noike, T; Nomura, K, 2003) |
| "Fluorouracil has been used for a long time, remission rates reported range from 0% to 80%." | 2.36 | [Chemotherapy of gastrointestinal tumors (review of the literature)]. ( Mayr, AC, 1978) |
| "Sorafenib treatment was discontinued." | 1.72 | A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases. ( Akutsu, N; Hirano, T; Ishigami, K; Kawakami, Y; Nakase, H; Numata, Y; Sasaki, S; Wagatsuma, K, 2022) |
| "She died of a sigmoid cancer 32 months after UFT/LV initiation." | 1.51 | [A Case Report of a Patient Over 90 Years of Age with Liver Metastasis after Sigmoid Colectomy Controlled by a Combination Oral UFT/LV Chemotherapy Regimen]. ( Hosono, M; Ienaga, T; Iwabuchi, S; Kawasaki, K; Okazaki, T; Owada, Y; Tanaka, S, 2019) |
| "A-67-year old man was diagnosed with gastric cancer and a liver tumor." | 1.51 | [A Case of Gastric Endocrine Carcinoma with a Huge Liver Metastasis]. ( Kawaoka, T; Kubo, H; Miyahara, M; Nabeya, M; Nishida, Y; Saeki, S; Sasaki, S; Tamesa, T; Tokunou, K; Yamamoto, S; Yamashita, Y, 2019) |
| "We report a case of recurrent gastric cancer that was successfully treated by S-1 chemotherapy." | 1.51 | [A Case of Recurrent Gastric Cancer Successfully Treated by S-1 Chemotherapy]. ( Hata, M; Hoshino, H; Imamoto, H; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Ogino, T; Okano, M; Okuyama, M; Tanizaki, K; Tsujinaka, T, 2019) |
| "In our case, we report a gallbladder cancer with portal vein thrombus." | 1.48 | Gallbladder cancer with tumor thrombus in the portal vein: A case report. ( Bai, XL; Chen, W; Liang, TB; Ma, T; Tu, JJ; Zhang, XZ, 2018) |
| "This study suggests that platelets in gastric cancer stroma may create a favorable microenvironment for chemoresistance." | 1.46 | Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study. ( Fushida, S; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohta, T; Oyama, K; Saito, H; Tajima, H; Tsukada, T; Yamaguchi, T, 2017) |
| "A 77-year-old man was diagnosed with gastric cancer with synchronous single liver metastasis and portal vein thrombus." | 1.46 | [A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment]. ( Adachi, Y; Mizukami, Y; Nomura, H; Okamura, M; Ota, S; Sumii, A; Tsuboi, K, 2017) |
| "Tegafur-uracil has been reported to have only minor adverse effects and is associated with liver injury in 1." | 1.46 | Tegafur-uracil-induced rapid development of advanced hepatic fibrosis. ( Fujiya, M; Hasebe, T; Honda, S; Nakajima, S; Okumura, T; Sawada, K, 2017) |
| "Although the prognosis of gastric cancer with synchronous liver metastases is very poor, it is possible for survival to be prolonged with multimodality therapy." | 1.46 | [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)]. ( Ebisui, C; Fukuchi, N; Hamano, R; Kinuta, M; Kitahara, T; Minoji, T; Murata, K; Ohishi, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2017) |
| "For patients with liver metastases from gastric cancer (LMGC), combination chemotherapy with fluoropyrimidines and platinum agents has been recognized as standard treatment." | 1.43 | Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin. ( Ohi, H; Ozaki, T; Seki, H; Yabusaki, H, 2016) |
| "The prognosis of Stage IV b pancreatic cancer is extremely poor; the mean survival time is 2-4 months." | 1.42 | [A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy]. ( Fujino, Y; Goto, H; Hasegawa, H; Kakinoki, K; Katsura, M; Ohara, T; Oshikiri, T; Oyama, M; Sendo, H; Sugimoto, T; Sugiyama, H; Tominaga, M; Ueda, Y; Yamashita, H; Yasuda, T, 2015) |
| "Recent advances in gastric cancer chemotherapy have made macroscopic complete resection possible in some patients with stage IV disease." | 1.42 | Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer. ( Fushida, S; Kinoshita, J; Makino, I; Miyashita, T; Nakamura, K; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Tajima, H; Takamura, H; Tsukada, T, 2015) |
| " The CT-guided percutaneous radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) procedure was performed on the liver metastasis using degradable starch microspheres (DSM)." | 1.42 | [Liver Metastasis in a Gastric Cancer Patient--A Case of Successful Radiofrequency Ablation Combined with Degradable Starch Microspheres Transcatheter Arterial Chemoembolization]. ( Dono, K; Hatano, H; Hirabuki, N; Hirota, M; Imamura, H; Nakata, S; Noda, T; Oh, RJ; Ohara, N; Ohira, R; Yakushiji, H; Yasumoto, T, 2015) |
| "We encountered a case of pancreatic cancer with multiple liver metastases that developed postoperatively and showed a complete response with S-1 monotherapy for a long time." | 1.42 | [A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy]. ( Asai, K; Baba, M; Hiratsuka, M; Katsuyama, S; Murata, M; Saso, K; Sawami, H; Takahashi, H; Takayama, O; Tanaka, N; Yagi, T; Yamada, M; Yamamoto, M, 2015) |
| "A 62-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy, and D1+b lymph node dissection." | 1.42 | [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)]. ( Hosoda, Y; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T; Yamasaki, M; Yasui, M, 2015) |
| "Therefore, a diagnosis of gastrointestinal stromal tumor (GIST) was made." | 1.42 | [A Case of Intraductal Growth Pattern Gastrointestinal Stromal Tumor of the Stomach That Was Difficult to Diagnose by Biopsy]. ( Hasegawa, J; Hirota, M; Ikenaga, M; Kameda, C; Kawabata, R; Koga, C; Miwa, H; Murakami, M; Noura, S; Ozato, Y; Shimizu, J; Yoshikawa, M, 2015) |
| "The patient was diagnosed with gastric cancer with liver metastasis, Stage Ⅳ, and treated with chemotherapy (S-1 plus CDDP)." | 1.42 | [A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis]. ( Ishigami, E; Kawamoto, J; Miyazaki, M; Nakada, S; Shinoda, K; Teranaka, R; Yoichi, T, 2015) |
| "He was diagnosed with advanced gastric cancer with multiple liver metastases." | 1.42 | [Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases]. ( Ako, E; Hirakawa, T; Kametani, N; Kanehara, I; Kato, Y; Komoto, M; Nakazawa, K; Nishimura, S; Taenaka, N; Tanaka, R; Yamada, N; Yamagata, S, 2015) |
| "Abdominal computed tomography showed gastric cancer invasion to the left liver lobe." | 1.42 | [A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy]. ( Kawamoto, S; Maeno, H; Munechika, T; Nagao, S; Nomi, M; Okamoto, T; Sasaguri, T; Sueishi, K; Tanaka, K; Yonemitsu, K, 2015) |
| "The patient had no recurrence for 1 year after the last surgery." | 1.42 | [A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer]. ( Arai, S; Kataoka, M; Miyazawa, K; Oeda, Y; Shiobara, M; Suda, K; Takagi, T; Wakatsuki, K; Yoshioka, S, 2015) |
| "The prognosis of pancreatic cancer is dismal compared to other types of cancer, and for a Stage Ⅳb cancers, the 5-year survival rate is reported to be approximately 3%." | 1.42 | [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
| "A 58-year-old woman with advanced gastric cancer underwent total gastrectomy in May 2012." | 1.42 | Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer. ( Inagaki, M; Iwagaki, H; Nonoshita, T; Otsuka, S, 2015) |
| "Unresectable metastatic colorectal cancer with very slow tumour growth rate does not necessarily require for strong short-interval chemotherapy." | 1.40 | Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer. ( Akiba, T; Enomoto, H; Kawahara, H; Tomoda, M; Watanabe, K; Yanaga, K, 2014) |
| "He was diagnosed with sigmoid cancer with multiple liver and lung metastases." | 1.40 | [A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs]. ( Hasegawa, Y; Hatanaka, M; Iwata, H, 2014) |
| "She was diagnosed with advanced lower rectal cancer with multiple liver and pulmonary metastases." | 1.40 | [Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer]. ( Goto, T; Sasaki, K; Shimao, K; Yano, M, 2014) |
| " The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
| "We present a case of recurrent gastric cancer in which stable disease status was achieved for four months due to treatment with capecitabine/cisplatin (CDDP)after the failure of multiple anticancer drugs including S-1/CDDP." | 1.40 | [A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP]. ( Sakamoto, K; Sakashita, K; Sawada, R; Sunami, T; Tauchi, J; Yukimoto, K, 2014) |
| "Widespread type 3 gastric cancer was detected in the lesser curvature." | 1.40 | [A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years]. ( Imaida, K; Kagawa, I; Kishi, S; Matsumoto, Y; Mitan, M; Miyamoto, M; Nishiwaki, K; Saoo, K; Tsuda, H; Yokohira, M, 2014) |
| "We report two cases of pancreatic cancer with multiple liver metastases for which successful gemcitabine (GEM) +S-1 therapy facilitated radical resection." | 1.40 | [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy]. ( Aizawa, M; Nashimoto, A; Nomura, T; Sato, Y; Tsuchiya, Y, 2014) |
| "Gemcitabine plus S-1 was again administered as postoperative adjuvant chemotherapy." | 1.40 | Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. ( Ide, T; Ide, Y; Kai, K; Kitahara, K; Koga, H; Miyoshi, A; Nakamura, H; Nakamura, J; Noshiro, H; Okumura, T, 2014) |
| "Although there was no progression of gastric cancer, medication of S-1 was discontinued." | 1.40 | [Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer]. ( Fujisaki, S; Sakurai, K; Takashina, M; Takayama, T; Tomita, R, 2014) |
| "A 55-year-old man suffering from gastric cancer associated with metastases to the lymph node, gallbladder, and liver was administered chemotherapy with S-1 and cisplatin." | 1.40 | [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. ( Akiyama, Y; Hasuike, Y; Higuchi, I; Miyamoto, M; Tanigawa, T; Yamamoto, M, 2014) |
| "A 71-year-old man was diagnosed with gastric cancer[cT4, cN0, cH1(S6), cP0, cM0, cStage IV]and underwent distal gastrectomy with cholecystectomy, partial colectomy for the invasion to the mesentery of transverse colon, and partial hepatectomy for metastatic liver tumor(segment 6)." | 1.39 | [A case of synchronous liver metastasis originating from advanced gastric cancer treated with combination chemotherapy involving S-1 and surgical intervention]. ( Ohishi, K; Ori, T; Sunayama, K; Takeda, M, 2013) |
| "She was diagnosed as colon cancer with hepatic metastasis." | 1.39 | [A case of metastatic colon cancer effectively treated by XELOX and IRIS]. ( Fujiyama, Y; Kaneko, H; Kikuchi, M; Kinoshita, S; Nishizawa, T; Sakuno, T; Suzuki, H; Takahashi, M, 2013) |
| " Two patients received only SOX as chemotherapy, while the others received SOX in combination with one of the three molecular-targeting agents, bevacizumab, cetuximab, and panitumumab." | 1.39 | Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases. ( Akiba, T; Enomoto, H; Kawahara, H; Toyama, Y; Watanabe, K; Yanaga, K, 2013) |
| "Two patients survived without recurrence for 12 and 21 months." | 1.39 | [Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer]. ( Hasuike, Y; Hirao, S; Ishida, K; Iwagami, Y; Koshino, T; Tomoda, K; Toyomasu, T; Yoshikawa, S, 2013) |
| "A 44-year-old man with advanced hepatocellular carcinoma (HCC) was admitted to our institution." | 1.39 | [A case of hepatocellular carcinoma (Vp4)-combination therapy prolonged survival in a patient with advanced hepatocellular carcinoma with a tumor thrombus in the portal vein trunk]. ( Kanbara, Y; Tai, K; Terai, S, 2013) |
| "A tumor thrombus from the metastatic lesion in the liver jutting out into the umbilical portion of the portal vein was observed." | 1.39 | [Resection of a synchronous liver metastasis from gastric cancer associated with portal vein tumor thrombosis - a case report]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2013) |
| "In June 2010, he underwent sigmoid colon cancer resection, followed by local ablation therapy for the liver tumors( S4, S5, and S6) and hepatic segmentectomy( S3 and S7)." | 1.39 | [Multiple hepatic metastases from colon cancer successfully treated with irinotecan and S-1 plus panitumumab as second-line therapy-a case report]. ( Kwon, AH; Motohiro, T; Nakatake, R; Saito, T; Tanaka, H; Ueda, A; Yamamichi, K, 2013) |
| "He is free of recurrence now without adjuvant chemotherapy four years after repeat hepatectomy." | 1.39 | [A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer]. ( Bando, E; Goto, H; Kawamura, T; Makuuchi, R; Miki, Y; Sugisawa, N; Tanizawa, Y; Terashima, M; Tokunaga, M; Uesaka, K; Yamakawa, Y, 2013) |
| "A 65-year-old male with type 5 gastric cancer and two lesions of liver metastases was initially treated with S-1/CDDP." | 1.38 | [A case of stage IV gastric cancer with multiple liver metastases responding to chemotherapy with weekly PTX after failure of chemotherapy with S-1 and CDDP combination]. ( Higashiyama, M; Kato, T; Nakamura, Y; Nakayama, H; Nobutou, Y; Okamura, R; Wada, S; Yoh, T, 2012) |
| "We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
| "Patients with liver cirrhosis or hepatocellular carcinoma (HCC) have decreased serum insulin-like growth factor (IGF)-1 levels." | 1.38 | Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy. ( Cheng, AL; Hsu, CH; Huang, CC; Lin, SD; Shao, YY, 2012) |
| "A57 years old man with gastric cancer underwent distal gastrectomy (pT3N1M0, pStage II B)." | 1.38 | [A case of pathological complete response after chemotherapy for liver metastasis with subcapsular hemorrhage from gastric cancer:]. ( Aramaki, T; Bando, E; Goto, H; Kanemoto, H; Kawamura, T; Tanizawa, Y; Terashima, M; Tokunaga, M; Uesaka, K; Yasui, H, 2012) |
| "The prognosis for pancreatic cancer with distant metastasis is not good." | 1.38 | [Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases]. ( Fujioka, M; Fukui, H; Kou, C, 2012) |
| "The patient was diagnosed with hepatocellular carcinoma during work-up for hepatic dysfunction." | 1.38 | [A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2012) |
| "In addition, we found concomitant gastric cancer by gastrointestinal fiberscopy." | 1.38 | [A patient with multiple liver metastases of gastric and rectal cancers after laparoscopic sigmoidectomy who responded completely to S-1 therapy followed by open gastrectomy]. ( Arai, I; Inoue, S; Ohashi, I; Tamura, C; Wakasa, K, 2012) |
| " Adverse events were assessed by the National Cancer Institute Common Terminology Criteria for Adverse Events." | 1.37 | Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study. ( Asaka, M; Hatanaka, K; Hosokawa, A; Iwanaga, I; Kato, T; Komatsu, Y; Kusumi, T; Miyagishima, T; Nakamura, M; Sakata, Y; Sogabe, S; Yuki, S, 2011) |
| " Though grade 3 neutropenia appeared after 2 courses of the combined therapy, the patient well tolerated it after controlling the dosing schedule." | 1.37 | [A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy]. ( Hatata, T; Ikeguchi, M; Kondo, A; Naka, T; Takaya, S; Taniguchi, K, 2011) |
| "Pancreatic acinar cell carcinoma is rare, and its incidence is less than 1% of all the malignant pancreatic tumors." | 1.37 | [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1]. ( Fukuoka, J; Hosokawa, A; Ishizawa, S; Itaya, Y; Kajiura, S; Kawai, K; Minemura, M; Nakayama, Y; Nishimizu, T; Sawasaki, T; Shimizu, S; Sugiyama, T; Tajiri, K; Takahara, T; Tokimitsu, Y; Yamawaki, H; Yanagisawa, A; Yasumura, S, 2011) |
| "Abdominoperineal resection+D3 of rectal cancer was performed, followed by chemotherapy with UFT for 28 days, and then partial resection of liver." | 1.37 | [A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions]. ( Doi, F; Ishikawa, N; Kohro, T; Kusumoto, C; Kusumoto, M; Matsumoto, T; Toyoda, S, 2011) |
| "He was an HBV carrier, and hepatocellular carcinoma (HCC) was detected for the first time in 2000." | 1.37 | [Retroperitoneal metastasis of hepatocellular carcinoma - a case report]. ( Kameda, R; Kanazawa, A; Kobayashi, S; Miyakawa, K; Morinaga, S; Ohkawa, S; Tamura, S; Ueno, M; Yamamoto, N, 2011) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| "We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain." | 1.37 | Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer. ( Deguchi, T; Fujisaki, M; Kadomura, T; Kato, A; Kato, Y; Kitajima, M; Kojima, M; Kubota, K; Kuroda, J; Nitori, N; Okada, A; Origuchi, N, 2011) |
| "Patients with severe metastatic pancreatic cancer received chemotherapy comprising S-1 (30mg/m² p." | 1.37 | [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis]. ( Asagi, A; Hori, S; Iguchi, H; Ikeda, Y; Kajiwara, T; Matsumoto, T; Nadano, S; Nishina, T; Takeji, S, 2011) |
| "We report a long-term survival case of rectal cancer that was initially thought unresectable treated with chemoradiotherapy (CRT)." | 1.37 | [A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy]. ( Kamiya, A; Kawachi, Y; Maruyama, H; Nagano, H; Nakajima, Y; Ohtsukasa, S; Okazaki, S; Takamatsu, S, 2011) |
| "A 60-year-old man with intrahepatic cholangiocarcinoma (ICC) underwent a left hepatectomy." | 1.37 | [A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Ikeda, K; Iwazawa, T; Kawanishi, K; Kitada, M; Miyake, M; Nagai, K; Shimano, T; Shimizu, J, 2011) |
| "A 77-year-old man was diagnosed as hepatocellular carcinoma, and was referred to our hospital." | 1.37 | [A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection]. ( Doki, Y; Eguchi, H; Katsura, Y; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H; Wakasa, K, 2011) |
| "A case of a 68-year-old man with hepatocellular carcinoma (HCC) is presented." | 1.37 | [A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium]. ( Doki, Y; Eguchi, H; Kawamoto, K; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Tanemura, M; Umeshita, K; Wada, H, 2011) |
| "Upper gastroscopy revealed advanced gastric cancer." | 1.36 | [A case of advanced gastric cancer with multiple liver metastases completely responding long term to paclitaxel plus S-1 therapy]. ( Akagi, S; Kanou, M; Kurisu, Y; Tanaka, T; Toge, K, 2010) |
| "A69-year-old man was diagnosed with sigmoid colon cancer and underwent resection of the sigmoid colon." | 1.36 | [Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT]. ( Higuchi, K; Ishikawa, T; Kamimura, T; Kubota, T; Ohta, H; Seki, K; Yoshida, T, 2010) |
| "The treatment for hepatocellular carcinoma with distant metastasis remains unclear." | 1.36 | [A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy]. ( Fukumori, D; Kamachi, H; Kamiyama, T; Matsushita, M; Nakanishi, K; Tahara, M; Todo, S; Yokoo, H, 2010) |
| "We report a case of hepatocellular carcinoma (HCC) in association with autoimmune hepatitis (AIH)." | 1.36 | [A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E]. ( Aizawa, N; Enomoto, H; Hirota, S; Iijima, H; Ikeda, N; Imanishi, H; Ishii, A; Iwai, T; Iwata, Y; Nishiguchi, S; Saito, M; Sakai, Y; Shimomura, S; Takashima, T; Tanaka, H; Yamamoto, T; Yoh, K; Yoshikawa, S, 2010) |
| " In view of the side effects such as reduction in appetite and leukocyte, the dosage has been reduced as of the second course of treatment." | 1.36 | [A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy]. ( Fujikuni, N; Hashimoto, M; Iwako, H; Kuranishi, F; Kuroda, Y; Moriyuki, T; Niitsu, H, 2010) |
| "CT demonstrated liver(S5/6)and lung(S9)metastases in August 2002." | 1.36 | [A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer]. ( Furuya, T; Hirao, H; Nagai, M; Nakamura, H; Nomura, Y; Ogura, M; Suzuki, Y; Takahashi, M; Takayama, T; Tanaka, N, 2010) |
| "No re-growth of gastric cancer has been seen for 9 months with this chemotherapy." | 1.36 | [A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1]. ( Hachisuka, T; Hattori, K; Kinoshita, T; Miyauchi, M; Mori, T; Shikano, T; Shinohara, M; Yamamoto, T, 2010) |
| "The prognosis for pancreatic cancer with distant metastases is not good." | 1.36 | [S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis]. ( Fukui, H; Kou, C; Matsumoto, M; Matsumoto, T, 2010) |
| "We encountered a case of AFP-producing gastric cancer that accompanied early gastric cancer and was treated effectively by S-1." | 1.36 | [A case of AFP-producing gastric cancer with hepatic metastases that accompanied early gastric cancer treated effectively by chemotherapy]. ( Amaya, S; Fujisawa, K; Iida, Y; Ishii, H; Koizumi, H; Mitsui, T; Miura, S; Munemoto, Y; Sato, Y; Terada, T, 2010) |
| "A detailed examination revealed a gastric cancer located from antrum to duodenal bulb with multiple liver metastases." | 1.36 | [Long-term survival of patient with gastric cancer treated by S-1 + paclitaxel combination chemotherapy against multiple liver metastases after gastrectomy and adrenalectomy]. ( Ikeda, J; Itokawa, Y; Koide, K; Otsuji, E; Shimizu, H; Shioaki, Y; Sonoda, H; Takashina, K; Taniguchi, F; Ueshima, Y, 2010) |
| "Despite a diagnosis of cStage IV gastric cancer (cN2, cH0, cM0, cT3 (SE), cP1), we preferentially performed a non-curative surgery to avoid stenosis or bleeding by tumor invasion." | 1.36 | [Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis]. ( Fukumoto, I; Fukumoto, K; Ishida, E; Itani, K; Kanemitsu, D; Kassai, K; Kobayashi, Y; Miyagaki, T; Nakase, Y; Sakamoto, K; Soga, K; Takagi, T; Takenaka, S; Yanagida, K, 2010) |
| "Sigmoidectomy was performed for sigmoid colon cancer in January 2002." | 1.36 | [A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy]. ( Doki, Y; Hirose, H; Ikeda, M; Kim, HM; Miyoshi, N; Mizushima, T; Mori, M; Okano, M; Sekimoto, M; Takemasa, I; Yamamoto, H; Yamashita, S, 2010) |
| "A 75-year-old man with advanced gastric cancer underwent distal gastrectomy with lymph node dissection(D1)and Roux-en Y reconstruction." | 1.35 | [A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy]. ( Arai, H; Kashiwabara, M; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Mizutani, T; Nishi, Y; Sasajima, K; Suzuki, S; Tajiri, T; Yanagi, K; Yokoyama, T, 2008) |
| "A 65-year-old man with common bile duct cancer was treated by pylorus-preserving pancreaticoduodenectomy with D2 lymph node dissection." | 1.35 | [A case of liver metastatic recurrence of bile duct cancer completely responding to single-drug S-1 chemotherapy]. ( Fukao, K; Irabu, S; Kasagawa, T; Kusashio, K; Matsumoto, M; Nobumoto, D; Suzuki, M; Tashima, Y; Tonooka, T; Udagawa, I; Yasutomi, J, 2008) |
| "Cholangiocarcinoma is a therapeutically challenging malignancy." | 1.35 | Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Wada, H; Yamamoto, Y, 2008) |
| "There is no standard treatment for hepatocellular carcinoma (HCC) patients with extrahepatic metastases." | 1.35 | Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases. ( Aikata, H; Azakami, T; Chayama, K; Jeong, SC; Kawakami, Y; Kawaoka, T; Mori, N; Takahashi, S; Takaki, S; Uka, K, 2008) |
| " We treated the patient with S-1 combined with CPT-11." | 1.35 | [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11]. ( Ishii, Y; Mado, K; Manmoto, J; Masuda, H; Mazaki, T; Okame, H; Suzuki, K; Takayama, T, 2008) |
| "A type 2 advanced gastric cancer was observed on the gastric antrum." | 1.35 | [A case of early recurrence with multiple liver metastases after curative operation of gastric cancer successfully treated by S-1/CDDP combination chemotherapy]. ( Akiho, H; Goto, A; Itaba, S; Murao, H; Nagai, E; Nakamura, K; Segawa, Y; Takayanagi, R; Tokunaga, N; Yoshinaga, S, 2008) |
| "We report a successful case of chemotherapy accompanied with grade 4 adverse events for unresectable advanced gastric cancer." | 1.35 | [A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event]. ( Furukawa, H; Imamura, H; Kishimoto, T; Miyazaki, Y; Ota, K; Tatsuta, M, 2008) |
| "A 60-year-old man diagnosed as advanced sigmoid colon cancer was performed sigmoidectomy and D3 lymph node dissection." | 1.35 | [A case of advanced sigmoid colon cancer performed resection of liver metastases after long-term control by S-1 and CPT-11 combination chemotherapy]. ( Miki, H; Nakahira, S; Nakata, K; Okada, K; Okamura, S; Sugimoto, K; Suzuki, R; Tamura, S; Uji, K; Yoshida, A; Yoshimura, M, 2008) |
| "A 82-year-old man with advanced gastric cancer underwent distal gastrectomy in January 2006." | 1.35 | [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer]. ( Kitajima, Y; Miyazaki, K; Nakafusa, Y; Ohtsuka, T; Sato, S; Tanaka, M; Yakabe, T, 2009) |
| "We report a case of gastric cancer with simultaneous multiple liver metastasis that was successfully treated by paclitaxel and UFT-E." | 1.35 | [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E]. ( Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H, 2009) |
| "Abdominal CT scan revealed pancreatic cancer with massive ascites showing peritoneal dissemination, combined with lymph node and liver metastases." | 1.35 | [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases]. ( Fushida, S; Kimura, H; Mukawa, A, 2009) |
| "Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years." | 1.35 | [A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009) |
| "We experienced this AFP-producing gastric cancer in which CR was possible by FLEP." | 1.35 | [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case]. ( Fujii, M; Funada, T; Kaiga, T; Kanamori, N; Kochi, M; Takahashi, T; Takayama, T, 2009) |
| "A 66-year-old man was diagnosed with hepatocellular carcinoma with Vp3 by abdominal enhanced CT." | 1.35 | [A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]. ( Doki, Y; Eguchi, H; Hatano, H; Kobayashi, S; Marubashi, S; Mori, M; Murakami, M; Nagano, H; Takeda, Y; Tanemura, M; Tomimaru, Y; Tomokuni, A; Wakasa, K, 2009) |
| "Primary liver cancer with lymph node metastasis was recognized as poor prognosis." | 1.35 | [A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT]. ( Akagi, K; Dono, K; Fujita, J; Hata, T; Hayashi, S; Ikeda, K; Kagawa, Y; Kawanishi, K; Kitada, M; Munakata, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yasumoto, T; Zenitani, M, 2009) |
| "We report a long-term survival case of pancreatic cancer with hepatic metastasis after surgical resection treated by S-1 and gemcitabine combination chemotherapy." | 1.35 | [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. ( Doki, Y; Eguchi, H; Hoshino, H; Kitagawa, T; Kobayashi, S; Marubashi, S; Monden, M; Mori, M; Nagano, H; Nakamori, S; Takeda, Y; Tanemura, M; Umeshita, K, 2009) |
| "A 82-year-old woman with gastric cancer underwent distal gastrectomy with level 2 lymph node dissection(M, Less, 2." | 1.35 | [A case of complete remission(CR)persisting from UFT-E in an old patient with liver metastasis of gastric cancer]. ( Aoki, K; Hirama, K; Kazunori Ikenaga, S; Maruyama, M; Matsumoto, R; Oguro, H; Sakamoto, Y; Sakuraba, H, 2008) |
| "After examination, she was diagnosed as sigmoid colon cancer with multiple liver metastases." | 1.35 | [A case of sigmoid colon cancer with multiple liver metastases responding to S-1]. ( Hara, K; Maruyama, T; Ohkohchi, N; Takagaki, T, 2008) |
| "Grade 3 leukocytopenia was observed in 1 patient (8." | 1.35 | Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. ( Dono, K; Kobayashi, S; Marubashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamura, M; Noda, T; Takeda, Y; Umeshita, K; Wada, H, 2008) |
| "All of the 9 gastric cancer cases were diagnosed as being resectable other than ones with metastases to the liver, or a primary tumor resection was performed on the cases." | 1.35 | [Therapeutic experience of S-1 plus other drug combination therapy for synchronia multiple liver metastases of gastric cancer]. ( Imaizumi, T; Kizaki, J; Koga, A; Miyagi, M; Shirouzu, K; Yano, S, 2008) |
| "Advanced hepatocellular carcinoma (HCC) with distant metastases, in particular to the lung, has a poor prognosis." | 1.34 | [Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1]. ( Asechi, H; Hatano, E; Ikai, I; Nagata, H; Narita, M; Uemoto, S; Yanagida, A; Yasuchika, K, 2007) |
| "No re-growth of gastric cancer has been seen for three years with chemotherapy of TS-1." | 1.34 | [A case of advanced gastric cancer with liver metastases successfully treated by combination therapy of TS-1 and docetaxel]. ( Ichinari, H; Kawano, F; Matsuda, S; Mine, K; Taneda, Y; Yonei, A, 2007) |
| " As for the dosing method of combination chemotherapy,the patient was treated with a course of TS-1 80 mg daily divided into two doses over 21 days continuously, followed by a 14-day cessation of the drug,together with a dose of CDDP 70 mg on day 8." | 1.34 | [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases]. ( Hayakawa, Y; Hioki, J; Irinoda, T; Kimura, T; Kobayashi, M; Matsumoto, Y; Meguro, E; Noda, Y; Takagane, A, 2007) |
| "The patient was diagnosed as advanced gastric cancer (type-3) with multiple liver metastasis and obstructive jaundice." | 1.34 | [A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1]. ( Funada, R; Harada, K; Hasegawa, K; Homma, N; Ogata, N; Shibasaki, K; Soga, K; Uchida, M; Watanabe, T, 2007) |
| "A 37-year-old female with advanced gastric cancer and liver metastases was treated with S-1." | 1.34 | A case of suspected S-1 induced interstitial pneumonia. ( Koizumi, W; Munakata, M; Sakata, Y; Shitara, K, 2007) |
| "Here, we report the case of a sigmoid colon cancer patient with initially unresectable hepatic metastases showing a prolonged survival (6." | 1.34 | [A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases]. ( Gega, M; Hashimoto, A; Ikeuchi, H; Kuno, T; Noda, M; Oshima, T; Tanaka, K; Tsukamoto, K; Yagyuu, T; Yamamura, T; Yanagi, H; Yoshikawa, R, 2007) |
| "A 62-year-old woman with Barrett's esophageal cancer was hospitalized." | 1.34 | Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer. ( Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S, 2007) |
| "A distal gastrectomy for advanced gastric cancer with liver metastasis was performed on a 71-year-old male." | 1.34 | [A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP]. ( Aoki, T; Mino, A; Murahashi, K; Nishino, K; Sowa, M; Tachimori, A; Takagaki, K, 2007) |
| " This article identifies the risk factors for severe adverse events of S-1 from nationwide survey data." | 1.34 | Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer. ( Fukushima, M; Ishiwata, R; Matsumoto, S; Nagai, Y; Teramukai, S; Yamanaka, T, 2007) |
| "We treated hepatic metastasis of gastric cancer with CPT-11 therapy and obtained complete remission of the hepatic tumor that has been maintained for than 2 years postoperatively." | 1.34 | [Complete remission of hepatic metastasis of gastric cancer with CPT-11]. ( Kohno, H; Ogawa, A; Okajima, A; Taguchi, T; Takenouchi, Y; Tsugane, K, 2007) |
| " Since a curative operation is impossible in this case, we started systemic chemotherapy employing S-1 combined with hepatic arterial infusion using epirubicin hydrochloride and mitomycin C." | 1.34 | [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]. ( Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T, 2007) |
| "We report a case of advanced gastric cancer with multiple liver metastases,in which a complete resection was performed following a bypass operation and chemotherapy." | 1.34 | [Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy]. ( Hatakeyama, K; Kobayashi, T; Kurosaki, I; Kurosaki, R; Matsuo, H; Ohashi, M; Yajima, K, 2007) |
| "We experienced a case of advanced gallbladder cancer with a remarkable response treated by oral fluoropyrimidine anticancer drug S-1 (120 mg/day on day 1 through 28 followed by a 14-day recovery period) as first-line chemotherapy." | 1.34 | [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer]. ( Amano, A; Ohkawa, S; Ueno, M, 2007) |
| "We report 2 cases of advanced gastric cancer with synchronous liver metastases who were successfully downstaged using S-1 plus low-dose cisplatin chemotherapy followed by surgical resection." | 1.34 | Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 cases. ( Aiba, K; Aoki, H; Kashiwagi, H; Koyama, T; Mitsumori, N; Nimura, H; Takahashi, N; Yanaga, K, 2007) |
| "4 patients with hepatocellular carcinoma (HCC) and 3 with cholangiocellular carcinoma (CCC) were employed for this study." | 1.34 | S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. ( Fujita, J; Hoshimoto, S; Ikeda, M; Kato, T; Morise, Z; Sugioka, A, 2007) |
| " 5-FU serum concentrations were higher at night time and the peak concentration of 5-FU was obtained at 3 a." | 1.33 | [Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report]. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "Case 1: 66-year-old male with advanced gastric cancer invading the pancreas with metastasis to the liver and left neck lymph nodes." | 1.33 | [Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K, 2005) |
| "The data on 307 patients with colorectal cancer at stage II or III, who underwent potentially curative resection with lymphadenectomy, were reviewed." | 1.33 | The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer. ( Ikeda, S; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Ogo, S; Ohkita, A; Ozasa, H; Sasatomi, T; Shirouzu, K, 2006) |
| "A 54-year-old woman who had ascending colon cancer with multiple liver and lung metastases underwent rt." | 1.33 | [A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11]. ( Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T, 2005) |
| "The prognosis of liver metastasis of gastric cancer is generally poor, and there is no comprehensive therapy." | 1.33 | [A case of gastric cancer with liver metastasis resected after the combination chemotherapy with CDDP and TS-1]. ( Amano, M; Hayashida, H; Higaki, N; Itani, Y; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M, 2005) |
| "These results suggest that gastric cancer,in which liver metastasis is considered to be a prognostic factor,can be effectively treated by combination therapy with hepatic arterial infusion therapy, followed by thermochemotherapy for the primary lesion." | 1.33 | [A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy]. ( Aoki, T; Hamaya, M; Kouno, T; Nishida, J; Ogata, T; Sato, S; Seo, K; Tsuchida, A; Yoshida, K, 2005) |
| " Because salvage therapy with S-1 alone showed good antitumor efficacy and beneficial tolerability when the standard dosage was maintained, it was considered that this home therapy was effective for advanced/recurrent breast cancer that was resistant to anthracycline and taxane antitumor drugs." | 1.33 | [Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer]. ( Itoh, K; Minami, H, 2005) |
| "The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history." | 1.33 | 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "Three cases with unresectable advanced gastric cancer with liver metastases were successfully treated by the combination therapy of TS-1 and cisplatin( CDDP)." | 1.33 | [Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy]. ( Goto, H; Ina, K; Inagaki, J; Ito, A; Ito, N; Kataoka, T; Matsui, W; Nagao, S, 2006) |
| "We experienced a case of recurrent breast cancer resistant to prior medications, which was treated with oral S-1, a fluoropyrimidine-class anticancer drug, and exhibited the marked shrinkage of liver metastasis." | 1.33 | [A case of liver metastasis successfully treated with S-1 monotherapy in the patient with recurrent breast cancer]. ( Mitsuyama, S; Nishihara, K, 2006) |
| "A 65-year-old man was diagnosed as esophageal cancer with multiple liver metastases (S2 10 mm, S7 10 mm, S8 15 mm)." | 1.33 | [A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy]. ( Doi, K; Furuhashi, S; Ishihara, A; Ishimoto, T; Kikuchi, N; Ogata, K; Ogawa, M; Ohchi, T, 2006) |
| "Pancreatic acinar cell carcinomas are rare, and little is reported on their chemotherapy." | 1.33 | [Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin]. ( Endo, S; Hashimoto, K; Higami, T; Itagaki, T; Itakura, M; Kataoka, Y; Koike, M; Nio, Y; Nishi, T; Yano, S, 2006) |
| "A 73-year-old man was admitted for sigmoid colon cancer with multiple hepatic metastases." | 1.33 | [A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy]. ( Ishigame, T; Ishii, Y; Okayama, H; Takahashi, M, 2006) |
| "The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy." | 1.33 | [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006) |
| "We report a rare patient with a DPD deficiency." | 1.33 | [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency]. ( Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M, 2006) |
| " We carried out 4-week administration of 80-120 mg/day of TS-1 according to body surface area, followed by a 2-week discontinuation, then repeated administration which adjusting the dosage according to the incidence of side effects, and discussed the antitumor effects and adverse events." | 1.33 | [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]. ( Hatori, S; Imada, T; Kunisaki, C; Makino, T; Ohshima, T; Rino, Y; Suda, T; Takanashi, Y; Yamada, R; Yamazaki, Y, 2006) |
| "At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
| "Gastrofiber-scopy revealed that type 3 gastric cancer was widespread in the lesser curvature." | 1.33 | [A resected case of advanced gastric cancer with multiple liver metastasis responding to preoperative TS-1/CDDP chemotherapy]. ( Kagawa, I; Matsumoto, Y; Nishiwaki, K; Ohi, A, 2006) |
| "In two patients with advanced pancreatic cancer with cervical lymph node or liver metastasis and no indication of pancreatic resection and radiotherapy, oral treatment with S-1 (an anti-cancer agent of fluoropyrimidine derivative) exerted high anti-tumor activity on the metastatic lesions." | 1.33 | [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy]. ( Funakoshi, A; Senju, T; Sumii, T, 2006) |
| "We report two metastatic pancreatic cancer patients who showed marked tumor shrinkage following administration of the oral fluorinated pyrimidine anticancer drug, S-1." | 1.33 | [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer]. ( Ikeda, M; Ueno, H, 2006) |
| "Grade 3 neutropenia was observed, but no other severe toxicities were noted." | 1.33 | [Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report]. ( Boku, N; Fukutomi, A; Yoshino, T, 2006) |
| "We report a case of advanced hepatocellular carcinoma (HCC)." | 1.33 | [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL]. ( Amano, M; Fujita, M; Hayashida, H; Higaki, N; Nakagawa, S; Niinobu, T; Nishikawa, Y; Sakon, M; Yamashita, S, 2006) |
| "Paclitaxel was administered to 4 patients at a weekly dose of 80 mg/m2/day for three weeks followed by a one week interval." | 1.32 | [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1]. ( Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H, 2003) |
| "The prognosis and QOL of unresectable pancreatic cancer are very poor." | 1.32 | [A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1]. ( Endo, W; Fujito, T; Goda, F; Hojo, S; Maeura, Y; Matsuyama, J; Yamazaki, K; Yano, Y, 2003) |
| "S-1 appears to be safe and highly active, with favorable longterm survival in patients with metastatic gastric cancer, particularly in those with diffuse-type histology and peritoneal metastasis." | 1.32 | Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey. ( Boku, N; Doi, T; Hamamoto, Y; Kawai, H; Mera, K; Muto, M; Nagashima, F; Ohtsu, A; Sano, Y; Yano, T; Yoshida, S, 2003) |
| "The patient was diagnosed with advanced gastric cancer (type-3) with lymphangitis carcinomatosa of the lung." | 1.32 | [A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1]. ( Kawabata, H; Murata, A; Nakajima, H; Takase, I; Watanabe, T, 2003) |
| " Furthermore, he was administered tegafur/uracil (400 mg/day) 5 days weekly as pharmacokinetic modulating chemotherapy (PMC)." | 1.32 | [A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Baba, Y; Hayashi, S; Ishikawa, T; Kamimura, T; Nomura, K; Oota, H; Yoshida, T, 2003) |
| " Pharmacokinetic modulating chemotherapy (PMC) was performed after the operation." | 1.32 | [A case of multiple liver metastases from colon cancer successfully treated with pharmacokinetic modulating chemotherapy]. ( Futamura, N; Matsutomo, M; Sakamoto, K; Tateyama, K; Yasumura, M, 2003) |
| "The upper endoscopy revealed advanced gastric cancer." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP]. ( Akaiwa, J; Kondo, Y; Makuuchi, H; Morita, M; Nabeshima, K; Nakamura, K; Nishi, T; Ogoshi, K; Okamoto, Y; Soeda, J; Tajima, T, 2003) |
| "We report a rectal cancer case with liver and lung metastases treated successfully with this protocol." | 1.32 | [A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT]. ( Ebuchi, M; Hasegawa, K; Kato, K; Maruyama, M; Nagahama, T; Shinoura, H; Takashima, I, 2003) |
| "He then underwent excision of the brain metastases and consecutive radiation by X-knife." | 1.32 | [A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy]. ( Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T, 2003) |
| "We report a case of advanced gastric cancer with antral stenosis that responded to an oral anticancer agent, TS-1, after metallic stent insertion." | 1.32 | [A case of malignant gastric outlet stenosis palliated with self-expandable metallic stent and responding to TS-1, an oral fluorouracil derivative]. ( Matsuura, T; Mitsugi, K; Nagano, C; Seo, M; Tokumitsu, Y, 2004) |
| "A 72-year-old man with common bile duct cancer was treated by pylorus preserving pancreatoduodenectomy with D3 lymph node dissection and preventive radiotherapy at hepaticojejunostomy." | 1.32 | [A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy]. ( Hirano, T; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Mori, M; Shimonishi, T, 2004) |
| "Twenty-five consecutive patients with rectal cancer were included, with tumor stages (c)T(2-4)N(x)M(0), during the period 1997-1999." | 1.32 | 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. ( Alvarez, E; Arranz, JA; Calvo, FA; Carreras, JL; Desco, M; Domper, M; Martínez-Lázaro, R; Matute, R, 2004) |
| " He was treated with pharmacokinetic modulating chemotherapy (PMC) and low-dose CPT-11." | 1.32 | [A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11]. ( Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H, 2004) |
| "A standard treatment for hepatocellular carcinoma with extrahepatic metastasis is not established and chemotherapy is ineffective." | 1.32 | [A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy]. ( Aozasa, S; Fujino, K; Hase, K; Ito, H; Okada, K; Shikina, A; Suganuma, T; Tanaka, M; Terauchi, R; Tsuda, T; Utsunomiya, K, 2004) |
| " S-1 has safe and potent antitumor effects in patients with gastric cancer via these respective functions." | 1.32 | Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis. ( Arakawa, T; Fujiwara, Y; Hamaguchi, M; Higuchi, K; Matsumoto, T; Okazaki, H; Oshitani, N; Sasaki, E; Shiba, M; Suto, R; Tanigawa, T; Tominaga, K; Watanabe, T, 2004) |
| "The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
| "Docetaxel will be a key drug for the gastric cancer." | 1.32 | [A case report of the 8 year survivor--unresectable liver metastases from advanced gastric cancer (Stage IV) were completely responsive, after 4 years from a total sequential gastrectomy, combining docetaxel treatment to regress the recurrence]. ( Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Ohshima, S; Tsujie, M; Yamamoto, H, 2004) |
| "Case 1: A 67-year-old male with gastric cancer." | 1.32 | [Three successful case reports of advanced gastric cancer with chemotherapy]. ( Fukunaga, K; Kawai, M; Kotobuki, T; Niinobu, T; Taniguchi, H; Yamamoto, M, 2004) |
| "Lentinan was administered at 2 mg/week." | 1.32 | [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer]. ( Andou, K; Hibi, T; Kurosawa, Y; Nagahashi, S; Nishiwaki, M; Okuda, K; Sugihara, T; Suzuki, H; Terada, S, 2004) |
| "A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with TS-1 and CDDP: Akihiro Tsukahara, Kazuhiro Kaneko and Syuji Tanaka (Dept." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP]. ( Kaneko, K; Tanaka, S; Tsukahara, A, 2004) |
| "We report a case of inoperable gastric cancer with multiple liver metastases, which responded significantly to the short-term administration of TS-1 following intravenous FMP therapy." | 1.31 | [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization]. ( Chinzei, T; Okada, Y; Tasaka, K; Tomofuji, Y, 2002) |
| "We treated a patient with unresectable rectal cancer with multiple liver, pulmonary and lymph node metastases that responded remarkably to pharmacokinetic modulating chemotherapy (PMC)." | 1.31 | [A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy]. ( Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Ohe, S; Watabe, S, 2002) |
| "We encountered a patient with gastric cancer for whom oral administration of S-1 was effective, and we report this case." | 1.31 | Advanced gastric cancer with liver metastases successfully treated with S-1. ( Hirayama, Y; Takabayashi, H; Takeuchi, T; Tanaka, T; Watanabe, S, 2002) |
| " Administration of modified pharmacokinetic modulating chemotherapy (PMC) using Leucovorin (intravenous infusion of 5-FU, 600 mg/m2/24 hours; oral administration of UFT, Taiho Pharmaceutical Co." | 1.31 | [A case of multiple liver metastases from colon cancer successfully treated with modified pharmacokinetic modulating chemotherapy using Leucovorin]. ( Hatada, T; Inoue, Y; Kobayashi, M; Kusunoki, M; Miki, C; Ojima, E, 2002) |
| "Advanced gastric cancer (AGC) with liver metastasis has a poor prognosis." | 1.31 | [A case of metastatic gastric cancer treated with CDDP plus TS-1 and surgical resection]. ( Ezumi, K; Furukawa, H; Imamura, H; Ishida, H; Kato, H; Kawasaki, T; Masuda, N; Masutani, S; Shimizu, J; Tatsuta, M, 2002) |
| "Advanced unresectable hepatocellular carcinoma (HCC) was treated with modified pharmacokinetic modulation chemotherapy (PMC)." | 1.31 | [Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC]. ( Ito, T; Kamachi, H; Kamiyama, T; Kondo, M; Kurauchi, N; Matsushita, M; Nakagawa, T; Nishikawa, M; Ogata, T; Todo, S, 2002) |
| "According to the General Rules for Gastric Cancer Study, the patient belongs to the class of complete response." | 1.31 | [A case of complete regression of liver metastases by treatment with Futraful supposition]. ( Bandoh, T; Fujiwara, M; Isoyama, T; Nagaoka, S; Noji, M; Takemura, T, 2000) |
| "Spontaneous regression of hepatocellular carcinoma (HCC) is a rare phenomenon." | 1.31 | Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery. ( Amano, J; Hanazaki, K; Koide, N; Matsunaga, Y; Shiohara, E; Terasaki, T, 2000) |
| "We report a case of advanced rectal cancer accompanied by unresectable liver metastasis in which remission has been achieved for 7 years." | 1.31 | [A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective]. ( Baba, H; Kikunaga, H; Matsudo, A; Miura, H; Morisue, A; Nakai, H; Osakabe, Y; Sotome, K; Takao, M, 2000) |
| "We encountered a case of unresectable colon cancer that disappeared following pharmacokinetic modulating chemotherapy (PMC)." | 1.31 | [A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)]. ( Asahara, T; Nakahara, H; Nakahara, M; Okajima, M; Yano, M, 2000) |
| " Intermittent hepatic arterial infusion of high-dose 5-FU was started on a weekly schedule and oral UFT was added as pharmacokinetic modulating chemotherapy 4 weeks after the initial chemotherapy." | 1.31 | [A successful case of preoperative intermittent hepatic arterial infusion of high-dose 5-FU and pharmacokinetic modulating chemotherapy against unresectable liver metastasis of colon cancer]. ( Hamazaki, K; Inagaki, M; Kawashima, T; Morichika, T; Sadamori, H; Shima, Y; Tanaka, N; Uetsuka, H; Yagi, T, 2000) |
| "For cases of liver metastasis from colon cancer that are non-resectable due to multiple liver metastases, other organ metastases (lung, bone, brain etc." | 1.31 | [Three cases of liver metastasis of colon cancer responding to systemic combination chemotherapy utilizing CPT-11]. ( Kobayashi, A; Yamaguchi, M, 2000) |
| "A total of 18 patients (13: colon cancer, 5: gastric cancer) with multiple liver metastases (H3) underwent hepatic arterial infusion chemotherapy (HAI) using an implanted arterial port with portable syringe pumps in our outpatient clinic." | 1.31 | [Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases]. ( Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H, 2000) |
| "A 67-year-old female with rectal cancer and multiple liver metastases underwent low anterior resection by total mesorectal excision (TME), cholecystectomy and hepatic arterial cannulation in June 1995." | 1.31 | [Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)]. ( Kusunoki, M; Noda, M; Yamamura, T; Yanagi, H; Yoshikawa, R, 2001) |
| "Ultrasound and CT scan showed that the hepatocellular carcinoma and lung metastatic foci had disappeared completely." | 1.31 | [Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)]. ( Haseme, E; Kikuchi, K; Ohnishi, Y; Shohkei, O, 2001) |
| "A 77-year-old man who had advanced gastric cancer with multiple liver metastases was treated by combined chemotherapy with 5-fluorouracil and low-dose cisplatin for 1 and half courses (1 course = 4 weeks)." | 1.31 | [A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis]. ( Ikeda, S; Iwamoto, M; Nagata, S; Niiya, F; Shirouzu, K, 2001) |
| "Human colon cancer cells (KM12SM) were injected into the cecal wall of the nude rats." | 1.31 | [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats]. ( Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K, 2001) |
| "We report a case of advanced gastric cancer producing Alpha Fetoprotein (AFP) with multiple liver metastases in which TS-1 is effective." | 1.31 | [A case of advanced gastric cancer producing alpha fetoprotein with multiple liver metastases responding to TS-1 after TAE]. ( Hayashi, Y; Kawasaki, Y; Kobayakawa, K; Ohtsuru, M; Oka, H; Okazaki, M; Yamamura, J; Yamamura, M; Yasuda, S, 2001) |
| "We present the case of a 72-year-old man with gastric tube cancer accompanied by multiple liver metastases, after esophagectomy for esophageal cancer, whose quality of life (QOL) was improved with a small dosage of TS-1." | 1.31 | [A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1]. ( Ajisaka, H; Fujita, H; Inokuchi, M; Iwata, K; Kaji, M; Konishi, K; Maeda, K; Miwa, A; Yabushita, K; Yamamoto, S; Yoshioka, I, 2002) |
| "We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
| " He was treated postoperatively with arterial infusion pharmacokinetic modulating chemotherapy (PMC) and venous infusion CPT-11 (modified PMC)." | 1.31 | [A case of rectal cancer with multiple liver metastases that responded dramatically to pharmacokinetic modulating chemotherapy/CPT-11 therapy]. ( Dan, T; Kitayama, Y; Kosaka, H; Maeda, S; Matsusaka, S; Okada, T; Tanabe, H; Yamasaki, H, 2002) |
| "A 56-year-old male had suffered from hepatocellular carcinoma treated by operation, PHoT and TAE since 1994." | 1.30 | [A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis]. ( Ando, A; Asano, N; Bamba, T; Fujiyama, Y; Fukano, M; Inoue, T; Ito, A; Koyama, S; Kubo, M; Sasaki, M; Sato, J; Tsujikawa, T; Yoshioka, U, 1998) |
| "The therapeutic effect of S-1 on human colon cancer xenografts (TK-13) with high metastatic potential to the liver was evaluated." | 1.30 | Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma. ( Baba, M; Kamiya, K; Kanai, T; Konno, H; Matsumoto, K; Nakamura, S; Tanaka, T, 1999) |
| "Multiple liver and lung metastasis of breast cancer were diagnosed because of high CA 15/3 serum levels and normal gastrointestinal study." | 1.30 | [Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report]. ( Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M, 1999) |
| " Dose escalation was required in order to control carcinoid symptoms, and the final dosage was 5,950 micrograms/day." | 1.29 | Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide. ( Deguchi, H; Deguchi, K; Iwasaki, E; Kobayashi, T; Murashima, S; Shirakawa, S; Tsuda, M; Tsukada, T, 1994) |
| "A 47-year-old man with ascending colon cancer with multiple liver metastases and bone metastasis (VII thoracic vertebra) showed a remarkable response to the combination therapy of tegafur and cisplatin." | 1.29 | [A case of remarkable response of colon cancer with multiple liver and bone metastasis treated with tegafur and cisplatin]. ( Arima, S; Futami, K; Hara, F; Harada, Y; Inada, S; Kotoh, T; Nishida, T; Tateishi, S; Yamasaki, K, 1995) |
| "Treatment of hepatocellular carcinoma with bone metastasis is often ineffective, but this is a rare case showing the clinical effectiveness of oral administration of UFT." | 1.29 | [A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT]. ( Chao, C; Imada, T; Maehara, T; Matsumoto, A; Miyazaki, T; Morinaga, S; Takehana, T, 1995) |
| "Macroscopically it was gastric cancer with P0H3N1T3M0, Stage IV b, histologically small cell carcinoma, intermed, INF gamma, ss, ly1, v3, n1(+), ow(-), aw(-)." | 1.29 | [A case of small cell carcinoma of the stomach with multiple liver metastases]. ( Ishizawa, S; Masuyama, K; Oonishi, Y; Sawataishi, M; Suzuki, S; Wakaki, K; Yamazaki, K, 1994) |
| "A 65-year-old male with hepatocellular carcinoma was admitted to our hospital." | 1.29 | [A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT]. ( Fujiyama, S; Hashiguchi, O; Hayashida, T; Ikebe, M; Noumaru, S; Sato, K; Sato, T; Shibata, J, 1994) |
| "A 74-year-old man was diagnosed as hepatocellular carcinoma (HCC) in the area of S6-7 with tumor thrombus continuously developed from hepatic vein to inferior vena cava (IVC)." | 1.29 | [Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report]. ( Ito, T; Koreeda, C; Naitoh, Y; Nakagawa, T; Okuno, H; Seki, T; Shiro, T; Tagawa, Y; Wakabayashi, M; Yamamura, H, 1993) |
| "We found a hepatocellular carcinoma, of about 9 cm in diameter in her right liver lobe." | 1.29 | [A case of giant hepatocellular carcinoma effectively treated by UFT]. ( Hino, F; Urabe, T, 1993) |
| "A 79-year-old female with hepatocellular carcinoma with portal invasion and right adrenal gland metastasis was treated by low dose UFT (200 mg/day)." | 1.29 | [A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone]. ( Itoh, Y; Ohkawa, S; Tamai, S; Tarao, K, 1994) |
| "Effects of 5-fluorouracil (5-FU) and UFT on an experimental liver metastasis model were compared at equi-effective dosage levels against subcutaneous tumor of mouse colon 26." | 1.29 | Effect of 5-fluorouracil and UFT on experimental liver metastasis model of colorectal cancer using mouse colon 26 cells. ( Kosaki, G; Kurihara, M; Tominaga, T; Yoshida, Y, 1993) |
| "A 77-year-old male with liver cirrhosis was admitted to our hospital for further examination and treatment of liver tumor." | 1.29 | [A case of hepatocellular carcinoma responding to oral administration of UFT]. ( Matsumoto, K; Onodera, H; Otawa, K; Sato, T; Ukai, K, 1996) |
| "At the same time, malignant lymphoma of the liver and several bones were disclosed, but these tumors had become remarkably smaller after chemotherapy, radiotherapy and transcatheter hepatic arterial chemoembolization." | 1.29 | [A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy]. ( Fujioka, S; Kato, K; Tomono, H, 1996) |
| "A 79-year-old man having advanced gastric cancer with liver metastasis was treated by gastric dissection and gastro-jejunostomy." | 1.29 | [Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis]. ( Hyakuna, Y; Kushibiki, K; Matsuoka, H; Shimada, M; Yokomichi, H, 1996) |
| " Pharmacokinetic examination after intravenous injection of low-dose MMC (0." | 1.29 | A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics. ( Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S, 1996) |
| "A case of gastric cancer with liver metastasis who responded well to low-dose PMUE (CDDP, MMC, UFT, etoposide) therapy is reported." | 1.29 | [A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy]. ( Hirono, T; Hirosawa, H; Izumi, R; Kadoya, N; Konishi, I; Ohta, N; Saito, K; Ueda, N; Yoshimitsu, Y, 1996) |
| "Often operations for gastric cancer accompanied with multiple liver metastasis meet with little success, and almost no case of prolonged survival has been reported." | 1.28 | [A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy]. ( Fukushima, W; Hirosawa, H; Kadoya, N; Konishi, K; Kuroda, Y; Sahara, H; Saitoh, F; Taniya, T; Tsuji, M; Yabushita, K, 1992) |
| "A 74-year-old man with advanced gastric cancer of Borrmann type III and liver metastasis was treated by combined administration of UFT (400 mg/day, p." | 1.28 | [A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan]. ( Hatayama, H; Kitamura, H; Mashiko, H; Satoh, J, 1992) |
| "Etoposide was administered orally at 25-50 mg/day to the gastric cancer patient with liver metastasis." | 1.28 | [A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT]. ( Bandou, H; Kobayashi, T; Mura, T; Nomura, T; Watanabe, K, 1992) |
| "injection against mouse colon cancer, colon 26." | 1.28 | [Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis]. ( Fujimaki, M; Kurokawa, M; Kuroki, Y; Ochiai, H; Okamoto, M; Tazawa, K; Yamashita, I, 1991) |
| "Thermochemotherapy was performed on gastric cancer cases of hepato-metastasis." | 1.28 | [Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer]. ( Fujimura, T; Fushida, S; Kamata, T; Matuki, N; Matumoto, H; Sawa, T; Takegawa, S; Tsugawa, K; Urade, M; Yonemura, Y, 1991) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "Seventeen patients with colorectal cancer metastatic to the liver underwent hepatic resection." | 1.28 | Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. ( Furusawa, M; Kakeji, Y; Maehara, Y; Sugimachi, K; Tomoda, H; Tsujitani, S; Watanabe, A, 1991) |
| "5-FU concentration in liver cancer lesion was 0." | 1.28 | [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases]. ( Amemiya, A; Emoto, T; Fujii, M; Han, N; Itou, A; Iwasaki, T; Tsujimura, T; Yoshikawa, K, 1990) |
| "These two cases showed no recurrent liver cancers." | 1.28 | [Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases]. ( Houjo, K; Kawano, N; Moriya, Y; Sugihara, K, 1990) |
| "In 55 hepatocellular carcinoma patients treated with transcatheter arterial embolization or one shot therapy, the prognosis of patients treated with UFT (group A; n = 23) were historically compared with those of patients treated without UFT (group B; n=32)." | 1.28 | [Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy]. ( Hayashi, K; Ishikawa, T; Ishinoda, Y; Iwaki, Y; Kisanuki, H; Kitamura, T; Maruyama, T; Nakamura, H; Okamoto, T; Shigehira, M, 1990) |
| "One year after total gastrectomy due to gastric cancer, the 50-year-old male patient underwent lateral segmentectomy, since metastatic foci occurred in the outer region of the liver." | 1.28 | [A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract]. ( Hayashi, T; Kitagawa, S; Nakagawa, M; Yamada, T, 1989) |
| " Determination of 5-FU concentrations in blood, normal and tumor tissues following a long term administration of Tegafur was performed." | 1.27 | [Enzymatic conversion of tegafur in human tumor tissue]. ( Hara, Y; Kono, A; Sugata, S; Tanaka, M, 1983) |
| "A 64-year-old male with advanced gastric cancer with multiple liver metastasis was treated with intensive chemotherapy including mitomycin C and tegafur after palliative gastrectomy." | 1.27 | [A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy]. ( Akita, N; Furukawa, H; Iwanaga, T; Koyama, H; Wada, A; Wada, T; Yasutomi, M, 1988) |
| "Primary hepatocellular carcinoma complicated by compensatory cirrhosis accompanying pulmonary metastasis was diagnosed from blood biochemistry tests, a high AFP value (390,000 ng/ml) and angiogram findings." | 1.27 | [Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT]. ( Hayashi, K; Hidaka, Y; Kitamura, T; Maruyama, T; Nakamura, H; Nakatsuru, K; Shigehira, M; Tsuda, K, 1987) |
| "A diagnosis of hepatocellular carcinoma with extrahepatic portal venous obstruction due to tumor invasion was made." | 1.27 | [A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT]. ( Kuroda, K; Maeda, S; Nagase, T; Nakagawa, C; Nakanishi, T; Nishikawa, M; Tokunaga, K, 1987) |
| "Primary hepatoma with infiltration of the inferior vena cava was diagnosed by various imaging techniques and the subject was started on a program of daily oral administrations of 800 mg of tegafur." | 1.27 | [A case of primary hepatoma with marked reduction of the tumor after oral administration of tegafur]. ( Hayashi, K; Ishizaki, J; Kitamura, T; Maruyama, T; Nakamura, H; Shigehira, M; Tsuda, K, 1988) |
| "A total of 850 patients with hepatocellular carcinoma seen during the last 8 years were analyzed retrospectively for survival in relation to treatment and disease stage." | 1.27 | Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. ( Hasegawa, H; Nakajima, Y; Obata, H; Ohnishi, K; Ohtsuki, T; Okazaki, N; Okuda, K; Tomimatsu, M, 1985) |
| "He was diagnosed as having primary hepatocellular carcinoma with bone metastasis by his high titer (111,683 ng/ml) of serum alpha-fetoprotein, computed tomography and abdominal angiography, and so UFT therapy, 400 mg daily, was instituted." | 1.27 | [A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]. ( Imai, Y; Inada, M; Inui, Y; Kawata, S; Matsuda, Y; Minami, Y; Miyoshi, S; Noda, S; Saito, R; Tamura, S, 1987) |
| " the same therapy in combination with UFT as a maintenance therapy (group B; 8 patients)." | 1.27 | [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma]. ( Matsuo, SK; Ohmura, K; Ohtsuka, Y; Suzuki, M, 1987) |
| "Preoperative total doses of UFT for gastric cancer were 3." | 1.27 | [Effects of preoperative administration of UFT in gastrointestinal cancer]. ( Kagaya, H; Matsuoka, S; Miyata, S; Nagabuchi, E; Sato, Y; Uchino, J; Une, Y; Yakura, Y, 1986) |
| " In these 5 cases the daily dosage was 800 mg, and the median duration of PR was 51 days." | 1.27 | [Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP]. ( Fujisawa, T; Imamura, Y; Irie, K; Mizogami, H; Nakamura, T; Nishimura, S; Sawada, Y; Yasutake, K; Yoshida, M; Yoshimura, Y, 1986) |
| "A case of relapsed gastric cancer postoperatively presenting obstructive jaundice due to metastases in the hepatic portal and periaortic lymph nodes and multiple lung metastases was given OK-432 continuously i." | 1.27 | [A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system]. ( Kawahara, M; Matsuo, T; Nagamatsu, Y; Nakarai, I; Shinoda, A, 1986) |
| "The tumor was revealed to be a sigmoid colon cancer with multiple metastasis to both halves of the liver." | 1.27 | [A case of remarkable regression of a colonic cancer involving metastasis to the liver as a result of FT-207 treatment]. ( Kinuta, M; Maruyama, H; Nakano, H; Naoi, M; Nishibe, S; Oka, Y; Okamura, J; Tachiyama, G; Tane, S; Yayoi, E, 1988) |
| "A 75-year-old man with gastric cancer metastatic to the liver was treated by combined administration of Tegafur (800 mg/body/day), 5-fluorouracil (300 mg/body/day) and Mitomycin C (hepatic arterial infusion of 20 mg/body and intravenous infusion of 8 mg/body)." | 1.27 | [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C]. ( Ito, T; Nehashi, Y; Sasaki, J; Sasaki, Y, 1988) |
| "These included 7 cases of pancreatic cancer, 2 cases of gall bladder cancer with infiltration to the liver, and 3 cases of hepatoma." | 1.27 | [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas]. ( Hasegawa, H; Takada, T; Uchiyama, K; Yasuda, H, 1985) |
| "Five patients with colorectal cancer and unresectable synchronous liver metastases have survived for over five years at this writing." | 1.27 | Long-term survivors of colorectal cancer with unresectable hepatic metastases. ( Fujimoto, S; Higuchi, M; Kitsukawa, Y; Miyazaki, M; Okui, K, 1985) |
| "Two patients who had advanced gastric cancer and metastatic liver tumors were treated with a combined chemotherapy using UFT and mitomycin C." | 1.27 | [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases]. ( Hanawa, S; Hara, S; Joya, K; Nakata, K; Sato, K; Shigemitsu, M, 1985) |
| "A retrospective study of 37 colorectal cancer patients with synchronous liver metastases was made." | 1.26 | Comparative efficacy of antitumor treatment for liver metastases from colorectal cancer. ( Fujimoto, S; Kitsukawa, Y; Miyazaki, M; Okui, K, 1981) |
| "Fifteen cases with advanced cancer were treated with UFD-1 (mixture of FD-1 and uracil under molar ratio of 1: 20) in a daily dose of 300 mg of FD-1." | 1.26 | [Clinical experiences with UFD-1]. ( Furue, H, 1982) |
| "Pretreatment with tocopheryl nicotinate and indomethacin increased the K values in the control subjects, but was without effect on the K values in patients with primary hepatoma." | 1.26 | Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma. ( Hobara, N; Watanabe, A, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 65 (9.34) | 18.7374 |
| 1990's | 84 (12.07) | 18.2507 |
| 2000's | 294 (42.24) | 29.6817 |
| 2010's | 244 (35.06) | 24.3611 |
| 2020's | 9 (1.29) | 2.80 |
| Authors | Studies |
|---|---|
| Akutsu, N | 1 |
| Kawakami, Y | 3 |
| Numata, Y | 1 |
| Hirano, T | 4 |
| Wagatsuma, K | 1 |
| Ishigami, K | 1 |
| Sasaki, S | 2 |
| Nakase, H | 1 |
| Fujimoto, H | 2 |
| Ito, S | 1 |
| Kawaguchi, K | 1 |
| Isobe, H | 1 |
| Urayama, M | 1 |
| Fuse, A | 1 |
| Ota, K | 3 |
| Owada, Y | 2 |
| Kawasaki, K | 1 |
| Tanaka, S | 4 |
| Iwabuchi, S | 1 |
| Hosono, M | 1 |
| Okazaki, T | 1 |
| Ienaga, T | 1 |
| Hokkoku, D | 2 |
| Akamaru, Y | 2 |
| Wada, N | 2 |
| Wada, R | 3 |
| Ikeshima, R | 2 |
| Munakata, K | 3 |
| Takiuchi, D | 3 |
| Morimoto, O | 2 |
| Ota, H | 5 |
| Shibata, K | 2 |
| Ohash, H | 1 |
| Kataoka, N | 1 |
| Hiramatsu, S | 2 |
| Yasuda, K | 1 |
| Kashu, N | 1 |
| Yoshitake, H | 1 |
| Takami, T | 1 |
| Yamaguchi, T | 11 |
| Tomita, M | 2 |
| Shono, Y | 1 |
| Makimoto, S | 1 |
| Tamesa, T | 1 |
| Saeki, S | 1 |
| Nishida, Y | 1 |
| Nabeya, M | 1 |
| Tokunou, K | 1 |
| Kawaoka, T | 3 |
| Miyahara, M | 1 |
| Yamashita, Y | 6 |
| Kubo, H | 2 |
| Yamamoto, S | 3 |
| Zhou, L | 1 |
| Lin, J | 1 |
| Wu, G | 1 |
| Chen, J | 2 |
| Huang, X | 1 |
| Zhang, S | 1 |
| Kobayashi, T | 7 |
| Mizuno, S | 3 |
| Matsuba, H | 1 |
| Kanamori, M | 1 |
| Maruyama, S | 2 |
| Tamauchi, T | 1 |
| Tohyama, T | 1 |
| Sakamoto, K | 4 |
| Tamura, K | 2 |
| Nakamura, T | 4 |
| Watanabe, J | 4 |
| Wakisaka, H | 1 |
| Takada, Y | 3 |
| Fujita, T | 2 |
| Shimizu, Y | 2 |
| Dongping, F | 1 |
| Yamamoto, N | 6 |
| Kobayashi, M | 7 |
| Iwabu, H | 1 |
| Tsuji, A | 2 |
| Yan, X | 1 |
| Ning, ZY | 1 |
| Wang, P | 1 |
| Zhuang, LP | 1 |
| Xu, LT | 1 |
| Zhu, ZF | 1 |
| Sheng, J | 1 |
| Shen, YH | 1 |
| Hua, YQ | 1 |
| Meng, ZQ | 1 |
| Eguchi, S | 2 |
| Watanabe, Y | 6 |
| Shiobara, M | 2 |
| Wakatsuki, K | 2 |
| Suda, K | 2 |
| Miyazawa, K | 3 |
| Miyoshi, T | 1 |
| Aida, T | 1 |
| Yoneura, N | 1 |
| Yoshioka, S | 5 |
| Yamazaki, K | 7 |
| Shiraiwa, K | 1 |
| Suzuki, Y | 5 |
| Uchida, H | 1 |
| Iwashita, Y | 1 |
| Tanaka, R | 2 |
| Iwao, M | 1 |
| Tada, K | 3 |
| Hirashita, T | 1 |
| Masuda, T | 2 |
| Endo, Y | 4 |
| Inomata, M | 1 |
| Itoh, H | 1 |
| Mukai, T | 1 |
| Uehara, K | 5 |
| Goto, H | 13 |
| Hiramatsu, K | 3 |
| Kobayashi, S | 14 |
| Sakamoto, E | 3 |
| Maeda, A | 3 |
| Takeuchi, E | 3 |
| Okada, Y | 3 |
| Ebata, T | 2 |
| Nagino, M | 5 |
| Matsuda, K | 1 |
| Namiki, T | 1 |
| Ueno, M | 6 |
| Hashimoto, T | 4 |
| Hanafusa, T | 1 |
| Yokozeki, H | 1 |
| Sato, K | 3 |
| Akiyama, H | 1 |
| Kogure, Y | 1 |
| Suwa, Y | 1 |
| Momiyama, M | 1 |
| Ishibe, A | 1 |
| Endo, I | 2 |
| Saito, H | 6 |
| Fushida, S | 7 |
| Miyashita, T | 3 |
| Oyama, K | 5 |
| Tsukada, T | 3 |
| Kinoshita, J | 4 |
| Tajima, H | 3 |
| Ninomiya, I | 3 |
| Ohta, T | 6 |
| Kudo, M | 4 |
| Moriguchi, M | 2 |
| Numata, K | 1 |
| Hidaka, H | 2 |
| Tanaka, H | 9 |
| Ikeda, M | 13 |
| Kawazoe, S | 1 |
| Ohkawa, S | 5 |
| Sato, Y | 8 |
| Kaneko, S | 6 |
| Furuse, J | 6 |
| Takeuchi, M | 3 |
| Fang, X | 1 |
| Date, Y | 1 |
| Okusaka, T | 8 |
| Yoshizawa, J | 1 |
| Ishizone, S | 2 |
| Ikeyama, M | 1 |
| Nakayama, J | 2 |
| Nomura, H | 1 |
| Okamura, M | 1 |
| Sumii, A | 1 |
| Tsuboi, K | 1 |
| Mizukami, Y | 1 |
| Ota, S | 1 |
| Adachi, Y | 1 |
| Honda, S | 3 |
| Sawada, K | 2 |
| Hasebe, T | 1 |
| Nakajima, S | 1 |
| Fujiya, M | 1 |
| Okumura, T | 2 |
| Das, K | 1 |
| Taguri, M | 1 |
| Imamura, H | 12 |
| Sugimoto, N | 2 |
| Nishikawa, K | 2 |
| Yoshida, K | 8 |
| Tan, P | 1 |
| Tsuburaya, A | 3 |
| Kabashima, A | 2 |
| Kimura, K | 4 |
| Sanefuji, K | 1 |
| Maekawa, S | 1 |
| Ebisui, C | 4 |
| Hamano, R | 1 |
| Minoji, T | 1 |
| Kitahara, T | 1 |
| Yanagisawa, T | 2 |
| Okamura, S | 5 |
| Fukuchi, N | 3 |
| Murata, K | 3 |
| Yokouchi, H | 2 |
| Kinuta, M | 4 |
| Ohishi, K | 2 |
| Namikawa, T | 1 |
| Kawanishi, Y | 1 |
| Fujieda, Y | 1 |
| Fujisawa, K | 3 |
| Munekage, E | 1 |
| Munekage, M | 1 |
| Maeda, H | 2 |
| Kitagawa, H | 3 |
| Hanazaki, K | 3 |
| Miura, S | 4 |
| Ueda, N | 4 |
| Fujita, H | 3 |
| Kinami, S | 1 |
| Nakano, Y | 3 |
| Kosaka, T | 3 |
| Sakata, N | 2 |
| Nishino, R | 1 |
| Okano, N | 1 |
| Kasuga, A | 1 |
| Kawai, K | 3 |
| Yamauchi, Y | 1 |
| Naruge, D | 1 |
| Nagashima, F | 2 |
| Enomoto, T | 1 |
| Mikami, S | 2 |
| Kitajima, M | 4 |
| Hiwatari, M | 1 |
| Ono, T | 3 |
| Sasaki, N | 1 |
| Saji, O | 1 |
| Matsushita, T | 1 |
| Koizumi, S | 1 |
| Ariizumi, Y | 1 |
| Nakajima, T | 3 |
| Otsubo, T | 1 |
| Tatsubayashi, T | 1 |
| Tanishima, H | 1 |
| Iwakura, S | 1 |
| Tominaga, T | 3 |
| Kimura, M | 4 |
| Horiuchi, T | 1 |
| Hoshida, Y | 1 |
| Yokota, Y | 1 |
| Nagase, H | 1 |
| Noguchi, K | 1 |
| Hamabe, A | 1 |
| Hirota, M | 3 |
| Oshima, K | 1 |
| Tanida, T | 1 |
| Tomimaru, Y | 3 |
| Kawase, T | 2 |
| Morita, S | 2 |
| Iwazawa, T | 4 |
| Akagi, K | 3 |
| Dono, K | 12 |
| Shindo, Y | 1 |
| Fukuda, S | 3 |
| Kataoka, R | 1 |
| Kuwamoto, N | 1 |
| Takaishi, H | 1 |
| Miura, Y | 1 |
| Hirayama, R | 1 |
| Otsuka, R | 1 |
| Saito, S | 1 |
| Fujita, R | 1 |
| Komiyama, S | 1 |
| Izumiya, Y | 1 |
| Kimura, Y | 5 |
| Nakashima, S | 1 |
| Kin, S | 1 |
| Kawakami, S | 1 |
| Zhang, XZ | 1 |
| Tu, JJ | 1 |
| Chen, W | 1 |
| Ma, T | 1 |
| Bai, XL | 1 |
| Liang, TB | 1 |
| Ma, CL | 1 |
| Sun, RJ | 1 |
| Li, J | 2 |
| Tominaga, K | 2 |
| Kurumiya, Y | 1 |
| Sekoguchi, E | 1 |
| Kiriyama, M | 1 |
| Tago, T | 1 |
| Suzuki, K | 4 |
| Nishida, K | 1 |
| Maruyama, T | 6 |
| Shimazaki, J | 1 |
| Shimoda, M | 2 |
| Suzuki, S | 6 |
| Kou, K | 1 |
| Morishita, Y | 2 |
| Yoshida, N | 1 |
| Kanno, A | 1 |
| Masamune, A | 1 |
| Nabeshima, T | 1 |
| Hongo, S | 1 |
| Takikawa, T | 1 |
| Hamada, S | 2 |
| Kikuta, K | 1 |
| Kume, K | 1 |
| Shimosegawa, T | 1 |
| Kusano, M | 2 |
| Aoyama, T | 2 |
| Okabayashi, K | 1 |
| Hirata, K | 2 |
| Tsuji, Y | 3 |
| Nakamori, S | 5 |
| Asahara, T | 2 |
| Ohashi, Y | 3 |
| Yoshikawa, T | 3 |
| Sakamoto, J | 1 |
| Oba, K | 1 |
| Saji, S | 1 |
| Saito, K | 4 |
| Isayama, H | 2 |
| Nakai, Y | 2 |
| Takahara, N | 2 |
| Ishigaki, K | 1 |
| Takeda, T | 1 |
| Hakuta, R | 1 |
| Saito, T | 4 |
| Uchino, R | 3 |
| Kishikawa, T | 1 |
| Hamada, T | 4 |
| Sasaki, T | 5 |
| Kogure, H | 3 |
| Matsubara, S | 1 |
| Ijichi, H | 2 |
| Tateishi, K | 2 |
| Tada, M | 2 |
| Koike, K | 3 |
| Yang, H | 1 |
| Sui, Y | 1 |
| Guo, X | 1 |
| Tan, X | 1 |
| Li, Y | 2 |
| Wang, M | 1 |
| Akiyama, N | 1 |
| Karayama, M | 1 |
| Inui, N | 1 |
| Yasui, H | 5 |
| Hozumi, H | 1 |
| Furuhashi, K | 1 |
| Fujisawa, T | 2 |
| Enomoto, N | 1 |
| Nakamura, Y | 4 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 2 |
| Uto, T | 1 |
| Matsui, T | 2 |
| Asada, K | 1 |
| Matsuda, H | 1 |
| Fujii, M | 9 |
| Toyoshima, M | 1 |
| Suda, T | 2 |
| Takahashi, R | 1 |
| Ohashi, M | 6 |
| Kano, Y | 1 |
| Ida, S | 1 |
| Kumagai, K | 2 |
| Nunobe, S | 2 |
| Chin, K | 3 |
| Yamaguchi, K | 3 |
| Sano, T | 1 |
| Hiki, N | 1 |
| Kawada, J | 2 |
| Nishino, M | 2 |
| Hata, M | 2 |
| Tanizaki, K | 2 |
| Ogino, T | 2 |
| Hoshino, H | 2 |
| Okano, M | 3 |
| Nagai, K | 4 |
| Kim, Y | 2 |
| Okuyama, M | 3 |
| Tsujinaka, T | 2 |
| Imamoto, H | 2 |
| Miyata, T | 1 |
| Beppu, T | 3 |
| Imamura, YU | 1 |
| Hayashi, H | 4 |
| Imai, K | 1 |
| Chikamoto, A | 1 |
| Yamashita, YI | 1 |
| Fukubayashi, K | 1 |
| Ishiko, T | 1 |
| Baba, H | 8 |
| Mukai, Y | 1 |
| Matsuyama, R | 1 |
| Koike, I | 1 |
| Kumamoto, T | 2 |
| Kaizu, H | 1 |
| Homma, Y | 1 |
| Takano, S | 2 |
| Sawada, Y | 4 |
| Sugiura, M | 1 |
| Yabushita, Y | 1 |
| Ito, E | 1 |
| Sato, M | 2 |
| Zhai, JM | 1 |
| Yin, XY | 1 |
| Lai, YR | 1 |
| Hou, X | 1 |
| Cai, JP | 1 |
| Hao, XY | 1 |
| Liang, LJ | 1 |
| Zhang, LJ | 1 |
| Yoshida, Y | 3 |
| Sugawara, N | 1 |
| Minami, T | 1 |
| Iwata, N | 1 |
| Ikeda, K | 6 |
| Endoh, T | 1 |
| Sasano, H | 1 |
| Neki, K | 1 |
| Kawahara, H | 4 |
| Watanabe, K | 10 |
| Toyama, Y | 3 |
| Akiba, T | 4 |
| Yanaga, K | 7 |
| Fushiya, N | 1 |
| Takagi, I | 1 |
| Nishino, H | 1 |
| Akizuki, S | 1 |
| Ohnishi, A | 1 |
| Chen, L | 1 |
| Song, MQ | 1 |
| Lin, HZ | 1 |
| Hao, LH | 1 |
| Jiang, XJ | 1 |
| Li, ZY | 2 |
| Chen, YX | 1 |
| Takeda, M | 1 |
| Ori, T | 1 |
| Sunayama, K | 1 |
| Okazaki, M | 2 |
| Okazaki, A | 1 |
| Sato, F | 1 |
| Yamagishi, H | 1 |
| Nishizawa, T | 1 |
| Kinoshita, S | 1 |
| Sakuno, T | 1 |
| Fujiyama, Y | 2 |
| Kikuchi, M | 1 |
| Kaneko, H | 4 |
| Suzuki, H | 2 |
| Takahashi, M | 11 |
| Wang, CF | 1 |
| Wang, YQ | 1 |
| Huang, FZ | 1 |
| Nie, WP | 1 |
| Liu, XY | 1 |
| Jiang, XZ | 1 |
| Tanabe, K | 3 |
| Taura, K | 1 |
| Hatano, E | 3 |
| Koyama, Y | 3 |
| Uemoto, S | 2 |
| Kitahara, H | 1 |
| Oki, E | 2 |
| Saeki, H | 2 |
| Ando, K | 2 |
| Shirabe, K | 2 |
| Kounoe, S | 1 |
| Aishima, S | 1 |
| Kakeji, Y | 4 |
| Maehara, Y | 4 |
| Miyabayashi, K | 1 |
| Sasahira, N | 1 |
| Hirano, K | 1 |
| Enomoto, H | 4 |
| Ishida, K | 2 |
| Wang, LW | 1 |
| Hsiao, CF | 1 |
| Chen, WT | 1 |
| Lee, HH | 1 |
| Lin, TC | 1 |
| Chen, HC | 1 |
| Chen, HH | 1 |
| Chien, CR | 1 |
| Lin, TY | 1 |
| Liu, TW | 1 |
| Hasuike, Y | 4 |
| Iwagami, Y | 1 |
| Toyomasu, T | 1 |
| Yoshikawa, S | 2 |
| Hirao, S | 1 |
| Koshino, T | 2 |
| Tomoda, K | 1 |
| Terai, S | 1 |
| Tai, K | 1 |
| Kanbara, Y | 1 |
| Makino, H | 3 |
| Kametaka, H | 2 |
| Seike, K | 2 |
| Koyama, T | 4 |
| Nakatake, R | 1 |
| Yamamichi, K | 1 |
| Ueda, A | 1 |
| Motohiro, T | 1 |
| Kwon, AH | 1 |
| Kondo, J | 1 |
| Nisimura, T | 1 |
| Nagashima, Y | 1 |
| Okada, T | 3 |
| Nakamura, M | 9 |
| Setoguchi, M | 1 |
| Yoshino, S | 1 |
| Sakata, K | 1 |
| Omura, N | 1 |
| Fukuoka, M | 1 |
| Tachibana, S | 1 |
| Yoshimura, H | 1 |
| Tatsumi, Y | 1 |
| Yoshida, T | 15 |
| Nishizawa, Y | 1 |
| Tatara, T | 1 |
| Tomoda, M | 1 |
| Nagano, I | 1 |
| Yamada, I | 1 |
| Niwa, M | 1 |
| Kanazawa, H | 2 |
| Sato, T | 10 |
| Matsumoto, N | 3 |
| Yoshinaka, H | 1 |
| Ooka, Y | 1 |
| Chiba, T | 1 |
| Ogasawara, S | 1 |
| Arai, K | 5 |
| Suzuki, E | 3 |
| Tawada, A | 1 |
| Yamashita, T | 5 |
| Kanai, F | 1 |
| Yokosuka, O | 2 |
| Saiura, A | 3 |
| Yamamoto, J | 3 |
| Hasegawa, K | 10 |
| Oba, M | 3 |
| Takayama, T | 8 |
| Miyagawa, S | 4 |
| Ijichi, M | 3 |
| Teruya, M | 2 |
| Yoshimi, F | 2 |
| Kawasaki, S | 3 |
| Koyama, H | 5 |
| Makuuchi, M | 3 |
| Kokudo, N | 5 |
| Fujimura, Y | 1 |
| Nakahara, O | 1 |
| Otao, R | 1 |
| Hasegawa, Y | 4 |
| Iwata, H | 1 |
| Hatanaka, M | 1 |
| Shimao, K | 1 |
| Yano, M | 3 |
| Sasaki, K | 4 |
| Goto, T | 2 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 2 |
| Oh, DY | 2 |
| Im, SA | 2 |
| Kim, TY | 2 |
| Bang, YJ | 2 |
| Ha, SW | 1 |
| Zhang, ZD | 1 |
| Kong, Y | 1 |
| Yang, W | 1 |
| Zhang, B | 1 |
| Zhang, YL | 1 |
| Ma, EM | 1 |
| Liu, HX | 1 |
| Chen, XB | 1 |
| Hua, YW | 1 |
| Miyamoto, M | 5 |
| Misawa, S | 1 |
| Iida, T | 1 |
| Nakabayashi, Y | 1 |
| Okui, N | 1 |
| Shiba, H | 1 |
| Otsuka, M | 1 |
| Terazawa, T | 1 |
| Kondo, S | 2 |
| Hosoi, H | 1 |
| Morizane, C | 6 |
| Shimizu, S | 4 |
| Mitsunaga, S | 3 |
| Ueno, H | 9 |
| Shiina, S | 1 |
| Nakachi, K | 5 |
| Kojima, Y | 1 |
| Sakamoto, Y | 4 |
| Asaoka, Y | 1 |
| Tateishi, R | 1 |
| Arioka, H | 1 |
| Sunami, T | 1 |
| Tauchi, J | 1 |
| Sakashita, K | 1 |
| Yukimoto, K | 1 |
| Sawada, R | 1 |
| Koike, M | 4 |
| Mino, K | 2 |
| Shoji, H | 1 |
| Konishi, Y | 1 |
| Katayama, T | 1 |
| Kuwahara, H | 1 |
| Kon, H | 1 |
| Tamura, M | 1 |
| Iwasaki, S | 1 |
| Suzuki, A | 2 |
| Akasaka, Y | 2 |
| Mitan, M | 1 |
| Tsuda, H | 1 |
| Nishiwaki, K | 2 |
| Kagawa, I | 2 |
| Matsumoto, Y | 6 |
| Kishi, S | 1 |
| Yokohira, M | 1 |
| Imaida, K | 1 |
| Saoo, K | 1 |
| Cheng, AL | 4 |
| Vaid, AK | 1 |
| Ma, BB | 1 |
| Teh, C | 1 |
| Ahn, JB | 2 |
| Bello, M | 1 |
| Charoentum, C | 1 |
| Chen, LT | 1 |
| de Lima Lopes, G | 1 |
| Ho, GF | 1 |
| Kong, HL | 1 |
| Lam, KO | 1 |
| Liu, TS | 1 |
| Park, YS | 2 |
| Sriuranpong, V | 1 |
| Sudoyo, AW | 1 |
| Wang, JY | 1 |
| Zhang, J | 3 |
| Zhang, SZ | 1 |
| Ciardiello, F | 1 |
| Köhne, CH | 1 |
| Shaw, M | 1 |
| Kim, TW | 3 |
| Tsuchiya, Y | 2 |
| Aizawa, M | 1 |
| Nomura, T | 2 |
| Nashimoto, A | 2 |
| Fukuda, N | 1 |
| Niki, M | 2 |
| Sano, M | 1 |
| Ogura, R | 1 |
| Wada, J | 1 |
| Nakamura, J | 1 |
| Kai, K | 1 |
| Ide, Y | 2 |
| Nakamura, H | 6 |
| Koga, H | 1 |
| Ide, T | 1 |
| Miyoshi, A | 1 |
| Kitahara, K | 3 |
| Noshiro, H | 1 |
| Izumo, W | 1 |
| Furukawa, K | 2 |
| Katsuragawa, H | 1 |
| Komatsu, A | 1 |
| Shigematsu, K | 1 |
| Shan, F | 1 |
| Zhang, LH | 1 |
| Bu, ZD | 1 |
| Wu, AW | 1 |
| Wu, XJ | 1 |
| Zong, XL | 1 |
| Li, SX | 1 |
| Ji, X | 1 |
| Ji, JF | 1 |
| Konishi, K | 5 |
| Hiraoka, K | 1 |
| Nakagawa, T | 3 |
| Kim, C | 1 |
| Endo, S | 3 |
| Yamada, T | 6 |
| Nishijima, J | 1 |
| Imai, H | 1 |
| Sato, A | 1 |
| Nishi, K | 2 |
| Takahashi, T | 10 |
| Ohori, H | 1 |
| Du, F | 1 |
| Jiang, R | 1 |
| Gu, M | 1 |
| He, C | 1 |
| Guan, J | 1 |
| Kaneko, J | 2 |
| Isogai, J | 2 |
| Aoyagi, H | 3 |
| Maejima, S | 2 |
| Hata, T | 4 |
| Wada, H | 13 |
| Tomokuni, A | 3 |
| Hama, N | 3 |
| Kawamoto, K | 3 |
| Asaoka, T | 2 |
| Marubashi, S | 14 |
| Eguchi, H | 9 |
| Umeshita, K | 13 |
| Takiguchi, S | 2 |
| Mori, M | 12 |
| Doki, Y | 9 |
| Nagano, H | 17 |
| Fujisaki, S | 1 |
| Takashina, M | 1 |
| Tomita, R | 1 |
| Sakurai, K | 4 |
| Maeda, T | 2 |
| Tsuchiya, M | 1 |
| Ishii, J | 1 |
| Koda, T | 1 |
| Kubota, Y | 1 |
| Katagiri, T | 1 |
| Tamura, A | 1 |
| Otsuka, Y | 1 |
| Shibuya, K | 1 |
| Nakayama, A | 1 |
| Shoji, M | 1 |
| Nakanuma, S | 1 |
| Makino, I | 2 |
| Nakagawara, H | 1 |
| Takamura, H | 2 |
| Kumazu, Y | 1 |
| Kitani, Y | 1 |
| Yukawa, N | 1 |
| Rino, Y | 2 |
| Ozawa, Y | 1 |
| Masuda, M | 1 |
| Nagai, Y | 2 |
| Kato, T | 7 |
| Harano, M | 1 |
| Satoh, D | 1 |
| Choda, Y | 1 |
| Tokumoto, N | 1 |
| Kanazawa, T | 1 |
| Matsukawa, H | 1 |
| Ojima, Y | 1 |
| Idani, H | 1 |
| Shiozaki, S | 1 |
| Okajima, M | 2 |
| Ninomiya, M | 1 |
| Ohno, S | 1 |
| Otsuru, T | 1 |
| Iijima, S | 4 |
| Tsujimura, N | 1 |
| Nakao, E | 1 |
| Matsumoto, T | 7 |
| Takachi, K | 2 |
| Nishioka, K | 2 |
| Takemoto, H | 2 |
| Oshima, S | 2 |
| Uemura, Y | 2 |
| Kobayashi, K | 3 |
| Higuchi, I | 1 |
| Akiyama, Y | 1 |
| Yamamoto, M | 11 |
| Tanigawa, T | 2 |
| Tojima, Y | 2 |
| Yatsuya, H | 1 |
| Ohara, T | 1 |
| Fujino, Y | 1 |
| Yamashita, H | 3 |
| Oyama, M | 1 |
| Katsura, M | 1 |
| Sugiyama, H | 1 |
| Ueda, Y | 1 |
| Hasegawa, H | 6 |
| Yasuda, T | 2 |
| Kakinoki, K | 1 |
| Oshikiri, T | 1 |
| Sendo, H | 1 |
| Sugimoto, T | 1 |
| Tominaga, M | 1 |
| Lv, Y | 1 |
| Liang, R | 1 |
| Hu, X | 1 |
| Liu, Z | 1 |
| Liao, X | 1 |
| Lin, Y | 1 |
| Yuan, C | 1 |
| Liao, S | 1 |
| Li, Q | 2 |
| Okamoto, K | 2 |
| Nakamura, K | 4 |
| Ishizuka, M | 1 |
| Kubota, K | 2 |
| Nemoto, T | 2 |
| Kato, M | 2 |
| Iso, Y | 1 |
| Tago, K | 1 |
| Emi, Y | 3 |
| Miyamoto, Y | 3 |
| Higashi, H | 2 |
| Ogata, Y | 4 |
| Ikebe, M | 3 |
| Tokunaga, S | 1 |
| Uchida, S | 2 |
| Takatsuki, M | 1 |
| Sakoda, M | 1 |
| Akagi, Y | 2 |
| Natsugoe, S | 4 |
| Seki, H | 3 |
| Ohi, H | 1 |
| Ozaki, T | 1 |
| Yabusaki, H | 2 |
| Bando, H | 2 |
| Yamada, Y | 2 |
| Tanabe, S | 3 |
| Gotoh, M | 4 |
| Nishina, T | 2 |
| Amagai, K | 1 |
| Niwa, Y | 1 |
| Tsuda, M | 3 |
| Fujii, H | 3 |
| Hironaka, S | 3 |
| Shimada, K | 1 |
| Miwa, H | 3 |
| Hamada, C | 1 |
| Hyodo, I | 1 |
| Cao, C | 1 |
| Kuang, M | 1 |
| Xu, W | 1 |
| Zhang, X | 1 |
| Tang, C | 1 |
| Martin, M | 1 |
| Lopez-Tarruella, S | 1 |
| Takashima, T | 4 |
| Mukai, H | 1 |
| Hara, F | 3 |
| Matsubara, N | 1 |
| Takano, T | 1 |
| Park, Y | 1 |
| Toyama, T | 1 |
| Hozumi, Y | 1 |
| Tsurutani, J | 1 |
| Imoto, S | 1 |
| Watanabe, T | 6 |
| Sagara, Y | 4 |
| Nishimura, R | 2 |
| Shimozuma, K | 1 |
| Aoki, S | 2 |
| Mizuma, M | 1 |
| Oyauchi, M | 1 |
| Yoshida, H | 4 |
| Okada, R | 1 |
| Abe, T | 1 |
| Nakagawa, K | 4 |
| Morikawa, T | 1 |
| Motoi, F | 1 |
| Naitoh, T | 1 |
| Unno, M | 1 |
| Yasumoto, T | 2 |
| Yakushiji, H | 3 |
| Ohira, R | 1 |
| Ohara, N | 1 |
| Nakata, S | 1 |
| Hatano, H | 2 |
| Noda, T | 4 |
| Oh, RJ | 1 |
| Hirabuki, N | 1 |
| Saso, K | 1 |
| Murata, M | 1 |
| Asai, K | 2 |
| Yamada, M | 1 |
| Yagi, T | 2 |
| Katsuyama, S | 1 |
| Sawami, H | 1 |
| Takahashi, H | 2 |
| Takayama, O | 2 |
| Tanaka, N | 5 |
| Baba, M | 2 |
| Hiratsuka, M | 3 |
| Hosoda, Y | 1 |
| Yamasaki, M | 1 |
| Yasui, M | 2 |
| Shimada, T | 1 |
| Sakata, J | 2 |
| Usui, K | 1 |
| Naito, T | 1 |
| Tani, T | 1 |
| Hasegawa, J | 2 |
| Shimakage, N | 1 |
| Wakai, T | 5 |
| Ozato, Y | 1 |
| Kawabata, R | 2 |
| Yoshikawa, M | 1 |
| Kameda, C | 2 |
| Koga, C | 1 |
| Murakami, M | 3 |
| Noura, S | 1 |
| Ikenaga, M | 2 |
| Shimizu, J | 5 |
| Nakada, S | 1 |
| Kawamoto, J | 1 |
| Yoichi, T | 1 |
| Shinoda, K | 1 |
| Ishigami, E | 1 |
| Teranaka, R | 1 |
| Miyazaki, M | 4 |
| Okada, K | 6 |
| Oka, Y | 3 |
| Miyake, Y | 3 |
| Nakane, S | 1 |
| Ueshima, S | 1 |
| Higaki, N | 3 |
| Hayashida, H | 3 |
| Nezu, R | 1 |
| Nakazawa, K | 2 |
| Kametani, N | 1 |
| Hirakawa, T | 2 |
| Kato, Y | 4 |
| Komoto, M | 1 |
| Yamagata, S | 2 |
| Kanehara, I | 2 |
| Ako, E | 2 |
| Yamada, N | 3 |
| Nishimura, S | 3 |
| Taenaka, N | 2 |
| Okamoto, T | 2 |
| Tanaka, K | 5 |
| Yonemitsu, K | 1 |
| Munechika, T | 1 |
| Nomi, M | 1 |
| Maeno, H | 1 |
| Nagao, S | 4 |
| Kawamoto, S | 1 |
| Sasaguri, T | 1 |
| Sueishi, K | 1 |
| Oda, K | 1 |
| Kubosawa, H | 1 |
| Kataoka, M | 1 |
| Arai, S | 1 |
| Oeda, Y | 1 |
| Takagi, T | 3 |
| Suda, H | 1 |
| Omori, K | 1 |
| Suematsu, Y | 1 |
| Ishibashi, Y | 1 |
| Morita, A | 1 |
| Wakabayashi, K | 1 |
| Ito, Y | 4 |
| Eto, R | 1 |
| Nakatsu, H | 1 |
| Ozasa, H | 2 |
| Shimizu, R | 1 |
| Nonoshita, T | 1 |
| Otsuka, S | 1 |
| Inagaki, M | 2 |
| Iwagaki, H | 1 |
| Yamauchi, K | 1 |
| Kokuryo, T | 1 |
| Yokoyama, Y | 1 |
| Yamaguchi, J | 1 |
| Arita, J | 1 |
| Shinozaki, E | 1 |
| Mizunuma, N | 3 |
| Matsuyama, Y | 3 |
| Kuga, Y | 2 |
| Moriya, T | 2 |
| Nishida, T | 3 |
| Tomioku, M | 1 |
| Yazawa, N | 1 |
| Furukawa, D | 1 |
| Izumi, H | 1 |
| Mashiko, T | 1 |
| Ozawa, S | 1 |
| Sadahiro, S | 2 |
| Yasuda, S | 4 |
| Hirabayashi, K | 1 |
| Nakagohri, T | 1 |
| Hara, R | 1 |
| Fujii, T | 2 |
| Ikeda, A | 1 |
| Hashiyata, H | 1 |
| Nakamoto, K | 2 |
| Takeshige, M | 1 |
| Kiyota, S | 1 |
| Matsuda, Y | 3 |
| Hanada, S | 1 |
| Kinoshita, M | 2 |
| Nishizawa, S | 2 |
| Kanazawa, G | 1 |
| Egashira, S | 1 |
| Kajihara, I | 1 |
| Kanemaru, H | 1 |
| Uemura-Kiyohara, M | 1 |
| Yamada-Kanazawa, S | 1 |
| Nakahara, S | 1 |
| Nagamoto, E | 1 |
| Fukushima, S | 1 |
| Jinnin, M | 1 |
| Inoue, Y | 5 |
| Ihn, H | 1 |
| Kou, P | 1 |
| Zhang, Y | 1 |
| Shao, W | 1 |
| Zhu, H | 1 |
| Wang, H | 1 |
| Kong, L | 1 |
| Yu, J | 1 |
| Hiraki, S | 1 |
| Kanesada, K | 1 |
| Harada, T | 2 |
| Hashiguchi, M | 2 |
| Tamai, T | 1 |
| Nasu, Y | 1 |
| Sasaki, F | 1 |
| Higashi, M | 1 |
| Hijikuro, K | 1 |
| Futawatari, H | 1 |
| Shigeta, K | 1 |
| Hasegawa, S | 2 |
| Ido, A | 1 |
| Aoki, Y | 2 |
| Kojima, S | 1 |
| Kataoka, T | 3 |
| Kayukawa, S | 2 |
| Mori, F | 2 |
| Masaki, A | 2 |
| Yamada, K | 2 |
| Kawai, M | 2 |
| Kabeya, M | 1 |
| Hibi, S | 1 |
| Furuta, R | 2 |
| Ina, K | 4 |
| Fujimoto, C | 1 |
| Maruyama, Y | 1 |
| Niina, Y | 1 |
| Fujimori, N | 1 |
| Sumii, T | 2 |
| Funakoshi, A | 4 |
| Matsutani, T | 2 |
| Mizutani, T | 2 |
| Maruyama, H | 5 |
| Yokoyama, T | 2 |
| Yanagi, K | 2 |
| Matsushita, A | 3 |
| Kashiwabara, M | 1 |
| Matsuda, A | 1 |
| Nishi, Y | 1 |
| Arai, H | 1 |
| Sasajima, K | 2 |
| Tajiri, T | 3 |
| Ishigami, S | 3 |
| Nakajo, A | 2 |
| Uenosono, Y | 2 |
| Arigami, T | 2 |
| Setoyama, T | 2 |
| Uchikado, Y | 2 |
| Matsumoto, M | 6 |
| Aikou, T | 4 |
| Tokunaga, M | 3 |
| Tanabe, Y | 1 |
| Nasu, T | 3 |
| Abe, Y | 2 |
| Mitsuyama, S | 2 |
| Toyoshima, S | 1 |
| Tomimatsu, H | 1 |
| Nakano, T | 1 |
| Takeuchi, Y | 2 |
| Fukuoka, T | 1 |
| Miwa, T | 1 |
| Nishio, T | 1 |
| Ando, T | 3 |
| Lee, JL | 2 |
| Kang, YK | 2 |
| Kang, HJ | 1 |
| Lee, KH | 1 |
| Zang, DY | 1 |
| Ryoo, BY | 2 |
| Kim, JG | 1 |
| Park, SR | 1 |
| Kang, WK | 2 |
| Shin, DB | 1 |
| Ryu, MH | 2 |
| Chang, HM | 2 |
| Baek, JH | 1 |
| Min, YJ | 1 |
| Udagawa, I | 1 |
| Yasutomi, J | 1 |
| Kusashio, K | 1 |
| Kasagawa, T | 1 |
| Tonooka, T | 1 |
| Tashima, Y | 1 |
| Irabu, S | 1 |
| Nobumoto, D | 1 |
| Suzuki, M | 4 |
| Fukao, K | 1 |
| Morinaga, S | 3 |
| Yamamoto, Y | 2 |
| Sugano, N | 1 |
| Shiozawa, M | 1 |
| Akaike, M | 1 |
| Sugimasa, Y | 1 |
| Uka, K | 1 |
| Aikata, H | 2 |
| Mori, N | 2 |
| Takaki, S | 2 |
| Azakami, T | 1 |
| Jeong, SC | 1 |
| Takahashi, S | 5 |
| Chayama, K | 5 |
| Mazaki, T | 1 |
| Mado, K | 1 |
| Manmoto, J | 1 |
| Okame, H | 1 |
| Ishii, Y | 3 |
| Masuda, H | 1 |
| Shiba, E | 2 |
| Yamamoto, H | 7 |
| Takahara, S | 1 |
| Tokushima, H | 1 |
| Osaki, Y | 1 |
| Tokudome, N | 1 |
| Sugihara, T | 2 |
| Iwase, T | 1 |
| Hatake, K | 1 |
| Ishii, T | 2 |
| Komoriyama, H | 1 |
| Ashikawa, K | 1 |
| Ohtsubo, T | 1 |
| Tawada, K | 1 |
| Ishihara, T | 1 |
| Kobayashi, A | 4 |
| Tsuyuguchi, T | 1 |
| Matsuyama, M | 2 |
| Tokunaga, N | 2 |
| Itaba, S | 2 |
| Yoshinaga, S | 1 |
| Murao, H | 1 |
| Akiho, H | 1 |
| Nagai, E | 1 |
| Goto, A | 1 |
| Segawa, Y | 1 |
| Takayanagi, R | 1 |
| Hoshikawa, K | 1 |
| Aoki, K | 3 |
| Noda, H | 2 |
| Nitta, H | 1 |
| Wakabayashi, G | 1 |
| Idelevich, E | 2 |
| Greif, F | 1 |
| Mavor, E | 1 |
| Miller, R | 1 |
| Kashtan, H | 1 |
| Susmalian, S | 1 |
| Ariche, A | 1 |
| Brenner, B | 1 |
| Baruch, NB | 2 |
| Dinerman, M | 2 |
| Shani, A | 2 |
| Ueshima, K | 3 |
| Nagai, T | 1 |
| Tatsumi, C | 1 |
| Ueda, T | 1 |
| Hatanaka, K | 2 |
| Kitai, S | 1 |
| Ishikawa, E | 1 |
| Inoue, T | 3 |
| Hagiwara, S | 3 |
| Minami, Y | 4 |
| Chung, H | 2 |
| Watanabe, M | 5 |
| Nanami, T | 1 |
| Yajima, S | 1 |
| Oshima, Y | 1 |
| Takeyama, T | 2 |
| Ito, M | 1 |
| Saito, F | 1 |
| Kishimoto, T | 2 |
| Furukawa, H | 8 |
| Miyazaki, Y | 2 |
| Yamamoto, T | 5 |
| Fukunaga, M | 4 |
| Ohzato, H | 2 |
| Tatsuta, M | 3 |
| Tokairin, Y | 1 |
| Iida, M | 1 |
| Yamazaki, S | 1 |
| Nakata, K | 5 |
| Suzuki, R | 3 |
| Uji, K | 3 |
| Yoshida, A | 2 |
| Yoshimura, M | 2 |
| Nakahira, S | 4 |
| Miki, H | 4 |
| Sugimoto, K | 4 |
| Tamura, S | 7 |
| Iizuka, T | 1 |
| Hirano, N | 1 |
| Kikuchi, D | 1 |
| Hoteya, S | 1 |
| Yahagi, N | 1 |
| Chayahara, N | 1 |
| Tamura, T | 1 |
| Yamamori, M | 1 |
| Kadowaki, Y | 1 |
| Okuno, T | 1 |
| Miki, I | 1 |
| Nishisaki, H | 1 |
| Okumura, K | 1 |
| Azuma, T | 2 |
| Kasuga, M | 1 |
| Sakaeda, T | 1 |
| Hirai, M | 1 |
| Suzuki, T | 10 |
| Maeda, Y | 2 |
| Tanaka, A | 1 |
| Ishikawa, K | 1 |
| Makuuchi, H | 2 |
| Murayama, C | 1 |
| Tsuchiya, A | 2 |
| Imai, M | 2 |
| Kamimura, H | 2 |
| Togashi, T | 2 |
| Seki, K | 3 |
| Ishikawa, T | 12 |
| Ohta, H | 5 |
| Kamimura, T | 5 |
| Sekino, Y | 1 |
| Okada, M | 2 |
| Hamada, J | 1 |
| Tagami, S | 1 |
| Sakon, M | 7 |
| Okita, K | 2 |
| Takata, M | 1 |
| Hayashi, K | 6 |
| Munakata, Y | 1 |
| Kitajima, Y | 1 |
| Yakabe, T | 1 |
| Ohtsuka, T | 1 |
| Tanaka, M | 6 |
| Sato, S | 4 |
| Nakafusa, Y | 1 |
| Miyazaki, K | 3 |
| Okamura, H | 1 |
| Fujiwara, H | 2 |
| Ichikawa, D | 1 |
| Kikuchi, S | 2 |
| Kubota, T | 4 |
| Ikoma, H | 2 |
| Nakanishi, M | 1 |
| Ochiai, T | 2 |
| Sakakura, C | 1 |
| Kokuba, Y | 1 |
| Taniguchi, H | 3 |
| Sonoyama, T | 1 |
| Otsuji, E | 2 |
| Fujimura, T | 5 |
| Yagi, Y | 1 |
| Niwa, T | 1 |
| Amano, A | 2 |
| Masaki, T | 1 |
| Miyakawa, K | 3 |
| Matsuda, M | 2 |
| Shiba, S | 1 |
| Asakawa, M | 1 |
| Kono, H | 1 |
| Kimura, H | 2 |
| Mukawa, A | 1 |
| Tokunaga, Y | 1 |
| Sasaki, H | 1 |
| Naito, M | 2 |
| Shinohara, T | 2 |
| Ishii, F | 1 |
| Shibata, R | 1 |
| Yamaguchi, R | 1 |
| Maki, K | 1 |
| Hoshino, S | 1 |
| Shibata, N | 1 |
| Eto, TA | 1 |
| Asada, T | 1 |
| Takaya, T | 1 |
| Shimayama, T | 1 |
| Imada, S | 1 |
| Futami, S | 1 |
| Chijiiwa, K | 1 |
| Tanisaka, Y | 1 |
| Seike, H | 1 |
| Tanaka, Y | 3 |
| Tsubouchi, E | 1 |
| Miyauchi, S | 1 |
| Iwakawa, K | 1 |
| Ichikawa, M | 1 |
| Koizumi, W | 3 |
| Takiuchi, H | 3 |
| Boku, N | 6 |
| Fuse, N | 1 |
| Muro, K | 3 |
| Komatsu, Y | 3 |
| Kochi, M | 2 |
| Kanamori, N | 2 |
| Kaiga, T | 2 |
| Funada, T | 1 |
| Tomita, K | 1 |
| Nishijima, W | 1 |
| Tsukuda, M | 1 |
| Ishitoya, J | 1 |
| Yamane, H | 1 |
| Homma, A | 1 |
| Tomita, T | 1 |
| Itoh, Y | 2 |
| Nakagawa, S | 4 |
| Takii, Y | 1 |
| Otsuo, T | 1 |
| Kubota, H | 1 |
| Matsumoto, H | 8 |
| Saito, A | 1 |
| Murakami, H | 1 |
| Higashida, M | 1 |
| Hirabayashi, Y | 1 |
| Okumura, H | 2 |
| Uragami, A | 1 |
| Yamashita, K | 2 |
| Hirai, T | 1 |
| Yoden, E | 1 |
| Hiratsuka, J | 1 |
| Nakano, D | 2 |
| Iwanaga, T | 6 |
| Iwasaki, Y | 7 |
| Takahashi, K | 7 |
| Igarashi, Y | 1 |
| Aoki, T | 8 |
| Yamanaka, C | 2 |
| Komori, T | 1 |
| Hashimoto, K | 5 |
| Kashiwazaki, M | 1 |
| Okubo, K | 2 |
| Akitake, H | 1 |
| Ohtsuka, M | 1 |
| Maekawa, T | 1 |
| Taniguchi, M | 5 |
| Tsujie, M | 4 |
| Konishi, M | 1 |
| Fujimoto, T | 4 |
| Takeda, Y | 9 |
| Tanemura, M | 6 |
| Wakasa, K | 3 |
| Hayashi, S | 2 |
| Zenitani, M | 1 |
| Watanabe, N | 1 |
| Takamoto, K | 1 |
| Kagawa, Y | 1 |
| Kawanishi, K | 2 |
| Fujita, J | 3 |
| Kitada, M | 2 |
| Shimano, T | 2 |
| Kitagawa, T | 2 |
| Monden, M | 12 |
| Morishima, K | 1 |
| Hyodo, M | 1 |
| Nihei, Y | 1 |
| Sata, N | 1 |
| Yasuda, Y | 1 |
| Kanou, M | 1 |
| Kurisu, Y | 1 |
| Akagi, S | 1 |
| Tanaka, T | 8 |
| Toge, K | 1 |
| Nobuhara, Y | 1 |
| Kubo, N | 4 |
| Matuoka, T | 1 |
| Yo, T | 1 |
| Ji, SP | 1 |
| Dong, H | 1 |
| Higuchi, K | 3 |
| Kitaguchi, H | 1 |
| Nakai, T | 1 |
| Yoshifuji, T | 1 |
| Ueda, K | 1 |
| Tokoro, T | 1 |
| Hida, J | 1 |
| Okuno, K | 1 |
| Yamamoto, K | 2 |
| Matsuyama, S | 3 |
| Sonoda, K | 1 |
| Murakami, S | 3 |
| Higaki, K | 1 |
| Nasu, K | 1 |
| Kikuno, M | 1 |
| Kawaguchi, M | 1 |
| Asada, Y | 1 |
| Terada, T | 2 |
| Takehara, A | 1 |
| Munemoto, Y | 2 |
| Mitsui, T | 2 |
| Iida, Y | 2 |
| Sudo, Y | 1 |
| Miyahira, T | 1 |
| Teruya, N | 1 |
| Matsuura, F | 1 |
| Murayama, S | 1 |
| Aka, H | 1 |
| Teruya, J | 1 |
| Hanashiro, N | 1 |
| Nishihara, M | 1 |
| Okushima, N | 1 |
| Toda, Y | 1 |
| Kiyuna, M | 1 |
| Yokoo, H | 2 |
| Kamiyama, T | 4 |
| Nakanishi, K | 3 |
| Tahara, M | 2 |
| Fukumori, D | 1 |
| Kamachi, H | 3 |
| Matsushita, M | 3 |
| Todo, S | 3 |
| Tayama, Y | 1 |
| Hsu, CH | 3 |
| Shen, YC | 2 |
| Lin, ZZ | 1 |
| Chen, PJ | 1 |
| Shao, YY | 2 |
| Ding, YH | 1 |
| Hsu, C | 2 |
| Ishii, A | 1 |
| Imanishi, H | 1 |
| Saito, M | 2 |
| Iwata, Y | 1 |
| Sakai, Y | 2 |
| Iwai, T | 1 |
| Yoh, K | 1 |
| Aizawa, N | 1 |
| Ikeda, N | 3 |
| Shimomura, S | 1 |
| Iijima, H | 1 |
| Hirota, S | 1 |
| Nishiguchi, S | 1 |
| Oka, T | 1 |
| Tokumo, M | 1 |
| Yamakawa, T | 1 |
| Onoda, Y | 1 |
| Suzuka, I | 1 |
| Shiota, K | 1 |
| Yasutome, M | 3 |
| Mori, T | 4 |
| Hashimoto, M | 2 |
| Moriyuki, T | 1 |
| Kuranishi, F | 1 |
| Niitsu, H | 1 |
| Fujikuni, N | 1 |
| Iwako, H | 1 |
| Kuroda, Y | 2 |
| Sakaguchi, H | 2 |
| Aizawa, K | 1 |
| Muramatsu, S | 1 |
| Kumaki, T | 1 |
| Kasuga, Y | 1 |
| Ogura, M | 1 |
| Furuya, T | 1 |
| Nomura, Y | 1 |
| Nagai, M | 1 |
| Hirao, H | 1 |
| Miyano, M | 1 |
| Kurai, O | 1 |
| Yamasaki, T | 1 |
| Sasaki, E | 3 |
| Adachi, K | 1 |
| Oka, H | 2 |
| Taku, K | 2 |
| Yokota, T | 1 |
| Shitara, K | 5 |
| Kojima, T | 1 |
| Ueda, S | 2 |
| Machida, N | 2 |
| Kamigaki, S | 1 |
| Arai, T | 1 |
| Ohsato, H | 1 |
| Sohta, Y | 1 |
| Kaze, C | 1 |
| Matsuda, S | 2 |
| Yabuno, T | 1 |
| Mochizuki, Y | 1 |
| Kito, F | 1 |
| Kunisaki, C | 2 |
| Sato, I | 1 |
| Kinoshita, E | 1 |
| Minato, H | 1 |
| Ohno, K | 1 |
| Nakaya, N | 1 |
| Shimasaki, T | 1 |
| Nakajima, H | 2 |
| Motoo, Y | 1 |
| Akazawa, N | 1 |
| Taguchi, K | 1 |
| Imai, A | 1 |
| Kikuchi, H | 1 |
| Minato, M | 1 |
| Iwaki, H | 1 |
| Yamaki, K | 1 |
| Morisaki, T | 3 |
| Hasegawa, T | 1 |
| Tachimori, A | 2 |
| Enomoto, J | 1 |
| Yamaguchi, M | 3 |
| Takita, M | 1 |
| Haji, S | 1 |
| Arao, T | 1 |
| Nishio, K | 1 |
| Park, AM | 1 |
| Munakata, H | 1 |
| Shikano, T | 1 |
| Hattori, K | 1 |
| Kinoshita, T | 1 |
| Hachisuka, T | 1 |
| Shinohara, M | 1 |
| Miyauchi, M | 1 |
| Fukui, H | 2 |
| Kou, C | 2 |
| Tomizawa, K | 1 |
| Udagawa, H | 1 |
| Sawada, T | 4 |
| Watanabe, G | 1 |
| Kumazawa, S | 1 |
| Murata, Y | 1 |
| Ishita, T | 1 |
| Nakamura, S | 3 |
| Tamura, N | 1 |
| Oikawa, Y | 1 |
| Kubo, Y | 2 |
| Kurata, N | 1 |
| Yagi, K | 1 |
| Hattori, S | 1 |
| Bando, M | 1 |
| Matsumoto, K | 4 |
| Machinami, R | 1 |
| Sato, H | 4 |
| Ogasawara, T | 1 |
| Tsujii, S | 1 |
| Nagahori, J | 1 |
| Matsuoka, A | 2 |
| Ishii, H | 6 |
| Amaya, S | 1 |
| Koizumi, H | 1 |
| Yamamoto, D | 2 |
| Kanematsu, S | 1 |
| Ah, K | 1 |
| Kim, SJ | 2 |
| Yi, NJ | 1 |
| Kim, YJ | 1 |
| Yoon, JH | 1 |
| Kang, GH | 1 |
| Suh, KS | 1 |
| Jang, JJ | 1 |
| Shimizu, H | 2 |
| Itokawa, Y | 1 |
| Shioaki, Y | 1 |
| Sonoda, H | 1 |
| Ikeda, J | 1 |
| Koide, K | 1 |
| Taniguchi, F | 1 |
| Ueshima, Y | 1 |
| Takashina, K | 1 |
| Iwauchi, T | 1 |
| Amano, R | 4 |
| Ohira, G | 1 |
| Doi, Y | 1 |
| Ohira, M | 4 |
| Hirakawa, K | 5 |
| Nakase, Y | 1 |
| Fukumoto, K | 1 |
| Miyagaki, T | 1 |
| Ishida, E | 1 |
| Kobayashi, Y | 1 |
| Soga, K | 2 |
| Kanemitsu, D | 1 |
| Kassai, K | 1 |
| Takenaka, S | 1 |
| Yanagida, K | 1 |
| Itani, K | 1 |
| Fukumoto, I | 1 |
| Minagawa, R | 1 |
| Hamatsu, T | 1 |
| Honboh, T | 1 |
| Ushijima, C | 1 |
| Kitamura, M | 4 |
| Ohhinata, R | 1 |
| Kim, HM | 1 |
| Miyoshi, N | 1 |
| Hirose, H | 1 |
| Yamashita, S | 2 |
| Takemasa, I | 1 |
| Mizushima, T | 2 |
| Sekimoto, M | 2 |
| Nishigaki, T | 2 |
| Katsuta, E | 1 |
| Someno, Y | 1 |
| Saguchi, M | 1 |
| Takahata, T | 2 |
| Yamada, D | 1 |
| Sogabe, S | 1 |
| Yuki, S | 1 |
| Kusumi, T | 1 |
| Miyagishima, T | 1 |
| Hosokawa, A | 2 |
| Iwanaga, I | 1 |
| Sakata, Y | 7 |
| Asaka, M | 1 |
| Hsu, CY | 1 |
| Yu, CW | 1 |
| Hu, FC | 1 |
| Chen, BB | 1 |
| Wei, SY | 1 |
| Shih, TT | 1 |
| Hatata, T | 1 |
| Takaya, S | 1 |
| Taniguchi, K | 1 |
| Naka, T | 1 |
| Kondo, A | 1 |
| Ikeguchi, M | 1 |
| Nishimizu, T | 1 |
| Minemura, M | 1 |
| Kajiura, S | 1 |
| Tokimitsu, Y | 1 |
| Itaya, Y | 1 |
| Yamawaki, H | 1 |
| Tajiri, K | 1 |
| Nakayama, Y | 1 |
| Takahara, T | 1 |
| Yasumura, S | 1 |
| Fukuoka, J | 1 |
| Ishizawa, S | 2 |
| Sawasaki, T | 1 |
| Yanagisawa, A | 1 |
| Sugiyama, T | 1 |
| Kusumoto, M | 1 |
| Toyoda, S | 1 |
| Ishikawa, N | 1 |
| Kusumoto, C | 1 |
| Kohro, T | 1 |
| Doi, F | 1 |
| Kiyoto, S | 1 |
| Takabatake, D | 1 |
| Takashima, S | 2 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Kameda, R | 1 |
| Kanazawa, A | 1 |
| Schultheis, B | 1 |
| Strumberg, D | 1 |
| Bergmann, L | 1 |
| Graeven, U | 1 |
| Hanauske, AR | 1 |
| Lipp, R | 1 |
| Schuette, J | 1 |
| Scigalla, P | 1 |
| Scheulen, ME | 1 |
| Tamada, S | 1 |
| Baba, S | 1 |
| Yotsumoto, D | 1 |
| Matsukata, A | 1 |
| Andou, M | 1 |
| Rai, Y | 2 |
| Sada, M | 1 |
| Mizukami, T | 1 |
| Kakisaka, T | 1 |
| Iwase, H | 2 |
| Shimada, M | 3 |
| Tsuzuki, T | 1 |
| Sugihara, M | 2 |
| Haruta, J | 2 |
| Shinoda, M | 2 |
| Kumada, T | 1 |
| Satoh, M | 1 |
| Nakano, O | 1 |
| Kuwahara, M | 1 |
| Ito, A | 3 |
| Arai, Y | 4 |
| Lee, SJ | 1 |
| Lee, J | 3 |
| Park, SH | 1 |
| Park, JO | 1 |
| Yim, DS | 1 |
| Lim, HY | 1 |
| Kuga, T | 2 |
| Oka, K | 1 |
| Yamashita, A | 1 |
| Fujii, Y | 2 |
| Hanashima, M | 1 |
| Hamano, K | 1 |
| Yoshimura, G | 1 |
| Ito, D | 1 |
| Furumoto, K | 1 |
| Kogire, M | 1 |
| Endo, M | 1 |
| Tsuchida, A | 4 |
| Aono, K | 1 |
| Yasui, A | 1 |
| Takeno, A | 1 |
| Kanemura, T | 1 |
| Yanai, A | 1 |
| Yoshioka, Y | 2 |
| Teramoto, A | 1 |
| Egawa, C | 1 |
| Takatsuka, Y | 2 |
| Hara, Y | 3 |
| Kawano, T | 1 |
| Tsushima, T | 2 |
| Fukutomi, A | 2 |
| Todaka, A | 1 |
| Onozawa, Y | 1 |
| Narita, T | 1 |
| Seshimo, A | 1 |
| Itabashi, M | 1 |
| Aratake, K | 1 |
| Ogawa, S | 1 |
| Hirosawa, T | 1 |
| Amano, K | 1 |
| Kameoka, S | 1 |
| Nitori, N | 1 |
| Kato, A | 1 |
| Deguchi, T | 1 |
| Okada, A | 1 |
| Kojima, M | 1 |
| Kuroda, J | 1 |
| Kadomura, T | 1 |
| Origuchi, N | 1 |
| Fujisaki, M | 2 |
| Takeji, S | 1 |
| Asagi, A | 1 |
| Kajiwara, T | 1 |
| Hori, S | 1 |
| Ikeda, Y | 2 |
| Nadano, S | 1 |
| Iguchi, H | 1 |
| Koo, DH | 1 |
| Lee, SS | 1 |
| Moon, JH | 1 |
| Murayama, R | 1 |
| Nagata, N | 1 |
| Sawatsubashi, T | 1 |
| Shinohara, I | 1 |
| Kuroda, H | 1 |
| Sako, T | 1 |
| Sanefuji, H | 1 |
| Okazaki, S | 2 |
| Ohtsukasa, S | 1 |
| Nakajima, Y | 4 |
| Kamiya, A | 1 |
| Takamatsu, S | 1 |
| Kawachi, Y | 1 |
| Mikami, K | 2 |
| Ito, G | 1 |
| Muguruma, K | 3 |
| Nagahara, H | 3 |
| Noda, E | 3 |
| Yashiro, M | 1 |
| Maeda, K | 4 |
| Nakata, B | 2 |
| Sanada, T | 1 |
| Wakabayashi, M | 2 |
| Kuwabara, H | 1 |
| Nakajima, K | 1 |
| Goseki, N | 1 |
| Miyake, M | 1 |
| Katsura, Y | 2 |
| Ishizawa, Y | 1 |
| Aizawa, S | 1 |
| Okudera, D | 1 |
| Yokoyama, M | 3 |
| Aizawa, H | 2 |
| Satoh, Y | 1 |
| Kasai, M | 2 |
| Munakata, M | 5 |
| Hakamada, K | 1 |
| Wada, S | 1 |
| Okamura, R | 1 |
| Yoh, T | 1 |
| Nobutou, Y | 1 |
| Higashiyama, M | 1 |
| Nakayama, H | 1 |
| Teraishi, F | 2 |
| Ozaki, K | 2 |
| Shibuya, Y | 1 |
| Shima, Y | 2 |
| Hamada, M | 1 |
| Fukui, Y | 1 |
| Nishioka, Y | 1 |
| Horimi, T | 1 |
| Uchida, Y | 3 |
| Miyagawa, K | 1 |
| Hiura, M | 1 |
| Taguchi, M | 1 |
| Kihara, Y | 1 |
| Abe, S | 2 |
| Shimajiri, S | 2 |
| Harada, M | 1 |
| Mori, Y | 2 |
| Ohtani, H | 1 |
| Tamamori, Y | 1 |
| Ishibashi, N | 2 |
| Murakami, N | 1 |
| Kibe, S | 1 |
| Yahara, T | 1 |
| Shirouzu, K | 6 |
| Huang, CC | 1 |
| Lin, SD | 1 |
| Masuishi, T | 1 |
| Soma, T | 1 |
| Nagayama, K | 1 |
| Kusano, F | 1 |
| Tazawa, J | 1 |
| El-Omar, EM | 1 |
| Takashi, H | 1 |
| Murayama, M | 2 |
| Morise, K | 2 |
| Komatsubara, T | 1 |
| Inamoto, S | 1 |
| Teramura, Y | 1 |
| Hashida, S | 1 |
| Akamatsu, S | 1 |
| Hamai, Y | 2 |
| Hihara, J | 2 |
| Emi, M | 1 |
| Kushitani, K | 1 |
| Kagawa, K | 2 |
| Honda, Y | 1 |
| Nakahara, T | 1 |
| Naeshiro, N | 1 |
| Miyaki, D | 1 |
| Nagaoki, Y | 1 |
| Hiramatsu, A | 1 |
| Waki, K | 1 |
| Hyogo, H | 1 |
| Arihiro, K | 1 |
| Sanetou, H | 1 |
| Matsunaga, M | 1 |
| Ishiyama, Y | 1 |
| Kaneko, M | 3 |
| Kotake, M | 1 |
| Inaki, N | 1 |
| Kurokawa, M | 2 |
| Sakaguchi, K | 2 |
| Takahashi, Y | 4 |
| Tanizawa, Y | 2 |
| Bando, E | 2 |
| Kawamura, T | 2 |
| Kanemoto, H | 2 |
| Uesaka, K | 2 |
| Aramaki, T | 2 |
| Terashima, M | 3 |
| Terashima, T | 1 |
| Sunagozaka, H | 2 |
| Shimakami, T | 1 |
| Mizukoshi, E | 1 |
| Sakai, A | 1 |
| Honda, M | 1 |
| Francois, E | 1 |
| Smith, D | 1 |
| Dahan, L | 1 |
| Michel, C | 1 |
| Perrier, H | 1 |
| Mari, V | 1 |
| Seitz, JF | 1 |
| Follana, P | 1 |
| Evesque, L | 1 |
| Chamorey, E | 1 |
| Fujioka, M | 2 |
| Ito, T | 6 |
| Shiomi, M | 2 |
| Narita, M | 2 |
| Morita, K | 1 |
| Takeuchi, A | 1 |
| Hashizume, K | 1 |
| Shibahara, H | 1 |
| Nishimura, D | 1 |
| Katada, N | 1 |
| Katano, Y | 1 |
| Lee, T | 1 |
| Toyama, H | 1 |
| Matsumoto, I | 1 |
| Shinzeki, M | 1 |
| Shirakawa, S | 2 |
| Ajiki, T | 1 |
| Ueno, K | 2 |
| Sawa, H | 1 |
| Otsubo, I | 1 |
| Kido, M | 1 |
| Fukumoto, T | 1 |
| Ku, Y | 1 |
| Akita, H | 1 |
| Ohashi, I | 1 |
| Arai, I | 1 |
| Tamura, C | 1 |
| Inoue, S | 2 |
| Fujii, C | 1 |
| Izeki, C | 1 |
| Itsui, Y | 1 |
| Yoshida, R | 1 |
| Akashi, T | 1 |
| Yauchi, T | 1 |
| Takeyoshi, I | 1 |
| Hirai, K | 2 |
| Miyamae, Y | 1 |
| Takahashi, N | 2 |
| Tsukagoshi, H | 1 |
| Ogawa, H | 1 |
| Toya, H | 1 |
| Totsuka, O | 1 |
| Yoshinari, D | 1 |
| Sunose, Y | 1 |
| Makuuchi, R | 1 |
| Miki, Y | 1 |
| Yamakawa, Y | 1 |
| Sugisawa, N | 1 |
| Matsushita, N | 1 |
| Aruga, A | 1 |
| Kotera, Y | 1 |
| Takeda, K | 1 |
| Wang, X | 1 |
| Wang, ML | 1 |
| Zhou, LY | 1 |
| Lu, XY | 1 |
| Yang, JF | 1 |
| Yu, HG | 1 |
| Kubo, S | 2 |
| Misawa, T | 2 |
| Ihara, Y | 2 |
| Chinen, T | 1 |
| Harada, N | 2 |
| Nawada, H | 1 |
| Saikawa, Y | 2 |
| Kanai, T | 2 |
| Kawano, Y | 1 |
| Otani, Y | 1 |
| Sawai, T | 1 |
| Tsuji, T | 1 |
| Hidaka, S | 1 |
| Fukuoka, H | 1 |
| Shibasaki, S | 1 |
| Nanashima, A | 1 |
| Yamaguchi, H | 1 |
| Yasutake, T | 1 |
| Nakagoe, T | 2 |
| Ayabe, H | 1 |
| Tasaka, K | 1 |
| Tomofuji, Y | 1 |
| Chinzei, T | 1 |
| Koyama, M | 1 |
| Inaba, Y | 2 |
| Watabe, S | 1 |
| Ohe, S | 1 |
| Kamio, Y | 1 |
| Chiba, M | 1 |
| Watanabe, S | 2 |
| Takeuchi, T | 1 |
| Takabayashi, H | 1 |
| Hirayama, Y | 1 |
| Imamura, Y | 2 |
| Baba, Y | 3 |
| Tahara, K | 1 |
| Kubozono, O | 1 |
| Ogura, Y | 1 |
| Maenohara, S | 1 |
| Moriya, H | 1 |
| Miki, C | 1 |
| Ojima, E | 1 |
| Hatada, T | 1 |
| Kusunoki, M | 3 |
| Matsui, S | 3 |
| Tono, T | 2 |
| Yano, H | 1 |
| Kanoh, T | 2 |
| Imasato, M | 1 |
| Okamura, J | 2 |
| Monden, T | 2 |
| Maruyama, M | 5 |
| Ebuchi, M | 3 |
| Nagahama, T | 2 |
| Takashima, I | 3 |
| Natui, S | 1 |
| Ishida, H | 6 |
| Takeuchi, I | 4 |
| Ohsawa, T | 3 |
| Nakada, H | 4 |
| Ishizuka, N | 1 |
| Inokuma, S | 4 |
| Yamada, H | 3 |
| Odaka, A | 3 |
| Hoshino, T | 4 |
| Murata, N | 3 |
| Hashimoto, D | 2 |
| Miura, T | 3 |
| Masutani, S | 1 |
| Kato, H | 3 |
| Ezumi, K | 1 |
| Masuda, N | 1 |
| Kawasaki, T | 1 |
| Kurauchi, N | 1 |
| Kondo, M | 3 |
| Ogata, T | 2 |
| Nishikawa, M | 2 |
| Tanino, M | 1 |
| Mizuno, C | 1 |
| Shiomi, T | 1 |
| Shima, T | 1 |
| Nakajo, S | 1 |
| Hara, A | 2 |
| Yuan, WJ | 1 |
| Chen, FY | 1 |
| Zhang, GY | 1 |
| Iwabuchi, M | 1 |
| Imai, G | 1 |
| Yokoyama, H | 1 |
| Mochida, A | 1 |
| Shiina, M | 1 |
| Ishibashi, J | 1 |
| Chida, N | 1 |
| Tadokoro, K | 1 |
| Fujito, T | 1 |
| Goda, F | 3 |
| Matsuyama, J | 1 |
| Hojo, S | 1 |
| Yano, Y | 2 |
| Endo, W | 1 |
| Maeura, Y | 1 |
| Glimelius, B | 1 |
| Takahashi, I | 1 |
| Sakurai, M | 1 |
| Yonemura, Y | 6 |
| Endo, K | 1 |
| Toh, Y | 1 |
| Kohnoe, S | 1 |
| Okamura, T | 1 |
| Kawai, H | 1 |
| Ohtsu, A | 2 |
| Hamamoto, Y | 1 |
| Muto, M | 2 |
| Sano, Y | 1 |
| Mera, K | 1 |
| Yano, T | 1 |
| Doi, T | 1 |
| Yoshida, S | 3 |
| Cho, H | 1 |
| Kobayashi, O | 1 |
| Sairenji, M | 1 |
| Motohashi, H | 1 |
| Imada, T | 3 |
| Usuki, H | 2 |
| Ishimura, K | 1 |
| Yachida, S | 1 |
| Hagiike, M | 1 |
| Okano, K | 2 |
| Izuishi, K | 1 |
| Karasawa, Y | 1 |
| Maeta, H | 2 |
| Tsujitani, S | 2 |
| Fukuda, K | 1 |
| Kaibara, N | 1 |
| Takagane, A | 2 |
| Abe, K | 1 |
| Irinoda, T | 3 |
| Nakaya, T | 1 |
| Yonezawa, H | 1 |
| Kanzaki, N | 1 |
| Ohtani, S | 1 |
| Hoshino, Y | 1 |
| Kogure, M | 1 |
| Takemura, M | 1 |
| Osugi, H | 1 |
| Lee, S | 1 |
| Taguchi, S | 1 |
| Fukuhara, K | 1 |
| Fujiwara, Y | 5 |
| Kinoshita, H | 1 |
| Kawabata, H | 1 |
| Takase, I | 1 |
| Murata, A | 1 |
| Meguro, E | 2 |
| Kaizuka, H | 1 |
| Inaba, T | 1 |
| Hayakawa, Y | 3 |
| Okada, S | 3 |
| Yamaguchi, S | 1 |
| Wakabayashi, J | 1 |
| Hirahata, S | 1 |
| Maeda, D | 1 |
| Kamei, S | 1 |
| Tokura, H | 1 |
| Inuzuka, K | 1 |
| Hunabashi, M | 1 |
| Hino, T | 1 |
| Ishida, O | 1 |
| Nomura, K | 2 |
| Oota, H | 2 |
| Noike, T | 1 |
| Misawa, R | 1 |
| Nakata, T | 1 |
| Miwa, S | 1 |
| Futamura, N | 1 |
| Matsutomo, M | 1 |
| Yasumura, M | 1 |
| Tateyama, K | 1 |
| Takemoto, R | 2 |
| Shakado, S | 2 |
| Yamashita, N | 2 |
| Nishi, H | 2 |
| Fukumori, K | 3 |
| Fukuizumi, K | 2 |
| Miyahara, T | 2 |
| Sakai, H | 2 |
| Yasumori, K | 2 |
| Muranaka, T | 2 |
| Takami, Y | 2 |
| Saitsu, H | 2 |
| Sata, M | 2 |
| Nishi, T | 2 |
| Morita, M | 1 |
| Okamoto, Y | 1 |
| Nabeshima, K | 1 |
| Soeda, J | 1 |
| Kondo, Y | 2 |
| Ogoshi, K | 1 |
| Tajima, T | 1 |
| Akaiwa, J | 1 |
| Nakao, K | 2 |
| Koishi, K | 1 |
| Nishizaki, K | 1 |
| Ooiwa, N | 1 |
| Yamamura, T | 4 |
| Shirakawa, K | 1 |
| Okada, N | 1 |
| Itoyama, S | 1 |
| Shinoura, H | 1 |
| Kato, K | 3 |
| Kikkawa, N | 2 |
| Handa, R | 2 |
| Naoi, Y | 2 |
| Kurokawa, E | 2 |
| Katayanagi, S | 1 |
| Miyamoto, H | 1 |
| Maruyama, N | 1 |
| Maruyama, K | 1 |
| Furukawa, J | 1 |
| Tanaka, J | 1 |
| Katsumoto, Y | 1 |
| Nakaguchi, K | 1 |
| Sue, F | 1 |
| Uetake, H | 1 |
| Higuchi, T | 1 |
| Enomoto, M | 1 |
| Sugihara, K | 2 |
| Imamura, M | 2 |
| Yamaki, T | 1 |
| Yasuda, M | 1 |
| Tokumitsu, Y | 1 |
| Nagano, C | 1 |
| Matsuura, T | 1 |
| Seo, M | 1 |
| Mitsugi, K | 1 |
| Tamaki, T | 1 |
| Simada, K | 1 |
| Tubakihara, H | 1 |
| Tujimura, H | 1 |
| Magata, S | 1 |
| Shimonishi, T | 1 |
| Calvo, FA | 1 |
| Domper, M | 1 |
| Matute, R | 1 |
| Martínez-Lázaro, R | 1 |
| Arranz, JA | 1 |
| Desco, M | 1 |
| Alvarez, E | 1 |
| Carreras, JL | 1 |
| Gotanda, T | 1 |
| Uchimiya, H | 1 |
| Furukawa, T | 2 |
| Haraguchi, M | 1 |
| Ikeda, R | 1 |
| Sumizawa, T | 1 |
| Akiyama, S | 1 |
| Hayashida, Y | 1 |
| Takagi, M | 1 |
| Kawakita, H | 1 |
| Kubouchi, T | 1 |
| Kataba, Y | 1 |
| Ishiyama, T | 1 |
| Inazawa, K | 1 |
| Yagyu, T | 1 |
| Aihara, T | 1 |
| Nakamura, E | 1 |
| Nozaki, H | 1 |
| Niida, M | 1 |
| Yasuoka, H | 1 |
| Nishimoto, Y | 1 |
| Syouda, S | 1 |
| Kouno, T | 2 |
| Fukuhara, A | 1 |
| Shiraishi, K | 1 |
| Kitada, K | 1 |
| Takenaka, H | 1 |
| Morita, N | 1 |
| Iyo, T | 1 |
| Nakarai, K | 1 |
| Kaida, S | 1 |
| Indo, T | 1 |
| Doi, R | 1 |
| Okeya, M | 1 |
| Makari, Y | 2 |
| Watanabe, O | 1 |
| Shimizu, T | 2 |
| Okabe, T | 1 |
| Ogawa, K | 2 |
| Haga, S | 1 |
| Suganuma, T | 1 |
| Terauchi, R | 1 |
| Shikina, A | 1 |
| Aozasa, S | 1 |
| Utsunomiya, K | 1 |
| Fujino, K | 1 |
| Ito, H | 1 |
| Tsuda, T | 1 |
| Hase, K | 1 |
| Tokuhara, T | 1 |
| Izumi, N | 1 |
| Iwamoto, S | 2 |
| Satake, K | 1 |
| Yajima, T | 1 |
| Furukawa, Y | 1 |
| Hattori, Y | 1 |
| Yamaoka, Y | 1 |
| Fujihara, M | 1 |
| Fujita, M | 4 |
| Kuniki, H | 1 |
| Katsumata, D | 1 |
| Miyachi, K | 1 |
| Joujima, T | 1 |
| Tsumuraya, M | 1 |
| Onodera, S | 1 |
| Shimoda, W | 1 |
| Yoda, N | 1 |
| Ohkawa, T | 1 |
| Odaka, N | 1 |
| Sunagawa, M | 1 |
| Okazaki, H | 1 |
| Suto, R | 1 |
| Hamaguchi, M | 1 |
| Shiba, M | 1 |
| Oshitani, N | 1 |
| Arakawa, T | 1 |
| Nio, Y | 3 |
| Itakura, M | 4 |
| Yano, S | 5 |
| Higami, T | 3 |
| Inagaki, H | 1 |
| Ito, N | 2 |
| Kurokawa, T | 1 |
| Owa, Y | 1 |
| Kotake, K | 1 |
| Arikawa, T | 1 |
| Horikoshi, I | 1 |
| Tsubamoto, M | 1 |
| Nagata, H | 2 |
| Suzumura, K | 1 |
| Nonami, T | 1 |
| Mai, M | 2 |
| Mizuno, K | 1 |
| Aoyagi, K | 1 |
| Koufuji, K | 1 |
| Miyagi, M | 2 |
| Imaizumi, T | 2 |
| Takeda, J | 1 |
| Niinobu, T | 4 |
| Kotobuki, T | 2 |
| Otsuka, A | 1 |
| Ohshima, S | 2 |
| Fukunaga, K | 1 |
| Seshimo, I | 1 |
| Fukunaga, H | 1 |
| Ohue, M | 1 |
| Koide, A | 1 |
| Ohbu, M | 1 |
| Soma, I | 1 |
| Hayashi, N | 2 |
| Izawa, H | 1 |
| Sakita, I | 2 |
| Izumiyama, K | 1 |
| Damdinsuren, B | 4 |
| Yang, Y | 1 |
| Miyamoto, A | 7 |
| Nagahashi, S | 1 |
| Nishiwaki, M | 1 |
| Okuda, K | 2 |
| Kurosawa, Y | 1 |
| Terada, S | 1 |
| Andou, K | 1 |
| Hibi, T | 1 |
| Tsukahara, A | 1 |
| Kaneko, K | 3 |
| Watanabe, A | 5 |
| Ishikawa, H | 2 |
| Ohyama, T | 1 |
| Niimi, Y | 1 |
| Hirohashi, Y | 2 |
| Sumi, K | 1 |
| Sekikawa, K | 1 |
| Ohki, S | 1 |
| Ohshima, T | 2 |
| Fukushima, T | 1 |
| Kanazawa, M | 1 |
| Takenoshita, S | 1 |
| Muneoka, K | 4 |
| Shirai, Y | 4 |
| Yokoyama, N | 4 |
| Hatakeyama, K | 6 |
| Ohta, K | 1 |
| Taomoto, J | 1 |
| Toge, T | 1 |
| Inoue, M | 1 |
| Kaneda, H | 1 |
| Kume, S | 1 |
| Matsushita, H | 1 |
| Horino, K | 1 |
| Nishimura, T | 1 |
| Arima, T | 1 |
| Uemura, K | 1 |
| Takagaki, K | 2 |
| Ogawa, Y | 1 |
| Onoda, N | 1 |
| Okumura, S | 2 |
| Ogino, H | 1 |
| Sadamoto, Y | 2 |
| Hatta, W | 1 |
| Kumagai, S | 1 |
| Imamura, J | 1 |
| Oikawa, T | 1 |
| Asano, Y | 1 |
| Kayaba, S | 1 |
| Sawada, M | 1 |
| Kusuda, K | 1 |
| Takehana, K | 1 |
| Kimizuka, G | 1 |
| Tsuji, M | 2 |
| Maruyama, R | 1 |
| Matsumoto, S | 2 |
| Kawashima, K | 1 |
| Satoh, S | 1 |
| Ikai, I | 2 |
| Shimahara, Y | 1 |
| Hiraki, M | 1 |
| Hashiguchi, K | 1 |
| Harada, S | 1 |
| Seo, HY | 1 |
| Choi, JG | 1 |
| Sul, HR | 1 |
| Sung, HJ | 1 |
| Park, KH | 1 |
| Choi, IK | 1 |
| Oh, SC | 1 |
| Yoon, SY | 1 |
| Seo, JH | 1 |
| Choi, CW | 1 |
| Kim, BS | 1 |
| Shin, SW | 1 |
| Kim, YH | 1 |
| Kim, JS | 1 |
| Matono, K | 2 |
| Sasatomi, T | 2 |
| Ohkita, A | 1 |
| Mizobe, T | 1 |
| Ogo, S | 1 |
| Ikeda, S | 2 |
| Kitami, CE | 1 |
| Kurosaki, I | 3 |
| Hata, Y | 1 |
| Matsuoka, S | 3 |
| Nakajima, N | 1 |
| Yokoyama, R | 1 |
| Sano, F | 1 |
| Ohmori, K | 1 |
| Shoji, T | 1 |
| Fukasawa, T | 1 |
| Morita, Y | 1 |
| Kikuchi, Y | 1 |
| Ishiguro, A | 3 |
| Mizuno, Y | 2 |
| Naito, H | 1 |
| Shibazaki, W | 1 |
| Minagawa, N | 1 |
| Orimo, T | 1 |
| Ichimura, W | 1 |
| Matsuoka, T | 1 |
| Morikage, N | 1 |
| Nakayama, T | 1 |
| Tokuda, E | 1 |
| Hiyoshi, M | 1 |
| Aoki, F | 1 |
| Sugizaki, K | 1 |
| Masaki, Y | 1 |
| Yamanaka, T | 2 |
| Sano, O | 1 |
| Okabe, K | 1 |
| Itani, Y | 1 |
| Nishikawa, Y | 2 |
| Amano, M | 2 |
| Ishibashi, K | 1 |
| Yoshimatsu, K | 1 |
| Yokomizo, H | 1 |
| Umehara, A | 1 |
| Nishida, J | 2 |
| Seo, K | 1 |
| Hamaya, M | 1 |
| Terakura, M | 2 |
| Ikawa, S | 1 |
| Kubota, D | 1 |
| Katsuragi, K | 1 |
| Ohba, K | 1 |
| I, S | 1 |
| Itoh, K | 1 |
| Minami, H | 1 |
| Hirata, D | 1 |
| Okanobu, H | 1 |
| Imagawa, H | 1 |
| Takemura, Y | 1 |
| Ohya, T | 2 |
| Maruhashi, A | 1 |
| Matsui, W | 1 |
| Inagaki, J | 1 |
| Tsunoda, A | 1 |
| Amagasa, H | 1 |
| Suzuki, N | 1 |
| Kanazawa, S | 1 |
| Seo, A | 1 |
| Tokura, N | 1 |
| Honda, R | 1 |
| Kase, H | 1 |
| Teramoto, T | 2 |
| Nishihara, K | 1 |
| Ohchi, T | 2 |
| Kikuchi, N | 1 |
| Doi, K | 2 |
| Ogata, K | 2 |
| Ishimoto, T | 1 |
| Furuhashi, S | 1 |
| Ogawa, M | 3 |
| Ishihara, A | 1 |
| Kuwakado, S | 1 |
| Goto, M | 2 |
| Kawabe, S | 1 |
| Ohta, S | 1 |
| Kii, T | 1 |
| Nishitani, H | 1 |
| Katsu, K | 2 |
| Hirashima, Y | 1 |
| Kitajima, K | 1 |
| Sugi, S | 1 |
| Murakami, K | 1 |
| Fujioka, T | 1 |
| Noguchi, T | 1 |
| Kataoka, Y | 2 |
| Itagaki, T | 1 |
| Ishigame, T | 1 |
| Okayama, H | 1 |
| Ishizuka, T | 1 |
| Yoshiyasu, M | 1 |
| Bando, K | 1 |
| Yoshimura, K | 1 |
| Shibaki, T | 1 |
| Morimoto, N | 1 |
| Kagaya, T | 1 |
| Saze, Z | 1 |
| Hiruma, K | 1 |
| Yamao, K | 2 |
| Nagase, M | 1 |
| Horikawa, Y | 1 |
| Mizuno, N | 2 |
| Yamada, R | 1 |
| Hatori, S | 1 |
| Makino, T | 1 |
| Yamazaki, Y | 1 |
| Takanashi, Y | 1 |
| Hanada, N | 1 |
| Inoue, K | 3 |
| Osako, T | 1 |
| Kuriwaki, K | 1 |
| Mochinaga, M | 1 |
| Ueki, K | 1 |
| Wakakuwa, R | 1 |
| Ishizuka, D | 1 |
| Tada, T | 1 |
| Mouri, T | 1 |
| Mitsuyama, Y | 1 |
| Yamagata, T | 1 |
| Kosuge, M | 1 |
| Ushigome, T | 1 |
| Eto, K | 1 |
| Anazawa, S | 1 |
| Yamaura, H | 1 |
| Matsueda, K | 1 |
| Kagawa, S | 1 |
| Fujiwara, T | 1 |
| Nishizaki, M | 1 |
| Uno, F | 1 |
| Gouchi, A | 1 |
| Matsuoka, J | 1 |
| Ichimura, T | 1 |
| Abeshima, S | 1 |
| Hasegawa, N | 1 |
| Kawabata, M | 1 |
| Egami, K | 1 |
| Machida, H | 1 |
| Ushida, S | 1 |
| Toda, H | 1 |
| Sano, K | 1 |
| Sugawara, Y | 1 |
| Maruta, F | 1 |
| Koide, N | 2 |
| Sugiyama, A | 2 |
| Ohi, A | 1 |
| Haraguchi, Y | 1 |
| Ueno, S | 1 |
| Sakamoto, F | 1 |
| Toyoyama, H | 1 |
| Kamikado, C | 1 |
| Senju, T | 1 |
| Sawaki, A | 1 |
| Yoshino, T | 1 |
| Jeung, HC | 1 |
| Rha, SY | 1 |
| Cho, BC | 1 |
| Yoo, NC | 1 |
| Roh, JK | 1 |
| Roh, WJ | 1 |
| Chung, HC | 1 |
| Oguro, A | 2 |
| Nanri, M | 2 |
| Ujiie, K | 1 |
| Iitaka, D | 1 |
| Koh, T | 1 |
| Yamazaki, J | 1 |
| Fujiwara, S | 1 |
| Katsumata, K | 1 |
| Hisada, M | 1 |
| Ishizaki, T | 1 |
| Wada, T | 2 |
| Katakura, Y | 1 |
| Nakahara, K | 1 |
| Itoh, F | 1 |
| Asechi, H | 1 |
| Yanagida, A | 1 |
| Yasuchika, K | 1 |
| Yonei, A | 1 |
| Kawano, F | 1 |
| Taneda, Y | 1 |
| Ichinari, H | 1 |
| Mine, K | 1 |
| Kimura, T | 2 |
| Noda, Y | 1 |
| Hioki, J | 1 |
| Hokita, S | 2 |
| Uchida, M | 1 |
| Harada, K | 1 |
| Homma, N | 1 |
| Ogata, N | 1 |
| Funada, R | 1 |
| Shibasaki, K | 1 |
| Kawamura, S | 1 |
| Tei, M | 1 |
| Shimada, E | 1 |
| Ohnishi, T | 1 |
| Yano, K | 1 |
| Oshima, T | 1 |
| Noda, M | 3 |
| Kuno, T | 1 |
| Tsukamoto, K | 1 |
| Hashimoto, A | 1 |
| Gega, M | 1 |
| Yagyuu, T | 1 |
| Yoshikawa, R | 3 |
| Ikeuchi, H | 1 |
| Yanagi, H | 3 |
| Nakatani, K | 1 |
| Nishimura, K | 2 |
| Shimoda, T | 1 |
| Azuma, M | 1 |
| Katada, C | 1 |
| Saigenji, K | 1 |
| Karminsky, N | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shiraha, H | 1 |
| Shiratori, Y | 1 |
| Murahashi, K | 1 |
| Mino, A | 1 |
| Nishino, K | 1 |
| Sowa, M | 1 |
| Matsuo, A | 1 |
| Kudo, K | 2 |
| Ootao, R | 1 |
| Teramukai, S | 1 |
| Ishiwata, R | 1 |
| Fukushima, M | 2 |
| Hampton, T | 1 |
| Kohno, H | 2 |
| Okajima, A | 1 |
| Tsugane, K | 1 |
| Takenouchi, Y | 1 |
| Ogawa, A | 1 |
| Taguchi, T | 2 |
| Itoh, J | 1 |
| Munakata, A | 1 |
| Yajima, K | 2 |
| Kurosaki, R | 1 |
| Matsuo, H | 1 |
| Saito, N | 1 |
| Ohata, M | 1 |
| Ohori, M | 1 |
| Tokura, Y | 1 |
| Nakamura, R | 1 |
| Kiyota, T | 1 |
| Yoshida, M | 3 |
| Kumai, K | 1 |
| Nimura, H | 1 |
| Aoki, H | 1 |
| Mitsumori, N | 1 |
| Aiba, K | 3 |
| Kashiwagi, H | 1 |
| Ishida, M | 1 |
| Niguma, T | 1 |
| Mimura, T | 1 |
| Tsutsui, N | 1 |
| Yoshino, M | 4 |
| Di Meglio, G | 1 |
| Fazio, N | 1 |
| Nolè, F | 1 |
| Della Vigna, P | 1 |
| Lorizzo, K | 1 |
| Goldhirsch, A | 1 |
| Farris, A | 1 |
| Kanekiyo, S | 1 |
| Zavaglia, C | 1 |
| Prisco, C | 1 |
| Pinzello, G | 1 |
| Tomita, N | 1 |
| Kazunori Ikenaga, S | 1 |
| Hirama, K | 1 |
| Matsumoto, R | 1 |
| Sakuraba, H | 1 |
| Oguro, H | 1 |
| Nishigori, T | 1 |
| Iwagami, S | 1 |
| Morise, Z | 1 |
| Sugioka, A | 1 |
| Hoshimoto, S | 1 |
| Aridome, K | 1 |
| Imano, M | 1 |
| Fujitani, K | 1 |
| Narahara, H | 1 |
| Shimokawa, T | 1 |
| Takagaki, T | 1 |
| Hara, K | 1 |
| Ohkohchi, N | 1 |
| Kizaki, J | 1 |
| Koga, A | 1 |
| Adachi, A | 1 |
| Uchiyama, T | 1 |
| Uchisako, H | 1 |
| Hashimoto, H | 1 |
| Han, CJ | 1 |
| Ikebe, T | 1 |
| Yoshioka, H | 1 |
| Mimatsu, K | 1 |
| Kawasaki, A | 1 |
| Aramaki, O | 1 |
| Kuboi, Y | 1 |
| Amano, S | 1 |
| Oida, T | 1 |
| Inagaki, D | 1 |
| Katayama, K | 3 |
| Shiraishi, R | 1 |
| Tanabe, H | 2 |
| Tani, K | 1 |
| Oosawa, H | 1 |
| Ueda, H | 2 |
| Kida, Y | 1 |
| Fukuchi, H | 1 |
| Ichinose, M | 1 |
| Tamura, F | 1 |
| Nagashima, H | 2 |
| Oura, K | 1 |
| Kukitsu, T | 1 |
| Sumiyoshi, T | 1 |
| Yoshizaki, N | 1 |
| Kondo, H | 2 |
| Kuwahara, A | 1 |
| Nakadaira, K | 1 |
| Ueki, H | 1 |
| Davis, HL | 1 |
| Anttila, MI | 1 |
| Sotaniemi, EA | 1 |
| Kairaluoma, MI | 1 |
| Mokka, RE | 1 |
| Sundquist, HT | 1 |
| Onji, M | 2 |
| Horiike, N | 1 |
| Kanaoka, M | 1 |
| Ohta, Y | 2 |
| Hattori, M | 1 |
| Kojima, J | 4 |
| Kamada, T | 1 |
| Monna, J | 1 |
| Sugata, S | 1 |
| Kono, A | 2 |
| Ishibashi, H | 1 |
| Iguchi, K | 1 |
| Hashimoto, I | 1 |
| Reyes, JM | 1 |
| Okazaki, N | 5 |
| Hanatani, Y | 1 |
| Kano, T | 2 |
| Kumashiro, R | 1 |
| Notsuka, T | 1 |
| Tamada, R | 1 |
| Inokuchi, K | 2 |
| Ishidoya, T | 1 |
| Joko, Y | 1 |
| Kiyasu, Y | 1 |
| Sakai, K | 2 |
| Kimura, S | 1 |
| Azuma, N | 1 |
| Kamano, T | 2 |
| Yuasa, S | 1 |
| Tamura, J | 1 |
| Katami, A | 1 |
| Kishino, H | 1 |
| Mizukami, K | 1 |
| Kidokoro, T | 1 |
| Saka, M | 1 |
| Itoh, S | 1 |
| Fujimoto, S | 2 |
| Kitsukawa, Y | 2 |
| Okui, K | 2 |
| Furue, H | 1 |
| Deguchi, H | 1 |
| Deguchi, K | 1 |
| Murashima, S | 1 |
| Iwasaki, E | 1 |
| Kunii, Y | 1 |
| Kikuchi, K | 3 |
| Takenaka, K | 1 |
| Nishizaki, T | 1 |
| Korenaga, D | 1 |
| Hiroshige, K | 1 |
| Ikeda, T | 1 |
| Sugimachi, K | 2 |
| Saitoh, S | 1 |
| Koida, I | 1 |
| Tsubota, A | 1 |
| Arase, Y | 3 |
| Kumada, H | 3 |
| Harada, Y | 1 |
| Arima, S | 1 |
| Futami, K | 1 |
| Yamasaki, K | 1 |
| Kotoh, T | 1 |
| Tateishi, S | 2 |
| Inada, S | 1 |
| Ikuta, H | 1 |
| Shibagaki, F | 1 |
| Chao, C | 1 |
| Takehana, T | 1 |
| Miyazaki, T | 1 |
| Maehara, T | 1 |
| Matsumoto, A | 1 |
| Machida, T | 1 |
| Kitazaki, M | 1 |
| Ishihara, S | 1 |
| Noma, M | 1 |
| Ota, M | 1 |
| Ban, K | 1 |
| Masuda, K | 1 |
| Shida, H | 1 |
| Seki, N | 1 |
| Higaki, T | 1 |
| Oishi, H | 1 |
| Nakata, Y | 1 |
| Kono, S | 1 |
| Kishimoto, S | 2 |
| Sasaki, Y | 5 |
| Imaoka, S | 2 |
| Nakano, H | 3 |
| Ishikawa, O | 2 |
| Ohigashi, H | 2 |
| Kabuto, T | 1 |
| Kameyama, M | 1 |
| Masuyama, K | 1 |
| Oonishi, Y | 1 |
| Sawataishi, M | 1 |
| Wakaki, K | 1 |
| Hayakawa, M | 1 |
| Morooka, Y | 1 |
| Hattori, T | 2 |
| Maruhashi, Y | 1 |
| Hirose, S | 2 |
| Nakagawa, H | 2 |
| Satomura, Y | 1 |
| Demachi, H | 1 |
| Miwa, A | 2 |
| Nakanuma, Y | 1 |
| Shibata, J | 1 |
| Hayashida, T | 1 |
| Noumaru, S | 1 |
| Fujiyama, S | 1 |
| Hashiguchi, O | 1 |
| Miyauchi, T | 1 |
| Yamada, A | 1 |
| Fuji, N | 1 |
| Yoshikawa, K | 3 |
| Dousei, T | 1 |
| Moriguchi, S | 1 |
| Taketani, S | 1 |
| Utsumi, T | 1 |
| Suhara, H | 1 |
| Sasatomi, E | 1 |
| Tsutsumi, N | 1 |
| Iwanaga, A | 1 |
| Iyama, A | 1 |
| Fukagawa, H | 1 |
| Miyagawa, H | 1 |
| Kamioka, N | 1 |
| Kohara, H | 1 |
| Yuube, R | 1 |
| Nakatoh, H | 1 |
| Kawada, M | 1 |
| Utsunomiya, T | 1 |
| Izumiyama, F | 1 |
| Akimori, T | 1 |
| Tagawa, Y | 1 |
| Seki, T | 1 |
| Shiro, T | 1 |
| Yamamura, H | 1 |
| Koreeda, C | 1 |
| Naitoh, Y | 1 |
| Okuno, H | 1 |
| Urabe, T | 1 |
| Hino, F | 1 |
| Tamai, S | 1 |
| Tarao, K | 1 |
| Kosaki, G | 1 |
| Kurihara, M | 2 |
| Itsubo, M | 1 |
| Nomiyama, T | 1 |
| Nakae, J | 1 |
| Nishikawa, H | 1 |
| Kinoshita, K | 1 |
| Sawa, T | 3 |
| Yoshimitsu, S | 1 |
| Tomita, F | 2 |
| Takano, Y | 2 |
| Miyazaki, I | 2 |
| Matsui, H | 1 |
| Iida, A | 1 |
| Komatsu, T | 1 |
| Ookubo, K | 1 |
| Ohta, J | 1 |
| Maruiwa, M | 1 |
| Noutomi, M | 1 |
| Tokuhara, K | 1 |
| Inutsuka, K | 1 |
| Tsurumachi, T | 1 |
| Honda, I | 1 |
| Yamada, S | 1 |
| Jingu, K | 1 |
| Satomi, D | 1 |
| Onodera, H | 1 |
| Ukai, K | 1 |
| Otawa, K | 1 |
| Tomono, H | 1 |
| Fujioka, S | 1 |
| Kushibiki, K | 1 |
| Matsuoka, H | 1 |
| Hyakuna, Y | 1 |
| Yokomichi, H | 1 |
| Komatsu, M | 1 |
| Fujii, K | 1 |
| Masamune, O | 1 |
| Fukuda, T | 1 |
| Ohkuwa, M | 1 |
| Tajiri, H | 1 |
| Kusada, O | 1 |
| Yoshimitsu, Y | 1 |
| Ohta, N | 1 |
| Kadoya, N | 2 |
| Hirosawa, H | 3 |
| Konishi, I | 1 |
| Izumi, R | 2 |
| Hirono, T | 1 |
| Satake, H | 1 |
| Takechi, T | 1 |
| Nakano, K | 2 |
| Uchida, J | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Une, Y | 3 |
| Nishibe, M | 1 |
| Shimamura, T | 1 |
| Haneda, T | 1 |
| Uchino, J | 4 |
| Rios-Buceta, L | 1 |
| Buezo, GF | 1 |
| Peñas, PF | 1 |
| Dauden, E | 1 |
| Fernandez-Herrera, J | 1 |
| Garcia-Diez, A | 1 |
| Mani, S | 1 |
| Arakawa, A | 1 |
| Takagi, Y | 1 |
| Asano, N | 1 |
| Fukano, M | 1 |
| Kubo, M | 1 |
| Sato, J | 1 |
| Tsujikawa, T | 1 |
| Ando, A | 1 |
| Sasaki, M | 1 |
| Yoshioka, U | 1 |
| Koyama, S | 1 |
| Bamba, T | 1 |
| Kume, M | 1 |
| Ogoshi, S | 1 |
| Hisa, N | 1 |
| Yamashita, F | 1 |
| Ando, E | 1 |
| Kato, O | 1 |
| Fukuda, H | 1 |
| Kusaba, T | 1 |
| Tanikawa, K | 2 |
| Kazumori, H | 1 |
| Sizuku, T | 1 |
| Moritani, M | 1 |
| Chimori, Y | 1 |
| Yamane, E | 1 |
| Nishioka, B | 1 |
| Seki, M | 1 |
| Azekura, K | 1 |
| Moroguchi, A | 1 |
| Matsubara, T | 1 |
| Konno, H | 1 |
| Kamiya, K | 1 |
| Ichida, T | 2 |
| Ishimoto, Y | 2 |
| Yokoyama, J | 2 |
| Nomoto, M | 1 |
| Ebe, Y | 1 |
| Usuda, H | 1 |
| Asakura, H | 2 |
| Hoshino, K | 1 |
| Ikeda, H | 1 |
| Díáz-Rubio, E | 1 |
| Sastre, J | 1 |
| Abad, A | 1 |
| Navarro, M | 1 |
| Aranda, E | 1 |
| Carrato, A | 1 |
| Gallén, M | 1 |
| Marcuello, E | 1 |
| Rifá, J | 1 |
| Massuti, T | 1 |
| Cervantes, A | 1 |
| Antón, A | 1 |
| Fernández Martos, C | 1 |
| Nishijima, N | 1 |
| Kai, S | 1 |
| Kondo, K | 1 |
| Kishi, T | 1 |
| Shimomura, K | 1 |
| Idezuki, Y | 1 |
| Takemura, T | 2 |
| Sadou, S | 1 |
| Nishinuma, T | 1 |
| Tsurui, H | 1 |
| Noji, M | 1 |
| Bandoh, T | 1 |
| Isoyama, T | 1 |
| Nagaoka, S | 1 |
| Fujiwara, M | 1 |
| Koujima, M | 1 |
| Miyagi, Y | 2 |
| Motosato, K | 1 |
| Siomichi, S | 1 |
| Amagase, Y | 1 |
| Terasaki, T | 1 |
| Shiohara, E | 1 |
| Matsunaga, Y | 1 |
| Amano, J | 1 |
| Saitoh, K | 1 |
| Shirasaka, T | 1 |
| Kikunaga, H | 1 |
| Sotome, K | 1 |
| Morisue, A | 1 |
| Matsudo, A | 1 |
| Nakai, H | 1 |
| Takao, M | 1 |
| Osakabe, Y | 1 |
| Miura, H | 1 |
| Nakahara, H | 1 |
| Nakahara, M | 1 |
| Onoyama, H | 1 |
| Urakawa, T | 1 |
| Sugihara, S | 1 |
| Hashimoto, Y | 1 |
| Azumi, Y | 1 |
| Takao, S | 1 |
| Saitoh, Y | 1 |
| Sadamori, H | 1 |
| Kawashima, T | 1 |
| Uetsuka, H | 1 |
| Morichika, T | 1 |
| Hamazaki, K | 1 |
| Kusama, M | 1 |
| Kaise, H | 1 |
| Nakayama, S | 1 |
| Oota, D | 1 |
| Koyanagi, Y | 1 |
| Wakabayashi, H | 1 |
| Maeba, T | 1 |
| Mori, S | 1 |
| Mihara, T | 1 |
| Okada, H | 1 |
| Ohkawa, M | 1 |
| Senda, S | 1 |
| Shinohara, H | 1 |
| Nomura, E | 1 |
| Nishiguchi, K | 1 |
| Okuzawa, M | 1 |
| Chon, Y | 1 |
| Hara, H | 1 |
| Tanigawa, N | 1 |
| Matsuoka, K | 1 |
| Hisamatsu, T | 1 |
| Aoyagi, S | 1 |
| Motohashi, Y | 1 |
| Ikezawa, T | 1 |
| Tatsuno, S | 1 |
| Haseme, E | 1 |
| Shohkei, O | 1 |
| Ohnishi, Y | 1 |
| Niiya, F | 1 |
| Nagata, S | 1 |
| Iwamoto, M | 1 |
| Matsuzawa, J | 1 |
| Mita, Y | 1 |
| Tashiro, K | 1 |
| Tashiro, S | 1 |
| Matsuki, H | 1 |
| Sugitani, S | 1 |
| Tsuboi, Y | 1 |
| Genda, T | 1 |
| Sugahara, S | 1 |
| Inayoshi, J | 1 |
| Nozoe, Y | 1 |
| Nakagawa, M | 2 |
| Kobayashi, H | 1 |
| Yamanoi, A | 1 |
| Nazmy El Assal, O | 1 |
| Nagasue, N | 1 |
| Matsusaka, S | 2 |
| Oriyama, T | 1 |
| Chang, W | 1 |
| Maeda, S | 3 |
| Son, G | 1 |
| Satake, M | 1 |
| Doi, S | 1 |
| Naoi, M | 2 |
| Nishimura, G | 1 |
| Kayahara, M | 1 |
| Shimizu, K | 1 |
| Miwa, K | 1 |
| Aguayo, A | 1 |
| Patt, YZ | 1 |
| Ishihama, H | 1 |
| Yamamura, J | 1 |
| Kawasaki, Y | 1 |
| Ohtsuru, M | 1 |
| Kobayakawa, K | 1 |
| Yamamura, M | 1 |
| Hayashi, Y | 1 |
| Nozue, M | 1 |
| Sakamoto, T | 1 |
| Fukue, M | 1 |
| Kodaira, Y | 1 |
| Monma, E | 1 |
| Shidara, S | 1 |
| Ikezawa, K | 1 |
| Shimakura, S | 1 |
| Yoshioka, I | 1 |
| Inokuchi, M | 1 |
| Iwata, K | 1 |
| Ajisaka, H | 1 |
| Kaji, M | 2 |
| Yabushita, K | 2 |
| Tsuchiya, K | 1 |
| Takemura, N | 1 |
| Osaka, Y | 1 |
| Sako, H | 1 |
| Ioka, Z | 1 |
| Nakane, Y | 1 |
| Daijo, H | 1 |
| Morikawa, A | 1 |
| Okabe, R | 1 |
| Emoto, T | 2 |
| Fujikawa, M | 1 |
| Hamada, E | 1 |
| Naka, Y | 1 |
| Komaki, T | 1 |
| Yamasaki, H | 1 |
| Kitayama, Y | 1 |
| Dan, T | 1 |
| Kosaka, H | 1 |
| Kuriyama, H | 1 |
| Umekita, N | 1 |
| Mayr, AC | 1 |
| Shirakabe, H | 1 |
| Izumi, T | 2 |
| Miyasaka, K | 1 |
| Ariyama, J | 1 |
| Hobara, N | 2 |
| Obayashi, H | 1 |
| Yasugawa, T | 1 |
| Kamata, T | 6 |
| Monna, T | 3 |
| Nose, H | 1 |
| Yoshimori, M | 1 |
| Okuda, T | 1 |
| Onda, M | 1 |
| Tokunaga, A | 1 |
| Fujita, I | 1 |
| Kiyama, T | 1 |
| Kyono, S | 1 |
| Muraoka, K | 1 |
| Nakai, M | 1 |
| Tsugawa, K | 2 |
| Segawa, M | 1 |
| Fukushima, W | 1 |
| Sahara, H | 1 |
| Saitoh, F | 1 |
| Taniya, T | 1 |
| Shimazoe, T | 1 |
| Kusano, H | 1 |
| Ifuku, M | 1 |
| Mashiko, H | 1 |
| Satoh, J | 1 |
| Hatayama, H | 1 |
| Kitamura, H | 1 |
| Mura, T | 1 |
| Bandou, H | 1 |
| Shindo, K | 1 |
| Mizuno, T | 1 |
| Yurino, N | 1 |
| Fujii, S | 1 |
| Murai, N | 1 |
| Okuno, F | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Hori, Y | 1 |
| Isogawa, S | 1 |
| Saho, M | 1 |
| Yokoyama, K | 1 |
| Chiba, Y | 1 |
| Fukushi, G | 1 |
| Matsukawa, M | 1 |
| Wada, K | 1 |
| Aoyama, H | 1 |
| Fukushi, M | 1 |
| Nakagawa, A | 1 |
| Hiramatsu, Y | 1 |
| Kitade, H | 1 |
| Ogura, T | 1 |
| Yoshioka, K | 1 |
| Takada, H | 1 |
| Hioki, K | 1 |
| Tsuru, S | 2 |
| Shinomiya, N | 1 |
| Noritake, M | 1 |
| Nomoto, K | 2 |
| Horikoshi, N | 1 |
| Mukaiyama, T | 1 |
| Itami, S | 1 |
| Hirano, A | 1 |
| Matsumura, T | 1 |
| Kuroki, Y | 1 |
| Yamashita, I | 1 |
| Okamoto, M | 1 |
| Ochiai, H | 1 |
| Tazawa, K | 1 |
| Fujimaki, M | 1 |
| Hazama, S | 1 |
| Oka, M | 1 |
| Murakami, T | 1 |
| Yunoki, S | 1 |
| Hizuta, A | 1 |
| Sou, J | 1 |
| Nagata, Y | 1 |
| Kataoka, K | 1 |
| Matumoto, M | 1 |
| Kawaguchi, H | 1 |
| Miyagi, K | 1 |
| Urade, M | 3 |
| Takegawa, S | 3 |
| Matumoto, H | 1 |
| Matuki, N | 1 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Nakashima, Y | 1 |
| Ohkusa, T | 1 |
| Ohtomo, K | 1 |
| Tomoda, H | 1 |
| Furusawa, M | 1 |
| Kuzuya, N | 1 |
| Koide, Y | 1 |
| Matsumara, M | 1 |
| Tomizawa, H | 1 |
| Murayama, Y | 1 |
| Okuda, Y | 1 |
| Takuwa, Y | 1 |
| Iwasaki, T | 1 |
| Amemiya, A | 1 |
| Han, N | 1 |
| Itou, A | 1 |
| Tsujimura, T | 1 |
| Kawano, N | 1 |
| Moriya, Y | 1 |
| Houjo, K | 1 |
| Ooi, A | 1 |
| Kitamura, T | 3 |
| Shigehira, M | 3 |
| Iwaki, Y | 1 |
| Ishinoda, Y | 1 |
| Kisanuki, H | 1 |
| Granov, AM | 1 |
| Tarazov, PG | 1 |
| Akita, N | 1 |
| Wada, A | 2 |
| Yasutomi, M | 1 |
| Komov, DV | 1 |
| Barkanov, AI | 1 |
| Roshchin, EM | 1 |
| Hayashi, T | 1 |
| Kitagawa, S | 1 |
| Kashii, A | 1 |
| Fushida, Y | 1 |
| Sakuma, H | 1 |
| Matsuki, N | 1 |
| Takano, N | 1 |
| Uogishi, M | 1 |
| Kodaira, S | 1 |
| Komi, N | 1 |
| Kondo, T | 1 |
| Abe, O | 1 |
| Ogawa, N | 2 |
| Ogasawara, K | 1 |
| Nagafuchi, E | 1 |
| Misawa, K | 1 |
| Sato, N | 1 |
| Miyamoto, K | 1 |
| Inagaki, Y | 1 |
| Miyairi, M | 1 |
| Nakatsuru, K | 1 |
| Tsuda, K | 2 |
| Hidaka, Y | 1 |
| Nakanishi, T | 2 |
| Nagase, T | 1 |
| Nakagawa, C | 1 |
| Kuroda, K | 1 |
| Tokunaga, K | 1 |
| Suenaga, M | 1 |
| Ishizaki, J | 1 |
| Nakamura, I | 1 |
| Murashima, N | 1 |
| Takeuchi, K | 1 |
| Nakajima, M | 1 |
| Yoshiba, A | 2 |
| Irimoto, M | 2 |
| Horie, Y | 1 |
| Shimizu, M | 1 |
| Inoue, J | 1 |
| Okumura, M | 1 |
| Hirayama, C | 1 |
| Shibata, T | 1 |
| Hirose, N | 1 |
| Gunji, T | 1 |
| Ohtsuki, T | 1 |
| Obata, H | 1 |
| Tomimatsu, M | 1 |
| Ohnishi, K | 1 |
| Hijikata, A | 1 |
| Mori, K | 1 |
| Fuse, M | 1 |
| Hizikata, A | 1 |
| Kawakami, H | 1 |
| Ando, B | 1 |
| Koga, S | 1 |
| Ibayashi, H | 1 |
| Ando, S | 1 |
| Inada, M | 1 |
| Kawata, S | 2 |
| Miyoshi, S | 2 |
| Imai, Y | 2 |
| Saito, R | 1 |
| Noda, S | 2 |
| Inui, Y | 1 |
| Ohmura, K | 1 |
| Matsuo, SK | 1 |
| Ohtsuka, Y | 1 |
| Oguma, S | 1 |
| Sato, R | 1 |
| Ouchi, K | 1 |
| Saitoh, R | 1 |
| Tarui, S | 1 |
| Nagabuchi, E | 1 |
| Kagaya, H | 1 |
| Miyata, S | 1 |
| Yakura, Y | 1 |
| Yamauchi, S | 1 |
| Hirata, T | 1 |
| Tsuruhara, Y | 1 |
| Irie, K | 1 |
| Yasutake, K | 1 |
| Yoshimura, Y | 1 |
| Mizogami, H | 1 |
| Piccinini, L | 1 |
| Corradini, R | 1 |
| Vandelli, C | 1 |
| Luppi, G | 1 |
| Di Marco, G | 1 |
| Miyata, R | 1 |
| Yamaguchi, A | 1 |
| Nagakawa, T | 1 |
| Kamaro, T | 1 |
| Nagamatsu, Y | 1 |
| Nakarai, I | 1 |
| Matsuo, T | 1 |
| Kawahara, M | 1 |
| Shinoda, A | 1 |
| Nishibe, S | 1 |
| Tane, S | 1 |
| Tachiyama, G | 1 |
| Yayoi, E | 1 |
| Kido, C | 2 |
| Endo, T | 2 |
| Ozawa, H | 1 |
| Togami, M | 1 |
| Sasaki, J | 1 |
| Nehashi, Y | 1 |
| Suyama, K | 1 |
| Hirahara, K | 1 |
| Hori, M | 1 |
| Kitagawa, M | 1 |
| Takada, T | 1 |
| Yasuda, H | 1 |
| Uchiyama, K | 1 |
| Higuchi, M | 1 |
| Shigemitsu, M | 1 |
| Joya, K | 1 |
| Hara, S | 1 |
| Hanawa, S | 1 |
| Terasawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction[NCT03519074] | Phase 2 | 48 participants (Anticipated) | Interventional | 2016-07-22 | Recruiting | ||
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
| Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| A Phase II Study of Sorafenib Plus Tegafur/Uracil for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma[NCT00464919] | Phase 2 | 50 participants (Anticipated) | Interventional | 2007-04-30 | Completed | ||
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
| Efficacy and Safety of Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection[NCT05161143] | Phase 2 | 30 participants (Anticipated) | Interventional | 2021-12-31 | Not yet recruiting | ||
| Human Liver Explants for HIF-1 Alpha- Analysis/Comparison[NCT00866957] | 180 participants (Actual) | Observational | 2006-02-28 | Completed | |||
| A Randomized Phase II Trial of Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma or Who Are Unfit for Standard Therapy[NCT01097083] | Phase 2 | 20 participants | Interventional | 2010-04-30 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for tegafur and Cancer of Liver
| Article | Year |
|---|---|
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Drug Combi | 2020 |
[A Case of Rhabdomyolysis Related to SOX Therapy for Liver Metastasis of Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Hepatectomy; Humans; Liver | 2017 |
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
[A Distal Bile Duct Carcinoma Patient Who Underwent Surgical Resection for Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo | 2018 |
[Complete remission of hepatocellular carcinoma with multiple lung metastases by oral administration of tegafur/uracil].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2013 |
[A case of liver metastasis from gastric cancer responding completely to S-1/docetaxel chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hep | 2013 |
[A case of quadruple cancer of the liver, stomach, bladder, and ureter].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Humans; Liver Neop | 2013 |
[A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Human | 2014 |
[Case report of chemotherapeutic control of a gastric cancer producing granulocyte-colony stimulating factor].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Fa | 2014 |
[A case of complete response to multiple liver metastasis of gastric cancer after discontinuation of S-1 administration].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; H | 2014 |
[A case of advanced gastric cancer with tumor embolus in the portal vein and liver metastasis responding to S-1 plus cisplatin chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2014 |
Preoperative chemotherapy with a trastuzumab-containing regimen for a patient with gastric cancer and hepatic metastases.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 2014 |
[A case of surgical resection for liver metastasis of gastric cancer with portal vein tumor thrombus].
Topics: Combined Modality Therapy; Drug Combinations; Humans; Liver Neoplasms; Male; Middle Aged; Oxonic Aci | 2014 |
[A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Gemcitabine; | 2014 |
[A case of gastric cancer with liver metastases achieving a clinical complete response after S-1 plus CDDP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com | 2014 |
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian | 2015 |
Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ch | 2017 |
A case of metachronous liver metastasis from neuroendocrine carcinoma of the stomach at 1 year and 10 months after endoscopic submucosal dissection.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoma, Neuroendocrine; Chemotherapy, Adju | 2017 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; | 2010 |
[A case with multiple liver metastases of gastric cancer responding completely to S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Oxonic Acid | 2010 |
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A case of long-term survival after undergoing S-1 based multidisciplinary therapy for liver metastasis of gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neoplasms; Neoadjuva | 2011 |
[A case report of a stage IV gastric cancer patient with rapid progression of liver metastases induced by postoperative anastomotic leakage].
Topics: Adult; Anastomotic Leak; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modalit | 2012 |
[Surgical resection and S-1 administration for the treatment of hepatocellular carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2012 |
Palliative treatment of patients with colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Camptothecin; Colorectal Neoplasms; Disease Progression; Enzyme Inh | 2003 |
[Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2003 |
[Chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administrat | 2003 |
[Recent progress in chemotherapy for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; C | 2004 |
[A case of liver metastasis of gastric cancer responding well to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Dru | 2004 |
[Hepatic arterial infusion chemotherapy for liver metastases from digestive cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colorectal Neoplasms; Drug | 2006 |
[Recent developments in systemic chemotherapy for hepatocellular carcinoma].
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Capecitabi | 2008 |
Chemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Humans; Liver Neop | 2008 |
Intraarterial infusion chemotherapy for unresectable hepatic metastases from colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Hepatic Artery; | 1996 |
[A noteworthy case of postoperative liver metastasis from gastric cancer which responded well to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrect | 2000 |
Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepa | 2001 |
Nonsurgical treatment of hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Capecitabine; Carcinoma, Hepatocellular; Chemoemboli | 2001 |
[Chemotherapy of gastrointestinal tumors (review of the literature)].
Topics: Ancitabine; Carcinoma, Hepatocellular; Colonic Neoplasms; Doxorubicin; Drug Therapy, Combination; Fl | 1978 |
[A case of liver metastasis of gastric cancer which was made resectable by hypertheromo-chemo-radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Hepate | 1989 |
85 trials available for tegafur and Cancer of Liver
| Article | Year |
|---|---|
Phase II trial of neoadjuvant chemotherapy with S-1 and oxaliplatin plus bevacizumab for colorectal liver metastasis (N-SOG 05 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colorectal Neoplasms; Drug | 2017 |
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Diarrhea; Double-Blind Method; Dru | 2017 |
Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Female | 2018 |
A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundatio
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neopla | 2018 |
A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2019 |
Endostar continuous intravenous infusion combined with S-1 and oxaliplatin chemotherapy could be effective in treating liver metastasis from gastric cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease-Free S | 2018 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradioth | 2014 |
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2014 |
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2014 |
Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 2014 |
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chem | 2014 |
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease- | 2015 |
Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemot | 2016 |
Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colorectal Neoplasms; Drug Combinations; | 2015 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2016 |
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Disease | 2016 |
Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2016 |
Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; | 2016 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dih | 2009 |
Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptot | 2009 |
Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Com | 2009 |
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Combination | 2009 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St | 2010 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Benzenesul | 2010 |
Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dis | 2011 |
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2010 |
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Area Under Curve; Carcinoma, Hepatocellular; Disease-Free Sur | 2010 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 2011 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; | 2012 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2011 |
Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonate | 2012 |
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisp | 2012 |
Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, | 2013 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherap | 2012 |
Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Colorectal Neoplasms; | 2013 |
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combin | 2013 |
[Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |
[Effect of indomethacin on natural killer(NK) cell and T lymphocyte subsets from patients with hepatocellular carcinoma].
Topics: Adjuvants, Immunologic; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Fem | 2000 |
Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2003 |
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch | 2003 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronothe | 2005 |
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 2005 |
Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antidotes; Antineoplastic Agents; Antineoplastic Combined | 2006 |
[Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug A | 2005 |
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2006 |
[S-1 monotherapy for pancreatic cancer].
Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2006 |
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemotherapy | 2006 |
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dru | 2006 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a p
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc | 2007 |
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; | 2007 |
A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female | 2008 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |
Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Combined Mo | 2008 |
Chemotherapy of large bowel cancer.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Floxuridine; Fluorouraci | 1982 |
[Clinical study on combination chemotherapy of primary liver cancer].
Topics: Adult; Aged; Azirines; Carbazilquinone; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Co | 1983 |
[Joint clinical Phase II study of SF-SP].
Topics: Clinical Trials as Topic; Colonic Neoplasms; Delayed-Action Preparations; Drug Evaluation; Female; F | 1984 |
[Cooperative study of surgical adjuvant chemotherapy for colorectal cancer. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Admi | 1995 |
A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Combinations; Embolization, The | 1995 |
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He | 1994 |
Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; | 1994 |
A pharmacological pilot study: application of an intermittent schedule of oral uracil and ftorafur (UFT) for hepatocellular carcinoma patients.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Female; Hepatectomy; Humans | 1996 |
UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma | 1997 |
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over | 1998 |
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy | 1999 |
[Clinical trial of prophylactic hepatic arterial chemotherapy for liver metastases in patients with Dukes' C colorectal cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Adm | 1999 |
Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2000 |
Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combina | 2001 |
Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; | 2002 |
[Randomized trial-comparing UFT and FT in the treatment of advanced hepatocellular carcinoma (second report: well controlled study on patients with transcatheter arterial embolization) Osaka Research Society for Liver, Gallbladder and Pancreas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz | 1992 |
[Comparative study of UFT plus mitomycin C and UFT plus doxorubicin in adenocarcinoma. Hirosaki Cooperative Group of Cancer Chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Proto | 1992 |
[Randomized trial comparing UFT and FT-207 in the treatment of advanced hepatocellular carcinoma (first report: well controlled study on the patients for whom transcatheter arterial embolization could not be applied) Osaka Research Society for Liver, Gall
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization | 1990 |
[A multicenter comparative study in patients with liver metastasis to compare tegafur in new forms with existing drugs. SF-RC.SF-SP Comparative Study Group].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Capsules; Colonic Neo | 1989 |
[Effect of PMU hepatic arterial chemotherapy for liver metastases of gastric cancer. Hokuriku Cisplatin Round-table Conference].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug A | 1989 |
[Cooperative study of surgical adjuvant chemotherapy of colorectal carcinoma (second study): a preliminary report. Cooperative Study Group of Surgical Adjuvant Chemotherapy of Colorectal Cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug A | 1989 |
[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
Topics: Administration, Oral; Biological Products; Carcinoma, Hepatocellular; Clinical Trials as Topic; Huma | 1988 |
[Comparative clinical study of SF-SP therapy and SF-SP plus BH-AC therapy in gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Study Group].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cytarabine; Delayed- | 1986 |
[Evaluation of immunochemotherapy in patients with primary liver cancer. Osaka Research Society for Liver, Gallbladder and Pancreas].
Topics: Adult; Aged; Biological Products; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Prote | 1987 |
573 other studies available for tegafur and Cancer of Liver
| Article | Year |
|---|---|
A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.
Topics: Carcinoma, Hepatocellular; Drugs, Investigational; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; | 2022 |
[A Case of Large-Cell Neuroendocrine Carcinoma of the Stomach with Multiple Liver Metastases That Show Complete Response to Multidisciplinary Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Gastrectomy; H | 2019 |
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Hepatectomy; Humans; Liv | 2019 |
[A Case Report of a Patient Over 90 Years of Age with Liver Metastasis after Sigmoid Colectomy Controlled by a Combination Oral UFT/LV Chemotherapy Regimen].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Female; Humans; Leucov | 2019 |
[A Case Report of Advanced Gastric Cancer with Synchronous Liver Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Liver | 2019 |
[A Case of Advanced Gastric Cancer with Liver Metastases Treated with Curative Conversion Therapy after S-1 plus Oxaliplatin].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Liver Neopla | 2019 |
[A Case of Gastric Endocrine Carcinoma with a Huge Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Gastrectomy; Humans; Liver Neoplasm | 2019 |
Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Car | 2020 |
[Long-Term Survival for a Patient with StageⅣ Gastric Cancer with Multiple Liver Metastases for Ten Years Who Was Treated with Only S-1Chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2020 |
[Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report]
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2020 |
Combined ablation-chemotherapy versus chemotherapy alone for pancreatic cancer with liver metastasis: a propensity score matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Combined Modality Ther | 2021 |
[A Long-Survived Case of Gastric Cancer with Multiple Liver Metastases Who Underwent Gastrectomy and Received Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2020 |
[A Case of Gastric Neuroendocrine Carcinoma with Rapidly Increasing Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Drug Com | 2020 |
Simultaneous quantification method for 5-FU, uracil, and tegafur using UPLC-MS/MS and clinical application in monitoring UFT/LV combination therapy after hepatectomy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Calibration; Chroma | 2021 |
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neop | 2017 |
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplati | 2017 |
[A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; | 2017 |
Tegafur-uracil-induced rapid development of advanced hepatic fibrosis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Carcinoma, Hepatocellular; Di | 2017 |
Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Drug Combinati | 2017 |
[A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2017 |
[A Case of Advanced Gastric Cancer with Liver Metastasis Treated by Curative Surgery after Chemotherapy Using S-1 plus Oxaliplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Hepatectomy; H | 2017 |
[A Case of Unresectable Gastric Cancer with Multiple Metastases Responding to Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2017 |
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neopla | 2018 |
[A Case in Which S-1 plus CDDP and S-1 Therapy Responded to Liver Metastasis Recurrence after Gastric Cancer Operation].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Com | 2018 |
[A Case of Long-Term Survival in Gastric Cancer with Multiple Liver Metastases Successfully Treated by Conversion Surgery after S-1 plus Cisplatin Combination Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2018 |
[A Case Report of SOX Treatment for Primary Duodenal Carcinoma with Liver Metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenal Neoplasms; Female; | 2018 |
[A Case of Advanced Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after S-1 plus CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Digestive System Surgical Procedures; Dru | 2018 |
Gallbladder cancer with tumor thrombus in the portal vein: A case report.
Topics: Administration, Intravenous; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; D | 2018 |
Short-term effect of metronomic chemotherapy of low-dose Tegafur on patients with primary hepatic carcinoma after radiofrequency ablation.
Topics: Administration, Metronomic; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; | 2018 |
[Severe Liver Injury Due to Sinusoidal Obstruction Syndrome Induced by Oxaliplatin in a Patient with Resectable Colorectal Liver Metastases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Drug Combinations; Hepatectomy; Hepatic | 2018 |
[A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colon, Ascending; Colonic Neoplas | 2018 |
Pancreatic Acinar Cell Carcinoma with Multiple Liver Metastases Effectively Treated by S-1 Chemotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Drug Combinations; Endoscopic Ultraso | 2018 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Gastrectom | 2019 |
[A Case of Recurrent Gastric Cancer Successfully Treated by S-1 Chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans | 2019 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chol | 2019 |
Outcome of postoperative radiation therapy for cholangiocarcinoma and analysis of dose-volume histogram of remnant liver.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; | 2019 |
Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Hepatocellula | 2013 |
[A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Che | 2013 |
Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protoco | 2013 |
Genetic polymorphisms of enzymes related to oral tegafur/uracil therapeutic efficacy in patients with hepatocellular carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Asian People; C | 2013 |
Chemotherapy and resection for gastric cancer with synchronous liver metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations | 2013 |
[A case of synchronous liver metastasis originating from advanced gastric cancer treated with combination chemotherapy involving S-1 and surgical intervention].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality The | 2013 |
[Two cases of multiple liver metastases breast cancer successfully treated with combination chemotherapy by S-1, vinorelbine and medroxyprogesterone].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; | 2013 |
[A case of metastatic colon cancer effectively treated by XELOX and IRIS].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; | 2013 |
Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Topics: Acetates; Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemothera | 2013 |
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemo | 2013 |
Impact of chemotherapy with S-1 and oxaliplatin (SOX) in combination with molecular-targeting agents on colorectal liver metastases.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2013 |
Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid | 2013 |
[A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 2013 |
[Efficacy of combined local therapy especially with hepatic arterial infusion for liver metastasis from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2013 |
[A case of hepatocellular carcinoma (Vp4)-combination therapy prolonged survival in a patient with advanced hepatocellular carcinoma with a tumor thrombus in the portal vein trunk].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality | 2013 |
[Resection of a synchronous liver metastasis from gastric cancer associated with portal vein tumor thrombosis - a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fem | 2013 |
[Multiple hepatic metastases from colon cancer successfully treated with irinotecan and S-1 plus panitumumab as second-line therapy-a case report].
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, | 2013 |
[A case of locally advanced residual gastric cancer treated with combined resection of multiple adjacent organs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2013 |
Usefulness of monthly chemotherapy for patients with unresectable metastatic colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytid | 2014 |
[A case of large cell neuroendocrine carcinoma of the stomach with liver metastasis effectively treated with S-1 and CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocri | 2014 |
[A case of Stage IV sigmoid colon cancer that achieved long-term survival with oral anticancer drugs].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2014 |
[Induction chemotherapy with S-1/oxaliplatin prevented colostomy in a patient with advanced rectal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colostomy; Drug Combin | 2014 |
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
Topics: Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Ad | 2016 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
Successful management of metachronous liver metastasis after pancreaticoduodectomy for pancreatic ductal carcinoma using hepatectomy and chemotherapy: a case report.
Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Combined Modality Therapy; Deoxycytidine; Drug | 2014 |
[A case of S-1/CDDP-resistant recurrent gastric cancer responsive to capecitabine/CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Combined Modality The | 2014 |
[A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Cisplatin; Drug Combinat | 2014 |
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2014 |
[Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidin | 2014 |
[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 2014 |
[A case of liver and para-aortic lymph node metastasis of colorectal cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Colonic Neoplasms; Drug Combinations; Female; Humans; | 2015 |
[Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protoc | 2015 |
The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
Topics: Adult; Aged; Angiography, Digital Subtraction; Biopsy; Camptothecin; Carcinoma, Hepatocellular; Chem | 2015 |
[A case of hepatic metastases from colorectal cancer in a long-term survivor undergoing local combined modality therapy for repeated local recurrences].
Topics: Aged, 80 and over; Catheter Ablation; Combined Modality Therapy; Drug Combinations; Embolization, Th | 2014 |
[Treatment of repeat TACE plus S-1 for multiple intrahepatic recurrence of hepatoma and gastric cancer].
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Drug Com | 2014 |
[A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemc | 2014 |
[A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Es | 2014 |
[A case of gastric cancer with multiple liver metastases that was successfully treated by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Cisplatin; Combined Modali | 2014 |
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combin | 2014 |
[A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy].
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Fatal Outcome; Female; Gemcitabin | 2015 |
Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 2014 |
Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Cohor | 2015 |
Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwellin | 2016 |
S-1 versus taxanes for HER2-negative metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans | 2016 |
[A Patient with Three-Year Relapse-Free Survival after Surgical Resection for Lung and Liver Metastases of Cholangiocarcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidi | 2015 |
[Liver Metastasis in a Gastric Cancer Patient--A Case of Successful Radiofrequency Ablation Combined with Degradable Starch Microspheres Transcatheter Arterial Chemoembolization].
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemoembolization, Therapeutic; C | 2015 |
[A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Human | 2015 |
[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2015 |
[Surgical Resection after Chemotherapy for Ampullary Carcinoma with Synchronous Liver Metastasis--Report of a Case].
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; | 2015 |
[A Case of Intraductal Growth Pattern Gastrointestinal Stromal Tumor of the Stomach That Was Difficult to Diagnose by Biopsy].
Topics: Aged; Antineoplastic Agents; Biopsy; Drug Combinations; Gastrectomy; Gastrointestinal Stromal Tumors | 2015 |
[A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2015 |
[A Case of Successful Treatment of Metachronous Liver Metastasis from Gastric Cancer with Hepatectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Ga | 2015 |
[Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2015 |
[A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2015 |
[A Case of Sigmoid Colon Cancer with Synchronous Liver Metastasis, Treated with Laparoscopic Liver Resection after SOX plus BV Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Drug Combinations; Fema | 2015 |
[A Case of Repeat Liver Resection after Laparoscopic Resection of a Synchronous Liver Metastasis of Colon Cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 2015 |
[Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxyc | 2015 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
Complete Response Obtained with S-1 Plus CDDP Therapy in a Patient with Multiple Liver Metastases from Gastric Cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisp | 2015 |
Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Drug Combination | 2016 |
[Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxy | 2016 |
Repeated Hepatectomy for Recurrent Intrahepatic Cholangiolocellular Carcinoma: Report of a Case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cholangiocarcinoma; Deoxycyt | 2016 |
[A Patient with Stage IV Advanced Gastric Cancer with Multiple Liver Metastases Living for More Than 6 Years after Treatment with TS-1 Alone].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Middle Aged; Neop | 2016 |
[A Case of Long-Term Survival after Combination Therapy for Gastric Cancer with Synchronous Multiple Liver Metastasis].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Hepatectomy | 2016 |
Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; H | 2017 |
[A Case of Locally Advanced Gallbladder Cancer That Developed Early Multiple Liver Metastasis after Curative Resection, and Achieved Long-TermPartial Remission Using S-1 and Gemcitabine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinatio | 2016 |
[A case of interstitial pneumonia induced by S-1/irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2008 |
[A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combina | 2008 |
[A case of Stage IV gastric cancer with liver and peritoneal metastases responding completely to tailored S-1/CPT- 11 combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Drug Combinat | 2008 |
[A case of advanced gastric cancer with multiple liver metastases completely responding to combination of paclitaxel and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastroscopy; Humans; Live | 2008 |
[A case of peritoneal disseminated sigmoid colon cancer with liver metastasis responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Humans; | 2008 |
[A case of simultaneous hepatic metastases of ascending colon cancer responding completely to tegafur/uracil plus oral Leucovorin therapy after primary lesion resection].
Topics: Administration, Oral; Aged, 80 and over; Colonic Neoplasms; Female; Humans; Leucovorin; Liver Neopla | 2008 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single-drug S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biomarkers, Tumor; Drug C | 2008 |
Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2008 |
Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 2008 |
[Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; | 2008 |
[Marked efficacy of S-1 against hepatic metastasis of multiple drug-resistant breast cancer--a report of 2 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Drug Comb | 2008 |
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Bone Neoplasms; Bre | 2009 |
[A case of multiple liver metastases of sigmoid colon cancer responding well to UFT+Leucovorin therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; M | 2008 |
Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Com | 2008 |
[A case of early recurrence with multiple liver metastases after curative operation of gastric cancer successfully treated by S-1/CDDP combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2008 |
[A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptotheci | 2008 |
Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Combination | 2008 |
[Regression of metastatic hepatic cancer from gastric cancer by polysaccharide K and UFT administration--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Humans; Liver Neoplasms; Ma | 2008 |
[A case of liver and lung metastases in gastric cancer successfully treated with S-1 and paclitaxel mono-therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Liver Neoplasms; Lu | 2008 |
[A case of unresectable advanced gastric cancer successfully treated with continuous S-1 + CPT-11 chemotherapy accompanied by dose reduction against grade 4 hematological adverse event].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Blood Cell Count; Camptothecin; Cell P | 2008 |
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Deoxycytidine; Drug Combinations; | 2008 |
[A case of advanced sigmoid colon cancer performed resection of liver metastases after long-term control by S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Drug Combina | 2008 |
[A case of simultaneous double cancers with multiple liver metastases responding to S-1+CPT-11].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoembryonic Antigen | 2009 |
[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Fata | 2009 |
Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 2009 |
[A case of complete response (CR) persisting for 3 years and 3 months from combination therapy of S-1 and CDDP in a patient with advanced gastric cancer with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Combinations; Humans; | 2009 |
[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Drug Co | 2009 |
[A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2009 |
The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Kaplan-M | 2009 |
Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expres
Topics: Administration, Oral; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality T | 2009 |
[A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2009 |
[A case of disease-free survival with low-dose chemotherapy after resection of hepatic and pulmonary metastases from rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Hepatectomy; Humans; Liver Ne | 2009 |
[A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[A case of recurrent gastric cancer during adjuvant chemotherapy with S-1, treated by S-1 combination chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, A | 2009 |
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2009 |
[Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 2009 |
[Effect on neoadjuvant chemotherapy using s-1 for unresectable liver metastasis from rectal cancer-a case report].
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Drug Combinations; Female; Hepatectomy; Huma | 2009 |
Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2009 |
[A case of chemo-radiation therapy with high degree of efficacy for esophageal cancer with liver metastasis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2009 |
[A case report of multiple liver metastases from colorectal cancer effectively treated with systemic chemotherapy and hepatic arterial infusion].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2009 |
[A long-term survival case of liver metastasis of gastric cancer under interdisciplinary therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of metachronous liver metastasis from gastric cancer treated with multidisciplinary therapy including hepatectomy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Catheter Ablation; Cis | 2009 |
[A case of advanced gastric cancer with liver metastases resected successfully after S-1 monotherapy and S-1/CDDP combination chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neo | 2009 |
[A case of complete response to S-1 therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Hu | 2009 |
[A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 2009 |
[A case of acinar cell carcinoma of pancreas with liver metastases treated effectively by S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Acinar Cell; Drug Combinations; Gastrectomy; Hepat | 2010 |
[A case of advanced gastric cancer with multiple liver metastases completely responding long term to paclitaxel plus S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Combinations; Gastrec | 2010 |
[Successful treatment with S-1 + CPT-11 for hepatic metastasis from gastric cancer--a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Combina | 2010 |
[Liver metastasis from sigmoid colon cancer showed a complete response to S-1 after recurrence with FOLFOX6 treatment].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2010 |
Therapy and prognostic features of primary clear cell carcinoma of the liver.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; | 2010 |
[Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Catheter Ablation; C | 2010 |
[A case of complete response after treatment with UFT and leucovorin for synchronous multiple liver metastases of rectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovorin; Liver Neoplasms; Magneti | 2010 |
[A case of multiple pulmonary and remnant liver metastases of hepatocellular carcinoma (HCC) after partial hepatic resection remarkably responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2010 |
[A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoembryonic Antigen | 2010 |
[A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Hepatectomy; Humans; Liver Neopl | 2010 |
[A case of fluoropyrimidine-resistant recurrent colon cancer successfully treated with weekly administration of irinotecan].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic Antigen; Coloni | 2010 |
[A case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of UFT-E].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biom | 2010 |
[Long survival of a colon cancer case with synchronous multiple liver metastases responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; | 2010 |
[A case of breast cancer with multiple hepatic metastasis successfully treated with S-1/PTX and S-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; | 2010 |
[A case of recurrence with liver metastasis after total gastrectomy for StageIA gastric carcinoma successfully treated with S-1/CDDP combination followed by S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2010 |
[A case of long-term survival after undergoing S-1 treatment and splenectomy for liver, lung and splenic metastases following curative distal gastrectomy for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; | 2010 |
[A case of hepatocellular carcinoma with portal vein thrombus(Vp3)and lung metastases(stage IVB),which responded completely to treatment with Tegafur/Uracil].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Humans; Liv | 2010 |
[A case of luminal B recurrent breast cancer with liver and lymph node metastases successfully treated with combination therapy of S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophageal Neoplasms; | 2010 |
[Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metastases after downstaging with S-1 monotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Liver Neoplasms; Male; Neoplasm St | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentin | 2010 |
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma.
Topics: AC133 Antigen; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Pr | 2011 |
[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Com | 2010 |
[S-1+gemcitabine (GEM) therapy effective in a case of pancreatic body cancer with multiple liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Female; Gemc | 2010 |
[A case report of advanced gallbladder cancer with multiple liver metastases effectively treated by concentrated therapy with S-1].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxo | 2010 |
[A case of advanced rectal cancer with multiple liver metastases successfully treated by perioperative administration of UFT and oral leucovorin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 2010 |
[A case of liver metastasis of pancreatic acinar cell carcinoma treated with S-1 and intra-arterial CDDP combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Acinar Cell; Cisplatin; Drug Combinations | 2010 |
[A case of AFP-producing gastric cancer with hepatic metastases that accompanied early gastric cancer treated effectively by chemotherapy].
Topics: Aged; alpha-Fetoproteins; Drug Combinations; Humans; Liver Neoplasms; Oxonic Acid; Stomach Neoplasms | 2010 |
[A case of multi-drug resistant breast cancer with liver metastasis treated effectively by S-1 monotherapy].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Combinations; Dru | 2010 |
Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Hepatocel | 2010 |
[Long-term survival of patient with gastric cancer treated by S-1 + paclitaxel combination chemotherapy against multiple liver metastases after gastrectomy and adrenalectomy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2010 |
[A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis].
Topics: Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Disease-Free Survival | 2010 |
[A case of elderly advanced gastric cancer patient with multiple liver metastases effectively treated by hepatic arterial infusion chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Ph | 2010 |
[A case of gastric endocrine cell carcinoma with liver metastases treated with S-1/CDDP].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ant | 2010 |
[A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, | 2010 |
[Hepatic resection after systemic chemotherapy for liver metastasis of colorectal cancer].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Hu | 2010 |
[A case of unresectable multiple hepatic metastases from colorectal cancer successfully treated with IRIS (S-1, CPT-11) therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2010 |
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Thera | 2010 |
Retrospective cohort study on the safety and efficacy of bevacizumab with chemotherapy for metastatic colorectal cancer patients: the HGCSG0801 study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2011 |
[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2011 |
[A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Acinar Cell; Deoxycytidine; Drug | 2011 |
[A case of synchronous hepatic and multiple pulmonary metastases from rectal cancer responding completely to UFT therapy after resection of primary and hepatic lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Liver Neo | 2011 |
[Retroperitoneal metastasis of hepatocellular carcinoma - a case report].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
[A resected case of advanced gastric cancer with multiple liver metastasis successfully treated by preoperative and postoperative S-1/CPT-11 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Combined Modality Therap | 2011 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
[A case of advanced gastric cancer with multiple liver metastasis responding to S-1 and irinotecan combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug Combin | 2011 |
[Three cases effectively treated with S-1 therapy for liver metastasis of breast cancer in long term].
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Combinations; Female; Humans; Liver Ne | 2011 |
[A case of UFT-induced complete response against multiple lung metastases of hepatocarcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neopl | 2011 |
[A case of liver metastasis from gastric cancer responding to S-1/CDDP chemotherapy, allowing partial gastrectomy and left hepatectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2011 |
[A case of gastric cancer with liver metastasis had a good reaction to S-1/CDDP chemotherapy after S-1 chemotherapy was ineffective].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Synergism; Female | 2011 |
[A case of synchronous multiple liver metastases of rectal cancer successfully treated with tegafur/uracil and oral leucovorin chemotherapy].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combi | 2011 |
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2013 |
[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2011 |
Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Drug C | 2011 |
[Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxyc | 2011 |
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Female | 2011 |
[A case of long-term survival after curative resection of advanced rectal cancer treated by pre-operative chemoradiotherapy].
Topics: Antimetabolites, Antineoplastic; Chemoradiotherapy; Drug Combinations; Female; Humans; Liver Neoplas | 2011 |
[A case of laparoscopic radiofrequency ablation for liver metastatic tumor from colorectal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Colonic Neoplasms; Female; | 2011 |
[Curative resection of gallbladder cancer with simultaneous liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug | 2011 |
[A case of intrahepatic recurrence of intrahepatic cholangiocarcinoma treated with repeated hepatectomy].
Topics: Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; | 2011 |
[A case of complete response to interferon-α and S-1 combination therapy for multiple pulmonary recurrences of hepatocellular carcinoma after hepatic resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; | 2011 |
[A case of successful surgical resection followed by S-1 administration for hepatocellular carcinoma with lung metastases and a tumor thrombus into right atrium].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dr | 2011 |
[A case of advanced gastric cancer with liver metastases successively treated with S-1/CDDP combination therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Drug Combinations; Humans; | 2012 |
[A case of stage IV gastric cancer with multiple liver metastases responding to chemotherapy with weekly PTX after failure of chemotherapy with S-1 and CDDP combination].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cispl | 2012 |
[Marked response to oral administration of UFT and leucovorin for liver metastases from colon cancer in an elderly patient].
Topics: Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neo | 2012 |
Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Deoxycytidine; Dru | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
[A case of remnant liver metastases after resection of liver metastases from rectal cancer following treatment with 5-FU, L-OHP and CPT-11, with markedly effective treatment by cetuximab plus S-1].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2012 |
Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapy.
Topics: Administration, Metronomic; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Mon | 2012 |
[A case of advanced gastric cancer with multiple liver metastases that achieved long-term survival on monotherapy of S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Bronchiectasis; Drug Combinations; Fatal Outcome; Female; Hum | 2012 |
Programmed chemotherapy for patients with metastatic unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; | 2012 |
[A case of multiple liver metastases of gastric cancer successfully treated by combination chemotherapy of S-1 and paclitaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans | 2012 |
Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera | 2012 |
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Hepatocellular; Combined Modalit | 2012 |
[A case of liver metastases of sigmoid colon cancer treated effectively by oral UFT/LV].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Leucovor | 2012 |
[A case of pathological complete response after chemotherapy for liver metastasis with subcapsular hemorrhage from gastric cancer:].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2012 |
[A case report of S-1 monotherapy for advanced hepatocellular carcinoma].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Fatal Outcome; | 2012 |
[Effective multidisciplinary therapy mainly using S-1+ gemcitabine (GEM) for a case of pancreatic body cancer with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug | 2012 |
[A case of successful treatment of granulocyte colony-stimulating factor producing hepatocellular carcinoma accompanying type B hepatitis with tegafur-uracil].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, H | 2012 |
[A case of far-advanced gastric cancer successfully treated with S-1/paclitaxel/krestin immunochemotherapy, followed by curative resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Immunotherapy; Li | 2012 |
[A case of postoperative liver metastasis from pancreatic carcinoma treated with percutaneous isolated hepatic perfusion(PIHP)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Doxo | 2012 |
[A case of diffuse hepatocellular carcinoma(Vp4) treated by right hepatic trisegmentectomy and multidisciplinary therapy regimens].
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Fatal Outcome; Female; Hepa | 2012 |
[A patient with multiple liver metastases of gastric and rectal cancers after laparoscopic sigmoidectomy who responded completely to S-1 therapy followed by open gastrectomy].
Topics: Aged; Antimetabolites, Antineoplastic; Colectomy; Combined Modality Therapy; Drug Combinations; Gast | 2012 |
[A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent].
Topics: Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cisplatin; Drug Combinations; Ei | 2012 |
[A case of gastric neuroendocrine carcinoma with liver metastasis and portal vein invasion successfully treated by S-1 and cisplatin chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Drug C | 2013 |
[Questions on "gemcitabine plus S-1 combination therapy (G-S therapy) for pancreatic cancer with accentuated hepatic metastasis" (by Matsumoto, T. et al) published on Japanese Journal of Gastro-enterology Vol. 108, N0. 12].
Topics: Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Gemcitabine; Humans; Liver Neoplasms; O | 2013 |
[Pathological complete remission using low-dose cisplatin plus S-1 for gastric cancer patient with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Com | 2013 |
[A case experienced long-term survival after repeat hepatectomy for liver metastases from gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Hepatectomy; Hu | 2013 |
[Clinical study of individual TS-1 therapy for inoperable gastric cancer].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Femal | 2002 |
[A novel combined chemotherapy using TS-1 and low-dose cisplatin against liver metastasis of gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
[CPT-11 hepatic arterial injection plus oral UFT administration for liver metastasis of rectal cancer--report of two cases].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptoth | 2002 |
[Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combine | 2002 |
[A case of unresectable rectal cancer with liver and pulmonary metastases that responded remarkably to pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 2002 |
Advanced gastric cancer with liver metastases successfully treated with S-1.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neop | 2002 |
[A patient with hepatocellular carcinoma with intraperitonial lymph node metastases in whom oral UFT treatment was markedly effective].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2002 |
[A case of multiple liver metastases from colon cancer successfully treated with modified pharmacokinetic modulating chemotherapy using Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Col | 2002 |
[A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Dru | 2002 |
[5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |
[A case of metastatic gastric cancer treated with CDDP plus TS-1 and surgical resection].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bio | 2002 |
[Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combina | 2002 |
[A case of stomach cancer in which TS-1 neoadjuvant therapy was effective against multiple hepatic metastasis, allowing a radical cure A surgery].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combi | 2002 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto | 2003 |
[A case of advanced pancreatic cancer with multiple liver metastasis that improved remarkably with use of low-dose cisplatin and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationshi | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2003 |
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Drug Evaluation; Fe | 2003 |
Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; D | 2003 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd | 2003 |
[Remnant gastric cancer in which prolonged no change status was maintained with low-dose TS-1--a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellul | 2003 |
[A case of advanced gastric cancer with lymphangitis carcinomatosa of the lung, successfully treated with paclitaxel and TS-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Drug Resistance, | 2003 |
[A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2003 |
[Four cases of gastric cancer with multiple hepatic metastases successfully treated with TS-1 in combination with low-dose cisplatinum].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2003 |
[A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; | 2003 |
[A case of multiple liver metastases from colon cancer successfully treated with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neop | 2003 |
[A case of hepatocellular carcinoma treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver N | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2003 |
[A case of distant metastasis from advanced gastric cancer treated with TS-1, which maintained NC (no change) for 9 months].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Deh | 2003 |
[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 2003 |
[A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasm | 2003 |
[Pancytopenia and ARDS with high dose hepatic arterial infusion].
Topics: Aged; Antimetabolites, Antineoplastic; Cisplatin; Drug Combinations; Female; Fluorouracil; Gastrecto | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding completely to hepatic arterial infusion and systemic chemotherapies].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoth | 2003 |
[A case of malignant gastric outlet stenosis palliated with self-expandable metallic stent and responding to TS-1, an oral fluorouracil derivative].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gastric Outlet Obstruction; Humans; Liver Neopla | 2004 |
[A case of gastric cancer with multiple liver metastases and spleen metastasis that responded to low-dose CDDP/TS-1 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2004 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Common Bile Duct; Drug Administrat | 2004 |
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucos | 2004 |
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
Topics: Animals; Apoptosis; Deoxyribose; Drug Therapy, Combination; Interleukin-8; Liver Neoplasms; Male; Mi | 2004 |
[A case of gastric cancer with a synchronous hepatic metastasis responding to postoperative oral administration of UFT and intermittent intrahepatic arterial chemotherapy of 5-FU].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Adm | 2004 |
[Two cases of advanced and recurrent gastric cancer responding markedly to TS-1/CDDP therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2004 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Coloni | 2004 |
[A case of gastric cancer with multiple liver metastases responding completely to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Sch | 2004 |
[A case of complete response in a primary lesion treated by combined chemotherapy of TS-1 and CDDP for small cell carcinoma of the stomach with liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Adminis | 2004 |
[Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Administration Schedu | 2004 |
[A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; B | 2004 |
[A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Adminis | 2004 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Ad | 2004 |
[A case of effective treatment of oral TS-1 and intravenous MMC administration for multiple metastases of gastric cancer].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Che | 2004 |
Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.
Topics: Administration, Oral; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Kidney | 2004 |
[A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab].
Topics: Administration, Oral; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplast | 2004 |
[A case of giant hepatocellular carcinoma treatable with radio frequent ablation therapy after effective UFT administration].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2004 |
Oral administration of uracil-tegafur (UFT) inhibits liver micrometastasis of human colon cancer in an orthotopic nude mouse model and its early detection system.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2004 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[A case report of the 8 year survivor--unresectable liver metastases from advanced gastric cancer (Stage IV) were completely responsive, after 4 years from a total sequential gastrectomy, combining docetaxel treatment to regress the recurrence].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Do | 2004 |
[Three successful case reports of advanced gastric cancer with chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antig | 2004 |
[Case report--Complete response of liver metastasis of rectal cancer after combination chemotherapy of CPT-11 + UFT-E].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Humans; | 2004 |
[The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dr | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined | 2004 |
[A case of long-term survivor with multiple pulmonary metastases of HCC after hepatic resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Combinati | 2004 |
[TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Admi | 2004 |
[A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 2004 |
[Clinical efficacy of TS-1 combined with cisplatin for advanced cardiac gastric cancer with multiple liver metastases--two case reports].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Drug Admini | 2004 |
[Two cases of gastric cancer with multiple liver metastases responding to TS-1 with hepatic arterial infusion of CDDP following low-dose 5-FU and CDDP chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relat | 2005 |
[A case of hepatocellular carcinoma with bone metastasis treated by TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cisplatin | 2005 |
[A case of liver metastases from cecal cancer successfully treated with fluorouracil and folinic acid (UFT/LV)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, | 2005 |
[Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2005 |
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Adm | 2005 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Fem | 2005 |
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherap | 2005 |
[A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2005 |
[A case of curatively resected AFP producing gastric cancer that responded remarkably to 1 course of TS-1 and showed complete loss of multiple liver metastatic tumors].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Combined Modality Therapy | 2005 |
[Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dr | 2005 |
[Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report].
Topics: Adenocarcinoma; Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocol | 2005 |
The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemo | 2006 |
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined | 2005 |
[Effective treatment of unresectable advanced gastric cancer by TS-1-based chemotherapy with a sequential combination of cisplatin (CDDP) and paclitaxel (PTX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of gastric cancer with liver invasion responding to TS-1/low-dose CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[A case of advanced gastric cancer with obstructive jaundice that responded to TS-1/CPT-11 combination therapy after percutaneous transhepatic cholangio drainage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract; Camptothecin; Combined Modality Thera | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combi | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colect | 2005 |
[A case of multiple hepatic and peritoneal metastases from colon cancer responding to oral UFT+leucovorin chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Col | 2005 |
[A case of advanced gastric cancer with liver and lung metastases markedly responded to TS-1-based sequential chemotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplasti | 2005 |
[A case of gastric cancer with liver metastasis resected after the combination chemotherapy with CDDP and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2005 |
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combine | 2005 |
[Hepatic arterial infusion (HAI) chemotherapy achieved a complete response (CR) for multiple liver metastases of colorectal cancer--two case reports].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic C | 2005 |
[A successful surgical treatment for solitary pulmonary and adrenal metastases after hepatic resection to hepatocellular carcinoma--a case report].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2005 |
[A case of gastric cancer with multiple liver metastases effectively treated by hepatic arterial infusion of MMC, TS-1/CDDP therapy, and thermotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2005 |
[A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2005 |
[Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2005 |
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Dru | 2005 |
[A case of AFP-producing gastric cancer with multiple liver metastasis responding to TS-1 and cisplatin combination chemotherapy].
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug | 2005 |
[Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
[A case report of poorly-differentiated adenocarcinoma in sigmoid colon cancer with liver and pulmonary metastasis responding to TS-1 and CPT-11].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
[Liver metastasis from sigmoid colon cancer with peritoneal dissemination showed a complete response to TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryoni | 2006 |
[A case of liver metastasis successfully treated with S-1 monotherapy in the patient with recurrent breast cancer].
Topics: Anthracyclines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Bridged-Ri | 2006 |
[Two patients effectively treated with S-1 therapy for liver metastasis of breast cancer resistant to other anticancer drugs].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2006 |
[A 6-year-survival case of esophageal adenosquamous cancer with liver metastases cured by multidisciplinary therapy].
Topics: Aged; Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 2006 |
[A case of gastric cancer with multiple liver metastases resistant to TS-1 responding to chemotherapy with paclitaxel plus doxifluridine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administrat | 2006 |
[Successful bi-weekly paclitaxel treatment of an AFP-producing gastric cancer patient with peritoneal dissemination and multiple liver metastasis].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Adminis | 2006 |
[Pancreatic acinar cell carcinoma successfully treated with combination of oral TS-1 and intra-arterial cisplatin].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Acinar Cell; Cispla | 2006 |
[A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Co | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimi | 2006 |
[S-1 treatment against advanced HCC].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2006 |
[Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration | 2006 |
[A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Small Cell; Combined Modality Therapy; Drug Admini | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[Multiple hepatic metastases of colon cancer responding to combined therapy with TS-1 and CPT-11--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasm | 2006 |
[A case of advanced gastric cancer with liver metastasis completely responding to CPT-11+low-dose 5-FU+CDDP chemotherapy].
Topics: Adenocarcinoma; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardi | 2006 |
[A case of rectal cancer with multiple liver metastases responding to TS-1].
Topics: Adenocarcinoma; Ambulatory Care; Antimetabolites, Antineoplastic; Biomarkers, Tumor; CA-19-9 Antigen | 2006 |
[A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic | 2006 |
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Combined Mod | 2006 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combin | 2006 |
[A resected case of advanced gastric cancer with multiple liver metastasis responding to preoperative TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubic | 2006 |
[Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Anemia; Antimetabolites, Antineoplastic; Drug Administra | 2006 |
[Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Drug Administra | 2006 |
[Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
Topics: Adenocarcinoma; Aged; Anorexia; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; | 2006 |
[Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Deoxycytidine; | 2006 |
[Partial response of liver metastasis from colon cancer following intermittent oral administration of TS-1 after intra-hepatic arterial single injection of CDDP, doxorubicin and 5-FU].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2006 |
A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Dihydrouracil Dehy | 2006 |
[Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
Topics: Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; | 2006 |
[A case of colon cancer liver metastases treated by combined therapies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemotherapy, Adjuvant; Colon, Si | 2006 |
[CR of rectal cancer and synchronous liver and lung metastases obtained with TS-1 plus CPT-11 combination therapy--case report].
Topics: Adenomatous Polyposis Coli; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Com | 2007 |
Remission of primary duodenal adenocarcinoma with liver metastases with S-1 chemotherapy.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Duodenal Neoplasms; Female | 2007 |
[Retrospective analysis of clinical results in eight patients with advanced hepatocellular carcinoma with lung metastases treated by TS-1].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedul | 2007 |
[A case of advanced gastric cancer with liver metastases successfully treated by combination therapy of TS-1 and docetaxel].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration | 2007 |
[A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Clinical efficacy of biweekly paclitaxel and S-1 regimen for 14 gastric cancer patients with liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Administration Schedule; Drug | 2007 |
[A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Admini | 2007 |
[A case of TS-1 resistant recurrent gastric cancer with lung metastasis responding to TS-1 and irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug | 2007 |
A case of suspected S-1 induced interstitial pneumonia.
Topics: Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Dyspnea; Female; | 2007 |
[Successful low-dose TS-1 administration in an elderly colon cancer patient with liver metastasis].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Appendiceal Neoplasms; Colonic N | 2007 |
[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluoroura | 2007 |
Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; Drug C | 2007 |
Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic C | 2007 |
[A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2007 |
[Long survival of a colon cancer case with multiple liver metastases cured by multidisciplinary therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Catheter Ablation; Cisplatin; Co | 2007 |
Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Creatinine; D | 2007 |
Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; | 2007 |
[Complete remission of hepatic metastasis of gastric cancer with CPT-11].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Administration Schedule; | 2007 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epi | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
[Complete resection of advanced gastric cancer with multiple liver metastases following a bypass operation and one year of chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2007 |
[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid | 2007 |
[A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2007 |
[Two cases of advanced extrahepatic bile duct cancer successfully treated by S-1 monotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Drug | 2007 |
A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2007 |
Successful preoperative chemotherapy with S-1 plus low-dose cisplatin for advanced gastric cancer with synchronous liver metastases: report of 2 cases.
Topics: Cisplatin; Drug Combinations; Drug Therapy, Combination; Humans; Liver Neoplasms; Male; Middle Aged; | 2007 |
[A case report of successful control of liver metastasis from duodenal cancer with combined S-1 and docetaxel chemotherapy].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combina | 2007 |
Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2007 |
[A case report--combination chemotherapy with oral UFT and CPT-11, 5-FU, l-LV by hepatic arterial infusion for multiple hepatic metastasis from sigmoid colon cancer].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2007 |
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Agents; Antineoplastic Combined Chemothe | 2007 |
[A case of complete remission(CR)persisting from UFT-E in an old patient with liver metastasis of gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Liver Neoplasms; | 2008 |
A case of gemcitabine-refractory pancreatic cancer responsive to second-line chemotherapy using S-1.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; Drug Resistance, Neoplasm; Gemcit | 2007 |
[A successful case of liver metastasis from gastric cancer treated with S-1 + induced hypertensive hepatic arterial infusion chemotherapy--a case report].
Topics: Drug Combinations; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Age | 2007 |
S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; D | 2007 |
The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Combinations; Endo | 2007 |
[A case of sigmoid colon cancer with multiple liver metastases responding to S-1].
Topics: Aged; Biomarkers, Tumor; Drug Combinations; Female; Humans; Liver Neoplasms; Oxonic Acid; Sigmoid Ne | 2008 |
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2008 |
[Therapeutic experience of S-1 plus other drug combination therapy for synchronia multiple liver metastases of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Liver Neopl | 2008 |
[A case of complete response treated by gastrectomy with lymphadenectomy and combined chemotherapy of peroral S-1 and CDDP by arterial infusion for gastric cancer with multiple liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2008 |
[A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
Topics: Administration, Oral; Angiography; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2008 |
[Effective treatment with oral administration of UFT and leucovorin (Uzel) in a patient with liver metastasis and peritoneal dissemination from cecal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Female; | 2008 |
[Multiple hepatic metastases and ovarian metastases of colon cancer responding to combined therapy with S-1 and CPT-11--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; | 2008 |
[A case of metastatic gastric endocrine cell carcinoma which could be curably resected after chemotherapy with S-1/CDDP].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Ce | 2008 |
[A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Islet Ce | 2008 |
[Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2008 |
[Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Topics: Adult; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Fluor | 1982 |
Pharmacokinetics of ftorafur after intravenous and oral administration.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorouracil; Half-Life; Human | 1983 |
[Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans | 1982 |
[Enzymatic conversion of tegafur in human tumor tissue].
Topics: Adult; Female; Fluorouracil; Humans; In Vitro Techniques; Liver Neoplasms; Middle Aged; Stomach Neop | 1983 |
[Chemotherapy of gastric cancer patients with hepatic metastases].
Topics: Administration, Oral; Antibiotics, Antineoplastic; Fluorouracil; Humans; Liver Neoplasms; Mitomycin; | 1983 |
Phase II study of orally and rectally administered Tegafur in liver metastases from gastric carcinoma.
Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Female; Fluorouracil; Humans; Liver Neoplasms; M | 1984 |
Combination of hepatic arterial infusion and systemic chemotherapy for gastric cancer with synchronous hepatic metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hepatic Artery; H | 1984 |
[Constant intra-aortic infusion chemotherapy for advanced abdominal cancer--a technic and the effect in patients with peritoneal metastases].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Coloni | 1984 |
[Clinical trials of plasma exchange therapy in patients with recurrent colon cancer].
Topics: Abdominal Neoplasms; Adenocarcinoma; Administration, Oral; Adult; Aged; Colectomy; Colonic Neoplasms | 1984 |
[Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
Topics: Administration, Oral; Adult; Aged; Capsules; Colonic Neoplasms; Delayed-Action Preparations; Drug Ev | 1984 |
Comparative efficacy of antitumor treatment for liver metastases from colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Female; Fluorouracil; Hepatic Artery; Humans; | 1981 |
[Clinical experiences with UFD-1].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 1982 |
Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Combined Modal | 1994 |
Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Che | 1995 |
[A case of remarkable response of colon cancer with multiple liver and bone metastasis treated with tegafur and cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Colonic N | 1995 |
[A case of gastric cancer with multiple liver metastasis responding to combined therapy with UFT and mitomycin C].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined | 1995 |
[A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hep | 1995 |
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Adm | 1995 |
[A case of huge liver metastasis from jejunal leiomyosarcoma completely controlled by intra-arterial and intra-portal vein infusion chemotherapy following hepatectomy].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 1994 |
[A case of small cell carcinoma of the stomach with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; | 1994 |
[A case of poorly differentiated hepatic cell carcinoma which showed 90% decrease in size after chemotherapy with intraarterial infusion of mitomycin C and oral administration of tegafur].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
[The concentration of FT in peripheral blood and portal blood after oral, intravenous or rectal administration].
Topics: Administration, Oral; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Liver Neoplas | 1994 |
[Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dr | 1994 |
[A comparative study on the serum and tissue 5-FU concentrations in patients with hepatocellular carcinoma after preoperative oral administration of UFT and 5'-DFUR].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepato | 1994 |
[A case of advanced hepatocellular carcinoma, in which the tumor almost disappeared by orally administered UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; | 1993 |
[Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report].
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Embolization, Therape | 1993 |
[A case of giant hepatocellular carcinoma effectively treated by UFT].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tum | 1993 |
[A case of hepatocellular carcinoma with portal invasion and right adrenal gland metastasis showing marked contraction of primary tumor and metastasis with treated by UFT alone].
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocell | 1994 |
Effect of 5-fluorouracil and UFT on experimental liver metastasis model of colorectal cancer using mouse colon 26 cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Drug | 1993 |
[The present status of chemotherapy for hepatocellular carcinoma].
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1993 |
Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Esophageal Neoplasm | 1993 |
[A case of gastric cancer with multiple liver metastases showing marked efficacy of preoperative and postoperative chemotherapy with CDDP, MMC and UFT(PMU), or CDDP, MMC, UFT and etoposide (PMUE)].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 1993 |
[A case of advance colon cancer responding to sequential methotrexate and 5-fluorouracil therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administrati | 1993 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cispl | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Ne | 1996 |
[A case of hepatocellular carcinoma responding to oral administration of UFT].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Drug Combinat | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosp | 1996 |
[Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseas | 1996 |
[A case of advanced gastric cancer showing complete disappearance of cancer cells in multiple liver metastases due to low-dose PMUE therapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 1996 |
[Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
Topics: Animals; Body Weight; Drug Combinations; Floxuridine; Leukemia L5178; Liver Neoplasms; Male; Mice; T | 1996 |
Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Erythema; Female; Foot Dermatoses; Hand Dermatoses; | 1997 |
[A case of advanced hepatocellular carcinoma responding to suppository of Tegafur].
Topics: alpha-Fetoproteins; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Humans; Liver Neopla | 1998 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepat | 1998 |
[Complete disappearance of metastatic pulmonary tumors in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1998 |
[A case of giant hepatocellular carcinoma effectively treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1998 |
[Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinat | 1998 |
Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1998 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Combinations; Humans; Liver Neopla | 1999 |
Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 1999 |
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report].
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neopla | 1999 |
[A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Ad | 1999 |
[Three cases of multiple liver metastases of gastric cancer responding to tegafur/low-dose CDDP/CPT-11 combination chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug | 1999 |
[A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Len | 2000 |
[A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 2000 |
[A case of complete regression of liver metastases by treatment with Futraful supposition].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Remissi | 2000 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2000 |
Complete disappearance of recurrent hepatocellular carcinoma with peritoneal dissemination and splenic metastasis: a unique clinical course after surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Drug Thera | 2000 |
[Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cisplatin; Colonic Neoplasms; Drug Combinatio | 2000 |
[A case of advanced rectal cancer with unresectable liver metastasis for which chemotherapy was markedly effective].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Combined Modal | 2000 |
[A case report of unresectable colon cancer that disappeared following pharmacokinetic modulation chemotherapy (PMC)].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug | 2000 |
[A successful case of preoperative intermittent hepatic arterial infusion of high-dose 5-FU and pharmacokinetic modulating chemotherapy against unresectable liver metastasis of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Sched | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre | 2000 |
[Three cases of liver metastasis of colon cancer responding to systemic combination chemotherapy utilizing CPT-11].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptotheci | 2000 |
[Outcomes of home anti-cancer chemotherapy--estimation of hepatic arterial infusion chemotherapy for patients with multiple liver metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Fluorouracil; He | 2000 |
Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy of alpha-interferon and oral tegafur/uracil.
Topics: Administration, Oral; Adult; Angiography; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2000 |
[A case of stage IV gastric cancer with multiple liver metastases and carcinomatous ascites responding to TS-1 for six months before progression].
Topics: Aged; Antimetabolites, Antineoplastic; Ascitic Fluid; Disease Progression; Drug Combinations; Humans | 2001 |
[Long survival in a case of unresectable hepatic metastasis from rectal carcinoma treated with second-look hepatectomy plus pharmacokinetic modulating chemotherapy (PMC)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dru | 2001 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineopla | 2001 |
[Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; | 2001 |
[A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil | 2001 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitum | 2001 |
[A case of advanced gastric cancer with multiple liver metastases in an elderly patient that responded dramatically to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modal | 2001 |
[A case of hepatic metastasis of gastric cancer responding to TS-1, administered for two consecutive weeks and one week rest].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2001 |
[A case report of rectal cancer with liver and pulmonary metastases responding to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2001 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast | 2001 |
[A case of advanced gastric cancer producing alpha fetoprotein with multiple liver metastases responding to TS-1 after TAE].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Drug Administration Sched | 2001 |
[A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Dru | 2002 |
[A patient with advanced gastric cancer in the gastric tube whose QOL was improved by TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2002 |
[A case of complete response (CR) persisting for 2 years and 10 months from UFT-E in a patient with liver metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administr | 2002 |
[A case of liver metastasis of rectal cancer demonstrating complete response to 5-FU + Leucovorin + UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug C | 2002 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
[A case of gastric cancer with multiple liver metastases responding to TS-1].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Dru | 2002 |
[A case of rectal cancer with multiple liver metastases that responded dramatically to pharmacokinetic modulating chemotherapy/CPT-11 therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Hepatic Artery; | 2002 |
[Successful treatment of gastric cancer accompanied by multiple liver metastases with TS-1 followed by curative gastrectomy affiliation].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Liver Neop | 2002 |
Futraful therapy on liver cancer.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Carcinoma, Hepatocellular; Drug Administrat | 1977 |
[Characteristic pharmacodynamic in 1-(2-tetrahydrofuryl)-5-fluorouracil metabolism and its clinical efficacy in patients with primary hepatoma (author's transl)].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Li | 1978 |
Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fluorouracil; Humans; Indomethacin; Kinetics; Liver Cirrhosis; Liver Neop | 1979 |
[A case of gastric cancer with multiple liver metastasis treated with transarterial and transportal chemoembolization of tegafur/lipiodol and epirubicin].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therap | 1992 |
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.
Topics: alpha-Fetoproteins; Analysis of Variance; Antineoplastic Agents; Ascites; Bilirubin; Carcinoma, Hepa | 1992 |
[Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembr | 1992 |
[PMUE therapy (CDDP, MMC, UFT, etoposide) for advanced gastric cancer--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; | 1992 |
[A case of gastric cancer with multiple liver metastases effectively treated with PMUE (CDDP, MMC, UFT, etoposide) hepatic arterial chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administrati | 1992 |
[Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Humans; Liv | 1992 |
[Pharmacokinetic study of tegafur in the hepatic tissue obtained from the patients with liver cancer].
Topics: Aged; Colonic Neoplasms; Fluorouracil; Humans; Liver; Liver Neoplasms; Middle Aged; Stomach Neoplasm | 1992 |
[A case of advanced gastric cancer with liver metastasis completely responding to a combined immunochemotherapy with UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Lentinan; Liver Neopla | 1992 |
[A resected case of advanced gastric cancer with complete remission of liver metastasis by chronic daily administration of oral etoposide and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sche | 1992 |
Hepatocellular carcinoma response to low-dose oral tegafur.
Topics: Administration, Oral; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Remissi | 1991 |
[Rupture of hepatocellular carcinoma with multiple pulmonary metastasis successfully treated by transcatheter arterial embolization (TAE) of tumor: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, | 1991 |
[A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur].
Topics: Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carcino | 1990 |
[Complete response in a case of rectal carcinoma with multiple liver metastasis treated by infuse-a-port].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatic Artery; Humans | 1991 |
Effects of combined therapies with protein-bound polysaccharide (PSK, Krestin) and fluorinated pyrimidine derivatives on experimental liver metastases and on the immunologic capacities of the hosts.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; | 1991 |
Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclopho | 1991 |
[Antitumor activity of T-506, a novel synthetic FUDR derivative, on murine colon cancer and its hepatic metastasis].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; F | 1991 |
[Regional immunochemotherapy for liver metastasis of esophageal cancer in a patient with variant hepatic artery].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 1991 |
[Effect of UFT by oral administration using a murine hepatic metastasis model].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Hu | 1991 |
[Clinical experiences with hyperthermochemotherapy of hepatic metastasis from gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Moda | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Humans; Liver Ne | 1991 |
Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neop | 1991 |
Successful treatment of a metastatic hormone-producing adrenal cancer by a combination of mitotane, tegafur and surgical resection.
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Gland Neoplasms; Adult; Aldosterone; Androstenedione; Antineop | 1990 |
[Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Human | 1990 |
[Results of prophylactic intra-arterial infusion chemotherapy after hepatic resection in colorectal metastases].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorour | 1990 |
The effect of UFTM therapy on primary and metastatic colon cancer from the same human xenotransplanted into nude mice.
Topics: Adenocarcinoma, Mucinous; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Colo | 1990 |
[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality T | 1990 |
[The preoperative embolization of the hepatic artery in patients with malignant liver tumors].
Topics: Adult; Catheterization, Peripheral; Combined Modality Therapy; Embolization, Therapeutic; Evaluation | 1990 |
[A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Live | 1988 |
[Conservative treatment of malignant liver tumors].
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Methotr | 1989 |
[A case of biliary tract obstruction due to metastatic hepatic cancer, in which topical injection of CDDP and ADM into PTCD with concomitant use of UFT resulting in partial reopening of biliary tract].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Catheters, Indwelling; Cho | 1989 |
[Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Fluo | 1989 |
[Successful therapy with tegafur and lentinan after TAE for hepatocellular carcinoma--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Embolization, Therapeutic | 1989 |
[Almost complete disappearance of metastatic pulmonary tumor and reduction of the main hepatic mass in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Fem | 1987 |
[A case of hepatocellular carcinoma with extrahepatic portal vein obstruction due to tumor invasion, responsive to oral administration of UFT].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellul | 1987 |
[5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Fluoro | 1987 |
[A case of primary hepatoma with marked reduction of the tumor after oral administration of tegafur].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Administration Schedule; Humans; Liver Neoplas | 1988 |
[Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality T | 1987 |
[Anticancer effect of UFT in intrahepatic recurrence with tumor embolus in the left portal vein after hepatectomy of hepatoma--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Hepatectomy; Humans | 1988 |
[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Brain Diseases; Carcinoma, Hepatocell | 1988 |
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Fluorouracil; | 1985 |
A controlled study of intravenous doxorubicin versus oral tegafur in patients with hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Doxorubicin; Drug Evaluation; Female; Humans; | 1985 |
Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
Topics: Administration, Oral; Aged; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neop | 1985 |
[Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
Topics: Administration, Oral; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Fluorouracil; | 1985 |
[Systemic chemotherapy of hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1986 |
[Maintenance chemotherapy by UFT after trans-arterial embolization for hepatocellular carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy | 1986 |
[An unresectable case of hepatoma completely disappearing after oral administration of an anticancer drug (UFT)].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1986 |
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; L | 1987 |
[Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Adminis | 1987 |
[FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bile; Carcinoma, Hepatocellula | 1987 |
Hepatic conversion of 1-(tetrahydro-2-furanyl)-5-fluorouracil into 5-fluorouracil in patients with hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Drug Therapy, Computer-Assisted; Fluorouracil; Humans; In Vitro Tec | 1987 |
[Effects of preoperative administration of UFT in gastrointestinal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Humans; Kine | 1986 |
[Effects of oral administration of UFT in unresectable gastric cancer with liver metastasis].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Liver Neoplasms; Male; Middl | 1986 |
[Study of chemotherapy in the field of internal medicine--clinical experience with SF-SP].
Topics: Administration, Oral; Aged; Breast Neoplasms; Colonic Neoplasms; Delayed-Action Preparations; Drug A | 1986 |
Tegafur chemotherapy for the treatment of gut and liver cancer.
Topics: Adult; Aged; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lymphatic Metastasis; Male | 1986 |
[Effects of regional hyperthermia on metastatic carcinoma of the liver].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; | 1986 |
[A case of relapsed gastric cancer treated successfully by chemotherapy--lung metastasis and relapsed cancer in the hepatic portal system].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Humans; Liver | 1986 |
[A case of remarkable regression of a colonic cancer involving metastasis to the liver as a result of FT-207 treatment].
Topics: Adenocarcinoma; Antineoplastic Agents; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Sigmoi | 1988 |
[Changes in CT findings in patients with liver metastases of breast cancer during effective intra-arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Humans; Infusion Pump | 1988 |
[Effects of UFT on experimental liver metastases and on the immunologic capacity of the hosts].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Immune Tolera | 1988 |
[Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusion | 1988 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabi | 1985 |
[A case of complete regression of gastric carcinoma and liver metastases by treatment with tegafur].
Topics: Adenocarcinoma; Aged; Fluorouracil; Humans; Liver Neoplasms; Male; Stomach Neoplasms; Tegafur | 1985 |
[Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
Topics: Biliary Tract Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lymph Nodes; Pancreatic Neoplasms; P | 1985 |
Long-term survivors of colorectal cancer with unresectable hepatic metastases.
Topics: Administration, Oral; Aged; Carcinoembryonic Antigen; Colonic Neoplasms; Female; Fluorouracil; Human | 1985 |
[A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administr | 1985 |
[A case of long-term survival of liver metastasis of breast cancer successfully treated with chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Cy | 1985 |